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ABSTRACT
Proliferative responses of normal rat ventral prostate 
in vitro . were investigated using the incorporation of 
5-E*2^l]-iodo-2,-deoxyuridine (12^I-UdR) to monitor DNA 
synthesis, with the aim of establishing a model system for 
evaluating the direct effects of hormones and chemotherapeutic 
agents on prostatic growth. In androgen-free, chemically- 
defined organ culture, the proliferative activity of young 
adult rat (4 to 6 months old) ventral prostate declined with 
time and the tissue underwent retrogressive changes resembling 
post-castration atrophy in vivo. Treatment with testosterone 
(4 x 10 to 4 x exhibited a dose-dependent response,
with concentrations ranging from 4 x 10** to 4 x 10 
preventing the retrogressive changes associated with androgen 
deprivation and eliciting maximal increases (approximately 
3-fold) in 12^I-UdR uptake. Higher testosterone concentrations 
(2,5 x IO*5 to 4 x 10“5M) exerted a non-specific cytotoxic 
effect, resulting in marked suppression of 125I-UdR uptake. 
Following stimulation with an optimal concentration of 
testosterone (4 x 10*"m), 125I-UdR incorporation reached peak 
activity on day 4 of the culture period and rapidly declined 
thereafter, despite the continued presence of testosterone. 
Effects of variations in organ culture media ' and methodology 
were also examined to further establish optimal conditions 
for investigations of the proliferative response to testosterone 
stimulation.
The established method of quantitative organ culture was 
then used to compare the proliferative effect of testosterone 
with that of its major metabolites, 5^-dihydrotestosterone, 
androstenedione, androstanedione and 5c-aadrostane-3^, 1?y~diol.
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1ABBREVIATIONS AND SYMBOLS
A-3,17-dione 
A-3£,17/$-diol 
A^-A-3,17-dione
androstanedione 
androstane-3/$» 17/3-diol
androstenedione
BPH benign prostatic hyperplasia
°C
CBG
cc
Ci
C°2
CPM
degrees centrigrade
corticosteroid binding globulin 
cubic centimetre
curie
carbon dioxide
counts per minute
DHT 5<*-dihydrotestosterone
5/5-DHT 5/3-dihydrotestosterone
DNA deoxyribonucleic acid
DNase deoxyribonuclease
E2-17/$ oestradiol-17^
FCS foetal calf serum
g gram
h hour
HEPES N-2-hydroxyethyl-piperazine-N’-
2-ethane sulphonic acid
IU international unit
212^I-UdR 5-^25iodo-2’-deoxyuridine
L laevo
LH lutenizing hormone
LH-RF lutenizing hormone-releasing 
factor
LS 275 estramustine
LS 299 estramustine phosphate; Estracyt 
(free acid)
LS 299Z estramustine phosphate sodium; 
Estracyt (disodium salt)
M molar
mg milligram
ml millilitre
mm millimetre
mM millimolar
3mnr cubic millimetre
mmole millimolar
MW molecular weight
^Ci microcurie
^g microgram
/Lll microlitre
/zm micrometre
n number of replicate experiments
N normal
NaOH sodium hydroxide
NPH nodular prostatic hyperplasia
PAS periodic-acid Schiff
3RNA ribonucleic acid
rpm revolutions per minute
SBP sex steroid binding plasma protein
s.e.m. standard error of the mean
SHBG sex steroid hormone binding globul
T testosterone
TCA trichloroacetic acid
P-'PR [methyl~^H] -thymidine
TEBG testosterone oestradiol binding
globulin
TUR transurethral resection
> greater than
> greater than or equal to
< less than
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TRIVIAL NAMES AND SYSTEMATIC EQUIVALENTS
Androstane-3dr> 17^-diol
Androstane-3^»17^-diol
Androstanedione
Androstenedione
Androsterone
Cyproterone acetate
Diethylstilboestrol
5a>dihydrotestosterone
5^-dihydrotestosterone
Estramustine
Estramustine phosphate
Estramustine phosphate sodium
Iso-androsterone 
(Epiandrosterone)
Oestradiol-lV^
Testosterone
5(-andd,ostane-3(% 17j-diol
5<t-androstane~3^, l^-diol
5a-addrostane-3,17-dione
androst-^-ene^, ^-dione
3arhydioxy-5<*-andiooten-17•-tde
1,2a-aetehdend---chloro-A^ ’ t 
pregna^ene-lVo-cl-^, 20-dione- 
17<a-acetate
< ‘itrans - 3,3-bis( p-yyirtxypy enyl) 
hex-3-ene t
17/~hhdr oxy^a-anclr o s ^an-^ - o ne
etlocholad-17^-tl-3-ode
estra-1,3,5(10)-triene-3,17A~ •• diol,3-/n,N-bis-(2-chlortethyl 
carbamate >:
estra-1,3,5 ( 10 )^^3?i<^ne-3,17/3- diol, 3 -/N i N-bis- ^-chloro ethyl 
carbamaee/-17-iihydrtged 
phosphate
estrn-l,3,5(10)-eriedea3•178a * 
diol^-Al , N-bis-( 2-chloroethyl 
carbamate/-^-disodium 
phosphate
3^ahyirtxy-5<3rndrosead-17 -one
estm-1,3,:5(10)-triene-3» 17/3diol " '
17/3-yyiroxy-androst-4-ed-3-olhe
CHAPTER 1
INTRODUCTION
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1.1 INTRODUCTION TO. THE MALE ACCESSORY SEX GLANDS
A unique characteristic of the reproductive system 
in male mammals is the development of discrete accessory 
sex glands. These glands are androgen-dependent organs 
which develop in association with specific regions of the
male urogenital tract and function primarily in the 
production of seminal fluid (Mann, 1954, 1964, 1974; Mann 
and Lutwack-Mann, 1981). The male accessory sex glands 
include the seminal vesicles, the ampullary glands, the 
bulbourethral glands and the prostate gland, but 
considerable species-specific variation exists with 
regard to which of these glands are present (Price and 
Williams-Ashman, 1961). All male mammals do, however, 
possess at least one accessory sex gland and only the 
prostate has been universally found in all orders of 
mammals (Price, 1963).
1.1.1■ Pathology of the Human Prostate Gland
While proliferative lesions and neoplasms are
uncommon in most of the accessory reproductive glands, 
much biomedical interest and research has been focused 
on the prostate as a result of the frequent occurrence, 
and clinical importance, of benign prostatic hyperplasia 
(BPH) and prostatic cancer in aging men. BPH is the 
most common urologic disease in middle-aged and elderly 
men (Rotkin, 1975i Scott and Coffey, 1975i Elbadawi, 
1979b, 198O) and the most frequent cause of infravesioal 
obstruction in the human male (Elbadawi, 1979b, 1980), 
while prostatic cancer is the most common malignancy of 
the male urogenital tract (Chisholm, 1981) and a leading
- 7 -
cause of cancer mortality (Winkelstein and Ernster, 1979? 
Chisholm, 1981; Ablin, 1981; Greenwald, 1982; Baba, 1982).
The most common form of BPH, known as nodular prostatic 
hyperplasia (NPH), consists of multicentric nodules of 
stromal, glandular or stromoglandular tissue (Pranks, 1975; 
Elbadawi, 1979b, 1980) which characteristically arise in 
the periurethral region of the prostate (Scott, 1963;
McNeal, 1972, 1978? Franks, 1975? Elbadawi, 1979b, 1980; 
Blacklock, 1981). While cancer of the prostate occurs in 
men of the same age group as BPH, it is characterized by 
the following? (1) prostatic cancer may be multifocal in 
origin (Elbadawi, 1979a; Glenn, 1981) but the most frequent 
site of development is in the periphery of the gland, 
particularly on the posterior aspect (McNeal, 1968, 1969, 
1975%, 1980b; Franks, 1973? Grayhack and Wendel, 1974; 
Blacklock, 1981), (2) histologically, most prostatie tumours 
(> 95%) are adenocarcinomas which commonly exhibit varying 
degrees of differentiation (Grayhack and Wendel, 1974;
Gleason, 1977; Gaeta and Gardner, 1979; Elbadawi, 1979b;
Bruce and Mahan, 1980; Tannenbaua and Romas, 1981; Dhom and 
Hohbach, 1982), (3) prostatic tumours spread by direct local 
invasion and via lymphogenous and haematogenous dissemination, 
with the latter frequently giving rise to osseous metastases, 
particularly in the pelvic bones and lumbosacral vertebrae 
(Elbadawi, 1979b; Bruce and Mahan, 1980; Glenn, 1981) and 
(4) 70 to 90% of patients with bone metastases secondary to 
prostatic cancer exhibit elevated serum prostatic acid 
phosphatase levels (Gutman and Gutman, 1938b; Robinson et al., 
1939; Huggins and Hodges, 1941; Sodeman and Batsakis, 1977; 
Wajsman and Chu, 1979; Bruce and Mahan, 1980; Rose et al., 
1981; Prellwitz and Ehrenthal, 1982).
- 8 -
Despite extensive research, BPH and prostatic cancer • 
are proliferative diseases of unknown aetiology. Since 
both conditions are common and share a progressively- 
increasing incidence with age, BPH has been considered as 
a possible precursor of prostatic cancer (Greenwald et al,, 
1974; Armenian et al., 1974). However, the relationship, 
if any, between these two diseases remains unresolved 
(Murphy, 1977l Winkelstein and Ernster, 1979; Rotkin, 1975* 
1980f Baba, 1982). Extrinsic (chemical, physical and viral) 
and intrinsic (genetic and hormonal) factors have also been 
considered in the aetiology of prostatic cancer, but none 
have been conclusively proven to be direct causative agents 
(Winkelstein and Ernster, 1979). Although the classic work 
of Huggins and colleagues (Huggins and Clark, 1940; Huggins 
and Hodges, 1941j Huggins et al., 1941) clearly established 
the androgen-dependence of some prostatic tumours by 
demonstrating regression of both primary and secondary 
tumours following castration and/or oestrogen therapy, the 
involvement of hormonal factors in the aetiology of this 
disease remains poorly understood and, as yet, there is no 
direct evidence that hormones can initiate cancer of the 
prostate (Harper et al., 1981). At present, the single 
undisputed factor in the aetiology of prostatic cancer is 
that it- only develops spontaneously in aged men who were 
not castrated prepubertally.
1.1.2 Clinical Management of Prostatic Cancer
While cancer of the prostate is potentially curable
in its initial stages, the detection of early, surgically 
removable tumours is uncommon as most patients ( >80e) are 
in advanced stages of the disease when it is first diagnosed
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(Murphy, 1977; Wajsman and Chu, 1979> Bruce and Mahan, 1980; 
Altwein, 1982), Moreover, the age and general health of the 
patient are often a contraindication, to radical surgery.
Since Huggins and Hodges (1941) first demonstrated the
effectiveness of hormonal manipulation in the treatment of 
prostatic cancer, endocrine therapy has remained the major 
therapeutic modality for metastatic carcinoma of the prostate. 
As the rationale for this treatment is based on the ablation 
of androgenic stimuli, endocrine manipulations used in the 
management of prostatie cancer have included bilateral 
orchiectomy, oestrogen therapy, adrenalectomy or _ 
hypophysectomy or a combination of these modalities (Scott, 
1973; Chisholm and O’Donoghue, 1975; Menon and Walsh, • 1979; 
Murphy, 1979; Scott et al,, 198O; Yagoda, 1981; Altwein,
1982). While treatment with the synthetic oestrogen, 
diethylstilboestrol (DES), constitutes the conventional 
form of endocrine therapy, clinical evidence has suggested 
that it is associated with serious cardiovascular side- 
effects which may negate the therapeutic value of the 
treatment (VACURG, 1967). Consequently, there has been an 
increased tendency toward the use of bilateral orchiectomy 
as a primary form of endocrine therapy (Barnes, 1981).
Uncertainty about the consequences of oestrogen 
treatment has also stimulated interest in the use of 
antiandrogens as an alternative form of therapy for the 
management of prostatie cancer. In contrast to oestrogens, 
which suppress testicular androgen biosynthesis indirectly 
via the gonadal-pituitary-hypothalamlc axis, antiandrogens 
exert their effect primarily by direct competition with 
androgens at the target cell level (Dorfman, 196*7, 1970; 
Steinbeck et al., 1971; Neumann and Steinbeck, 1974;
10 -
Neumann and Schenck, 19761 Neri, 1976; Menon and Walsh, 1979l 
Mittelman, 1979; Tveter et al., 1980; Neumann et al*, 1976; 
1980). Among synthetic, steroidal antiandrogens, the 
hydroxyprogesterone derivative known as cyproterone acetate, 
has been most extensively investigated and shown to antagonize 
androgen-mediated responses in the prostate, including RNA 
and DNA synthesis (Fang et al., 1969i Jager et al., 1969; 
Geller et al., 1969; Belham and Neal, 1971; Walsh and 
Korenman, 1971l Carter et al., 1972; Sufrin and Coffey, 1973, 
1975; Liao et al., 1974; Coffey, 1974i Mainwaring, 1977; 
Tveter et al., 1980). Numerous experimental studies have 
further shown that treatment of - normal animals with 
cyproterone acetate causes marked involution of the prostate, 
similar to that following surgical castration (Neumann et al,, 
1967, 1976, 1980, 1982; Neumann, 1971, 1977; Steinbeck et al., 
1971; Neumann and Steinbeck, 1974; Neumann and Schenck, 1976i 
Tveter et al., 1975, 1980). Clinical evidence also suggests 
that cyproterone acetate is effective in the treatment of 
prostatic cancer and produces fewer side-effects than 
conventional oestrogen therapy (Neumann, 1971, 1977; Wein 
and Murphy, 1973» Neumann et al., 1976, 1982; Isurugi et(al,, 
1980; Jacobi et al., 1982), although Tveter et al. (1978,
1980) have reported that the incidence of-' cardiovascular 
side-effects is comparable to that with oestrogen therapy.
At present, clinical experience with cyproterone acetate has 
been largely limited to patients with metastatic carcinoma 
of the prostate refractory to hormonal therapy, thus the 
true value of this drug as an alternative to conventional 
oestrogen therapy remains to be established (Neumann et al., 
1980, 1982i Smith, 1981; Jacobi et al., 1982; Gupta, 1982> 
Pavone-Maealuso, 1982)•
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Despite the continued use of endocrine therapy in the 
treatment of prostatie cancer, it does not constitute a 
cure for this disease but, rather, serves as a temporary 
palliative measure. While the majority of patients initially 
respond to- endocrine treatment, most eventually relapse to 
a hormone-resistant state and at least 15 to 20e fail to 
respond at all (Nilsson and Jonsson, 1977* Menon and Walsh, 
1979; Barnes, 1981). Hence, the response to this treatment 
is often variable and, as yet, there is no method of 
predicting which patients will respond to endocrine 
manipulation (Karr and Sandberg, 1979l Ekman et al., 1979; 
Wagner, 1980j Pfitzenmaier et al., 1980; Concolino et al., 
1980; Ekman, 1980; Mobbs et al., I960; de Voogt and Dingjan, 
1980; Rennie and Bruchovsky, 1980; Brandes et al., 1981; 
Harper et al,, 1981> de Voogt, 1982).
The lack of hormonal response in some patients, along 
with the eventual relapse which occurs in patients initially 
responding to hormonal therapy, has stimulated a search for 
alternative chemotherapeutic approaches to the treatment of 
prostatie cancer. Until recently, chemotherapy has received 
little attention as a therapeutic modality for prostatie 
cancer primarily because of the relative success in managing 
this disease with endocrine therapy (Nilsson and Muntzing, 
1980j Murphy and Slack, 1981). Adverse side-effects often 
associated with conventional cytotoxic agents have also 
contributed to the reluctant attitude toward chemotherapy 
(Murphy, 1979; Nilsson and Muntzing, 1980). However, the 
introduction of hormone-cytotoxic agents specifically 
designed for the treatment of hormonally-linked tumours has 
stimulated renewed interest in the use of chemotherapy for 
prostatie cancer (Murphy, 1979; Nilsson and Muntzing, 1980;
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Murphy and Slack, 1981; Pavone-Maealuso» 1982). The
rationale for hormone-cytotoxic therapy is based on the 
concept that linking a cytotoxic agent to a steroid carrier- 
hormone may enhance the tissue specificity of the compound 
and perhaps reduce the systemic side-effects caused by either 
substance alone. Theoretically, the hormonal moiety imparts 
tissue specificity by interacting with steroid hormone 
receptor proteins in the target organ, thereby resulting in 
an accumulation of the alkylating agent within the•tissue. 
Subsequent hydrolysis of the drug complex releases the 
cytotoxic agent in an active form, and both the hormonal and 
cytotoxic moieties may then exert their effects independently 
(Mittelman, 1979> Nilsson and Muntzing, 1980; Pavone-Maealuso, 
1982). Among such compounds developed for the treatment of 
prostatie cancer, the nor-nitrogen mustard derivative of 
oestradiol-17//, known as estramustine phosphate or Estracyte, 
has been most extensively investigated. Both in the rat and 
man, estramustine phosphate is rapidly dephosphorylated to 
estramustine (Hj/isaeter, 1976a, 1976b, 1977; Edsmyr et al.» 
1982). Experimental studies have further shown that 
following the administration of %H-estramiustine phosphate to 
rats, radioactivity is preferentially localized in the 
prostate and is primarily associated with the metabolite, 
estramustine (Plym-Forshell and Nilsson, 1974; Forsberg and 
H/isaeter, 1975; H/fisaeter, 1976a, 1977), indicating that 
the intact steroid-carbamate complex is incorporated into 
the prostate (Edsmyr et al,, 1982). In the rat, treatment 
with eatramustin- phosphate reportedly causes reductions in 
the weight of the ventral prostate (Kirdani et al., 1974; 
Yamanakazet al., 1977), decreased Se-reeuctase activity 
(Kirdani et al., 1974; Forsberg and H/isaeter, 1975;
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H/isaeter, 1975a, 1977) and Inhibition of androgen-induced 
DNA synthesis (Forsberg and H/rfisaeter, 19751 H/fisaeter, 1975h, 
1976b, 1977), but its precise mode of action is unknown 
(Forsberg and H/(isaeter, 19751 H/(isaeter, 1975a, 1975b» 1976b, 
1977j Nilsson and Miintzing, 198O| Edsmyr et al,, 1982). 
Clinically» selective accumulation of radioactivity has also 
been detected in the human prostate gland following the 
administration of ^^^I-estramustine phosphate (Szendrbi et 
al., 1973). Clinical evidence has further indicated that 
Estracyt is often effective in the treatment of oestrogen- 
relapsed prostatic carcinoma (Jonsson and Hbgberg, 1971f 
Nilsson and Miintzing, 1972, 1980> Miintzing et al., 197^1 
Murphy, 1975l Jonsson et al., 1975t Mittelman,et-al., 1975» 
1977* Nilsson and JSnsson, 1977> Yamanaka et al., 198lb> 
Edsmyr et al., 1982), suggesting that its mode of action 
differs from that of oestrogens. Several studies have also 
found that Estracyt produces few side-effects (Jdnsson and 
Hd’gberg, 19711 Miintzing et al., 197*H Jonsson et al., 1975i 
Murphy, 1975f Mittelman et al., 1975» 19771 Nilsson and 
Jonsson, 1977)• although Yamanaka et al. (1981b) and Edsmyr 
et al. (1982) have reported that the untoward effects of 
Estracyt therapy are comparable to those associated with 
oestrogen treatment. As with oyproterone acetate, the 
true value of Estracyt as an alternative to primary oestrogen 
therapy remains to be established since clinical experience 
with this drug has generally been restricted to patients 
with hormone-resistant prostatic carcinoma (Nilsson and 
Jdnsson, 1977t Nilsson and Miintzing, 1980j Smith, 1981j 
Edsmyr et al., 1982i Favone-Macaluso, 1982).
While Insight into the molecular endocrinology of the 
prostate has had a profound influence on the development
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of drugs for the treatment of prostatie cancer (Mittelman,
1979), the sobering fact remains that the five year
survival rate for this disease is only 57% (Ablin, 1981), 
Moreover, little is known of the factors involved in the
regulation of prostatie growth.
1.1,3 Animal Models in Prostate Research
Research into the abnormal growth of the prostate, 
and its control, has been impeded by a lack of suitable 
animal models. With the exception of senescent dogs, BPH . 
rarely occurs spontaneously in subhuman animals. Although 
the natural history of canine BPH is remarkably similar to 
that in the human (Walsh, 1975l Sandberg et al., 1980), the 
two conditions differ in their histological characteristics 
and endocrine responses (Ofner, 19681 Walsh, 1975i Brendler, 
1975; Scott and Coffey, 1975; Neumann et al., 1975; Sandberg 
et al., 1980), Despite these differences, however, canine 
BPH is considered to be the most promising animal model 
currently available for studying the pathogenesis of BPH 
(Walsh, 1975; ' Sandberg at al., 1980; Chevalier et al,, 1981).
In contrast to the frequent occurrence of BPH in 
senescent dogs, prostatie cancer seldom develops spontaneously 
in this species. Although malignant tumours have been found 
in aged dogs (Brendler, 1963; Ofner, 1968; Leav and Ling,
1968; Sandberg et al., 1980), the incidence is probably less 
than 1%, thus precluding its use as a model for human 
prostatie cancer (Brendler, 1963; Neumann et al., 1975;
Coffey et al., 1979; Isaacs and Coffey, 1979t 1981).
BPH and prostatie cancer have also been reported to 
occur spontaneously in aged, non-human primates (Lewis and 
Kaack, 1980; Lewis et al., 1981) but these animals have not
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yet been adequately studied to determine the true spontaneous 
-nt-d-nte of either disease (Coffey and Issacs, 1980; Lewis 
et al., 1981). The long lifespan of these animals may, 
however, become a l-m-t-ng factor in their use as an 
experimental model for abnormal prostatie growth.
Spontaneous BPH is not known to occur ini rats (Price 
and Williams-Ashman, 1961; Walsh, 1975) and until recently, 
prostate cancer was considered to be extremely rare in this 
species (Price and Williams-Ashman, 1961; Brendler, 1963; 
Dunning, 19^3; Franks, 1967; Pranks and Maldague, 1976;
Burek, 1981). However, in aged (31 to 39 months old), 
germ-free LcbunU-Wistar rats the spontaneous -ntidente of 
prostatie aU-nctartinomas has been found to be 13#, and in 
animals beyond 35 months of age the incidence is 35#
(Pollard, 1973l Pollard and Luckert, 1975). Similarly,
Shain et *!• (1975, 1977, 1979) have reported that 
spontaneous prostatie adenotartincmas occur in a-n-scent 
(34 to 37 months old), tonvent-cnally-r-ar-d AXC rats with 
a frequency of 17# and in animals ranging from 30 to 46 
months of age the inc-d-nce is 57#. Shain et al, (1977, 1979) 
also found that in testoat-rone-treated, aged AXC rats the 
incidence of prostatie tumours increased to 70#. Similarly, 
Noble (1977a, 1977b) reported that the low (0.48#) 
spontaneous -nt-U-nc- of prostatie adenocarcinomas in 13 to 
14 month old Nb rats increased significantly (18.38#) 
following prolonged (9 to 18 months) treatment with 
t-atoateron- and estrone implants. Hence, the general 
assumption that prostatie cancer rarely occurs in rats is 
no longer justified. Moreover, several important 
tr-naplantable rat prostatie tumour models, notably the 
Dunning R-3327 series (Dcnn-ng, 1963> Lubaroff et el., 1980),
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the Pollard tumours (Pollard and Luckert# 19*751 Pollard,
1980) , the AXC tumours (Shain et al., 1977# 1979) and the
Nb tumours (Noble, 1977a, 1977b; Drago et al., 1980a)have 
been established by successful propagation of these 
spontaneous and hormone-induced adenocarcinomas. Detailed 
reviews of the known properties of these rat prostatic 
tumour models have been presented recently (Muntzing et al., 
1977; Smolev et al., 1977; Issacs and Coffey, 1979# 1981; 
Lubaroff et*al., 1980; Drago et al., 1979# 1980a, 1980bj 
Drago and Goldman, 1980; Pollard, 1980i Bogden, 1980; Issacs 
et al.» 1980 > » 1982) amd indicate that thiese twnours
exhibit a wide range of histology, growth rates, metastasizing 
potential and sensitivity to hormones and chemotherapeutic 
agents. Although no single rat prostatic tumour appears to 
encompass the diversity of human prostatic cancer, these 
tumours represent the most promising animal models presently 
available for investigations into the aetiology, pathogenesis 
and treatment of prostatic cancer.
Apart from hormone-induced tumours, research efforts 
have also focused ovt the development of carcinogen-induced 
prostatic adenocarcinomas ln vivo (Dunning, 1963; Brendler,
1963; Fraley and Paulson, 1974; Neumann at al., 1975; Pour,
1981) and in vitro (Lasnitzki, 1951# 1954, 1964, 19741 
Fraley and Paulson, 1974; Neumann et al., 1975; Norris, 1980). 
These efforts have, however, failed to produce an experimental 
tumour which Is a suitable analogue for human prostatic cancer.
While several promising animal models for BPH and 
prostatic cancer are currently available, it must be emphasised 
that no single animal prostate, either normal or neoplastic, 
has emerged as an ideal surrogate for the human prostate 
gland. Factors contributing to this problem include marked
— 17 —
species-specific differences in the morphology, biochemistry 
and pathology of the prostate (Price and Williams-Ashman,
1961; Price, 1963; Van Camp, 1969; Mann and Lutwack-Mann, 
1981), as well as the general lack of agreement regarding 
the regional morphology of the normal human prostate (Scott, 
1963; McNeal, 1968, 1972, 1980aj Tisell and Salander, 1975; 
Elbadawi, 1979a; Aumiiller, 1979). Furthermore, cancer of 
the prostate in man is, itself, a highly variable and 
multifaceted disease in which no two tumours are identical 
and often a single tumour exhibits marked heterogeneity.
Thus the quest for a single, ideal animal model for human 
prostatic cancer seems to be an unrealistic goal as it 
appears that several models may be necessary to adequately 
represent the diversity of the natural disease in man (Coffey 
et al,, 1979; Issacs and Coffey, 1979, 1981; Merchant, 1980; 
Schrdder, 1982). For similar reasons, Sandberg and colleagues 
(Sandberg, 1975; Sandberg et - - al., 1977; 'Sandberg and Kadohama, 
1980) have stressed the need for multiple in vivo and in vitro 
model systems to assess the effects of (drags whi±eh. may be of 
potential value in the clinical management of prostatic 
cancer. Time, cost and ethical considerations further 
necessitate the use of experimental models to develop and 
evaluate new modalities of therapy.
While the merit of 'animal studies in prostate research 
has long been recognized as a result of their great 
contribution to the basic knowledge of human pi?0B^1:«ia^t> biology 
and their influence on the development of therapeutic conccptt 
for the management of prostate cancer, the extrapolation of 
results from animal studies to the human must always be 
cautiously guarded (Merchant, 1979i Coffey and Issacs, 1980). 
Hacdelsmac (1977) has further stressed that any model system
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is limited in the Information that it can provide, therefore 
it is essential that animal models used in prostate research 
be well-characterized and demonstrate unique properties 
which correspond with the human prostate gland (Sandberg 
al., 1977, 1980; Coffey et al., 1979; Coffey and Issacs,
1980; Merchant, 1980; Schroder, 1982). Clearly, differences 
between the human prostate and the proposed animal model 
must also be taken into consideration if experimental results 
are to provide a better understanding of prostatic diseases 
in man.
1.1.4 Developmental andComparative Anatomy of the Human and ’ Rat jrosiate Glands "
Among experimental animals most frequently used in
prostate research has been the normal laboratory rat (Rattus 
norvegiens albinus). Although the rat and human prostate 
glands exhibit distinct morphological and biochemical 
differences, both organs follow a similar pattern of 
development (Price, 1963; Narbaitz, 1974).
Embryogenesis of the human prostate was extensively 
studied by Lowsley (1912) and has recently been the subject 
of several reviews (Narbaitz, 1974; ■ • McNeal, 1975a; Aumuller, 
1979; Cunha and Lung, 19790, Jir^sek, 1980). At approximately 
the twelfth week of gestation, primordia of the human 
prostate appear as short, solid cords of epithelial cells 
growing out from the cephalic portion of the urogenital sinus 
into the surrounding mesoderm. Development of the prostatic 
primordia appears to be dependent on the production of 
androgens by the foetal testis (Kello]k^mpu~Lecrtinen and 
Santti, 1979) which occurs during the tenth to twelfth week 
of gestation (Price et al., 1975; Faiman et al., 1981), In
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a thirteen week human foetus, Lowsley (1912) identified the 
following five groups of epithelial cords arising from the 
prostatic urethra* (1) a middle, or median, group originating 
from the posterior wall of the urethra between the bladder 
neck and the openings of the ejaculatory ducts and the 
prostatic utricle, (2) and (3) right and left lateral groups 
arising from the prostatic furrows and lateral walls of the 
urethra on either side of the verumontanum, (4) a posterior, 
or dorsal, group arising from the posterior wall of the 
urethra, caudad to the openings of the ejaculatory ducts, 
and (5) a small anterior group arises from the ventral wall 
of the urethra craniad to the prostatic utricle, but 
atrophies almost completely after the sixteenth week in 
utero. According to Lowsley’s (1912) definition, the glands 
arising from these foci give rise to five separate lobes of 
the foetal prostate, namely* the middle lobe, the right 
and left lateral lobes, the posterior lobe and the anterior 
lobe, respectively. However, as the prostatic cords grow 
longer and branch the boundaries separating the lobes 
become obscured, and the ejaculatory ducts and prostatic •< 
utricle become incorporated into the substance of the 
prostate gland (Narbaitz, 1974; Cunha and Lung, 1979a). 
Between the thirteenth and sixteenth weeks of gestation, 
lumenization of the epithelial cords begins and proceeds 
from the entrance of the glands into the urethra toward the 
periphery. At about the same stage of development, 
muscular differentiation and collagen fibrilogenesis occur 
in the surrounding mesenchyme (Cunha and Lung, 1979a).
At birth, the five lobes of the foetal prostate, as 
described by Lowsley (1912), are no longer evident (McNeal, 
1975&I Franks, 1975). Differentiation of the epithelial
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cords in the neonatal prostate is incomplete as only some 
glands have developed lamina lined with single or stratified 
cuboidal epithelium, while the terminal portions of others 
remain solid. Evidence of squamous metaplasia in the foetal 
( > 22 weeks) and neonatal prostate has been attributed to the 
influence of maternal oestrogens (Zondek and Zondek, 1975t 
1980). Regression of these metaplastic changes occurs 
gradually after birth.
Postnatally, differentiation and growth of the human 
prostate continues slowly until puberty. At this time 
prostatic growth accelerates rapidly in response to 
elevated androgen levels and the prostate gland achieves 
morphological and functional maturity.
The normal anatomy of the adult human prostate has been 
described in detail by Gray (1980) and discussed in reviews 
by Narbaitz (1974), Aumiiller (1979) and Spring-Mills and 
Hafez (1979# 1980). The normal adult prostate is a compact 
fibromuscular and glandular organ, which is almost conical 
in shape, and lies obliquely in the pelvic cavity between 
the symphysis pubis and the rectum, surrounding the urethra 
at the neck of the bladder. In a healthy male adult, the 
prostate is the largest of the accessory sex organs, measuring 
3 to 4cm transversely at the base, • approximately 2cm antero­
posteriorly and 3om vertically; and weighs about 20g.
The base of the prostate is directly contiguous with 
the inferior surface of the bladder and is pierced at its 
anterior border by the urethra. The prostatic portion of 
the urethra passes vertically through the prostate and 
emerges slightly anterosuperior to the apex of the gland, 
which lies at the level of the urogenital diaphragm.
The posterior aspect of the prostate is a triangular,
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flattened surface which is often marked with a shallow, 
longitudinal furrow. The two ejaculatory ducts pierce this 
surface near its superior border, pass obliquely antero­
inferiorly through the posterior part of the gland and 
terminate in openings on the floor of the prostatic urethra. 
Avascular rectovesical fascia separates the posterior 
surface of the prostate from the anterior wall of the rectum.
The narrow, convex anterior surface of the prostate lies 
about 2cm behind the symphysis pubis, but is separated from 
it by the prostatic venous plexus and adipose tissue which 
occupy the retropubic space. Puboprostatic ligaments join 
the upper border of the anterior surface to the symphysis 
pubis.
The inferolateral aspects of the prostate present two 
prominent, rounded surfaces. The anterior portions of the 
levatores ani (levatores prostatae) embrace the lateral 
walls of the prostate, but are separated from them by the 
prostatic venous plexus and pelvic fascia.
The prostate gland, itself, is immediately enveloped 
in a thin, but firm, fibreelastic capsule which is 
structurally continuous with the fibromuscular element of 
the gland. External to this capsule, and distinct from it, 
is a dense fibrous sheath which surrounds the entire gland 
and is continuous with the supporting ligaments of the 
prostate. Passage of the urethra and the ejaculatory ducts 
throuuh the substance of the prostate further secures its 
anatomical position.
Although the concept of anatomical lobation in the 
prostate was originally introduced by Lowsley (1912), the 
regional morphology of this organ still remains a 
controversial issue (Elbadawi, 1979a> Aumuller, 1979f
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Gray# 1980). Not only are there disagreements regarding i
the existence of anatomical subdivisions in the prostate 
(Huggins and Webster# 1948)# but even among those who 
support the concept of . lobation# there are divergent 
views on the boundaries of the subdivisions (McNeal# 1968#
1972# 1975b# 1980a; Franks, 1975; Tisell and Salander, 1975) 
which have been further confused by a lack of uniformity in 'I 
terminology (McNeal# 1972; 1980a). Comprehensive reviews of 
the current concepts in prostatic regional morphology have I
been presented recently by Aumuller (1979): and McNeal (1972# 
1980a). However# for the purpose of the present study# it 
is suffice to say that the normal human prostate does not 
exhibit a distinctly segmented body as seen in the prostate , 
glands of many lower mammals. J
Arterial blood supply to the prostate is derived i
primarily from the anterior divisions of the internal 
iliac artery (Patil# 1979; Aumuller# 1979; Spring-Mills 
and Hafez# 1980), Branches of this vessel join to form 
the main prostatic artery which subsequently divides into 
urethral and capsular groups of vessels. The periurethral 
region of the prostate receives urethral blood vessels# 4
while most of.the parenchyma is supplied by capsular vessels.
The apex of the gland receives both capsular and urethral 
blood vessels# but these do not anastomose freely (Patil#
1979). .•
Prostatic veins form the venous plexus of Santorini 
which is embedded in the fibrous sheath of the prostate# 
particularly on the anterior and lateral surfaces at the 
base of the gland. Drainage from the venous plexus flows 
into the internal iliac veins. However# valveless venous 
communications between the prostatic plexus and the
?£
- 23 -
extradural venous plexuses are of pathological significance 
in the dissemination of prostatic cancer* via retrograde 
venous spread* to the lumbar and sacral spine* and the 
pelvic bones (Patil* 19791 Muir, 1980).
Lymph vessels are abundant in the human prostate and 
drain primarily into the external and internal iliac, and 
sacral lymph nodes. Lymphatic drainage is also of 
pathological importance in the metastatic spread of 
prostatic cancer (Patil, 19791 Spring-Mills and Hafez,
1980i Muir, 1980).
Autonomic innervation of the prostate is supplied by 
both the parasympathetic and sympathetic systems (Patil,
19791 Aumuller, 19791 Elbadawi and Goodman, 1980).
Histologically, the prostate is composed of fibro­
muscular and glandular elements which have been described 
in detail by Aumuller (1979) and Spring-Mills and Hafez 
(1979, 1980). The prostatic capsule consists of regularly 
arranged rows of collagen, fibroblasts, elastic fibres 
and smooth muscle cells, and gives rise to septa which 
extend inward, embedding the glandular tissue in a meshwork 
of fibromuscular stroma. Smooth muscle cells and fibroblasts 
are the most abundant cell types in the stroma, but the 
cellularity of the interstitial tissue varies considerably 
throughout the prostate. Posterior to the urethra, in the 
region of the apex, the stroma forms a loose network which 
increases in density toward the base of the gland. Anteriorly 
the stromal tissue is very dense and this region is often 
devoid of glandtilar tissue.
The glandular element of the prostate is composed of 30 
to 50 branching, tubuloalveolar glands of various shapes and 
sizes, which empty into the prostatic urethra via 16 to 32
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excretory ducts. The glandular alveoli are lined with a 
single layer of folded columnar epithelium which frequently 
forms papillary projections that extend far into the lumen. 
Simple or pseudostratified columnar epithelium lines the 
ducts, except near the entrance to the urethra, where it 
changes to transitional epithelium. Within the prostatic 
epithelium are two cell typesi (1) tall secretory or 
glandular cells that line the lumina and (2) small, non- 
secretory basal cells which are interposed between the 
secretory epithelium and the basement membrane.
Typical secretory cells are columnar in shape and 
contain a large spherical or oval, basally-located nucleus 
which lacks prominent nucleoli. The fine structure of 
these cells exhibits organelle polarization which correlates 
well with the secretory function of the epithelium (Brandes 
et al., 1964j Brandes, 1966, 1974ai Auraiiller, 1979)« The 
basal region of the cell, which includes the nucleus, 
contains rough endoplasmic reticulum, secretory vacuoles 
and clusters of free ribosomes, while the supranuclear 
region is primarily occupied by elements of the Golgi 
apparatus, as well as some endoplasmic reticulum, secretory 
granules and vacuoles. In the apical region of the cell, 
the predominant feature is an abundance of densely packed 
secretory vacuoles. Mitochondria are also present throughout 
the cytoplasm, but occur less frequently in the apical pole. 
The luminal plasma membrane exhibits many microvilli and 
often apical blebs of cytoplasm project into the lumen, 
suggesting that the apocrine type of secretion occurs in the 
human prostate, as well as the merocrine type (Brandes et al. 
1964i Brandes, 1966, 1974a).
In a normal male adult, the prostate gland continuously
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secretes a thin# serous fluid (pH 6.5) which contributes 
numerous specialized products to the composition of seminal 
fluid and accounts for 15 to 30$ of its total volume 
(Spring-Mills and Hafez, 1980j Mann and Lutwack-Mann, 1981).
For a detailed list of the chemical constituents present in 
the human prostatie secretion, the reader is referred to 
reviews by Mann (1954, 1964, 1974), Price and Williams- 
Ashman-(1961), Aumuller (1979)# Ahmed et al. (1979a) and 
Mann and Lutwack-Mann (1981). Among the most characteristic 
components of human prostatic fluid is, however, the enzyme, 
acid phosphatase. The remarkably high concentration of acid 
phosphatase in the human prostate was first discovered by 
Kutscher and Wolbergs (1935) and later confirmed by Gutman 
and Gutman (1938a), who also established the clinical 
significance of elevated serum acid phosphatase levels in 
the diagnosis of metastatic carcinoma of the prostate 
(Gutman and Gutman, 1938b; Robinson et al.» 1939).
Histochemical studies subsequently demonstrated the 
localization of intense acid phosphatase activity in the 
secretory epithelium of the human prostate (Gomori, 1946; 
Burstone, 1958; Brandes, 1966; Kirchheim et al., 1964, 1974| 
Brandes and Kirchheim, 1977). In normal tissue, enzyme 
activity is present throughout the epithelial cytoplasm, 
but exhibits a preponderance toward the acinar lumen. Acid 
phosphatase activity has also been histochemioally demonstrated 
in the secretory blebs and luminal secretion, indicating that 
the enzyme is incorporated into the prostatic secretion as 
part of the bleb (Kirchheim et al. , 1974; Brandes and Kirchheim., 
197*7).
In contrast to the secretory epithelial cells, the basal 
cells contained within the prostatic epithelium are polygonal
5?
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in shape* do not reach the lumen of the gland* show little ■±
evidence of organelle polarization and no signs of secretory 
activity (Brandes et al.* 1964; Spring-Mills and Hafez* 1979» f 
1980). In addition to a few mitochondria* some endoplasmic 
reticulum and a poorly developed Golgi apparatus* these cells 
contain a moderate number of filaments, which presumably 
serve a contractile function* and pinocytotic vesicles which 
are assumed to be involved in the exchange of materials 
between the glandular epithelium and the stroma. However* the 
principal function of the basal cells is presumed to be as 
reserve cells for renewal of the prostatic secretory
epithelium (Dermer, 1978; Spring-Mills and Hafez* 1980).
The morphology of the human prostate gland remains
relatively stable until about the fifth or sixth decade. 's
when advancing age may be associated with prostatic atrophy 
(Moore, 1936; McNeal, 1968, 1975b* 1980b, 1981; Elbadawi,
1979af Coleman, 1980) and/or pathological changes due to 
BPH or prostatic cancer. While the latter tend to j
overshadow morphological changes strictly due to aging, 
focal and diffuse glandular atrophy are recognized as 
common features of the senile prostate. Age-assoeiated 
prostatic atrophy shows marked individual variability but 
is generally characterized by dilated alveoli lined with 
straightt flattened epithelium, diminished secretory activity 4 
and progressive stromal fibrosis (McNeal* 1968, 1980b). The 
progressive accumulation of large, lamellated concretions* 
known as corpora amylacea* in the glandular lumina and 
seoretion are also a characteristic feature of aging in the 
human prostate gland (Elbadawi* 1979a; Spring-Mills and 
Hafez, 1980). I
Embryogenesis of the rat prostate follows a similar
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pattern of development to that of the human prostate a
gland. Prostatic primordia in the rat arise from the A
urogenital sinus epithelium as independent groups of
epithelial cords which branch repeatedly and secondarily 
acquire a lumen (Price, 1936, 1963; Narbaitz, 1974).
According to Price (1936), embryologic development of the 
rat prostate occurs relatively late (19*5 days) in the 
gestation period (22 days). However,, as in the human, 
prostatic morphogenesis in the rat appears to be dependent 
upon'the production of androgens by the foetal testis 
(Wilson, 1975l Lasnitzki and Mizuno, 1977f Bard et al.,
1980; Cunha and Lung, 1979&# 1980) which occurs at 15.5 days 
and increases sharply at- - 18.5 'days (Price et al,, 1975).
1n a 19.5 day foetal rat, Price (1936, 1963) identified ■
the following groups of prostatic cordss (1) a middle 
group arising from the midline of the posterior wall of the 
urethra craniad to the openings of the ejaculatory ducts,
(2) right and left la-fceral groups originating from the 
dorsolateral walls of the urethra, - caudad to the openings 
of the ejaculatory ducts, (3) ri^it and left dorsal groups 
arising from the posterior wall of the urethra, caudad to 
the openings of the ejaculatory ducts, and (4) right and :
left ventral groups arising from the ventral wall of the 
urethra, caudad to the level of the prostatic utricle.
Glands arising from these foci give rise to the following 
segments of the rat prostatic complext the anterior 
prostate (coagulating gland), the lateral prostate, the -
dorsal prostate and the ventral prostate, respectively I
(Price, 1963). j
4Unlike the human prostate, the epithelial cords of
the rat prostate are undifferentiated at birth and do not
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begin to undergo luraenization until the first week of 
post-natal life (Price, 1936)• However, the process of 
lumenization follows a similar pattern to that in the 
human prostate, proceeding from the entrance of the glands 
into the urethra toward the periphery. Also, in contrast 
to the human prostate, the rat prostate does not exhibit 
evidence of maternal oestrogenic effects during normal 
foetal development (Price, 1963). Postnatally, the rat 
prostate is characterized by rapid growth and by 25 days it 
is structurally similar to the normal adult gland, although 
sexual maturity does not occur until about 35 days after 
birth (Price, 1936).
The gross anatomy of the normal adult rat prostate has 
been thoroughly described by Pranks (1967), Levy and Fair 
(1973)» Hebei and Stroraberg (1976) and Jesik et al. (1982). 
Unlike the human prostate, the rat prostate consists of 
four pairs of anatomically distinct lobes: (l) the anterior 
prostate is composed of two lobes which are attached to the 
ventromedial margins of the seminal vesicles by a common 
connective tissue sheath, (2) the ventral prostate consists 
of two symmetrical, pear-shaped lobes which embrace the 
urethra on the ventromedial side of the bladder, (3) the 
lateral prostate lies posterior to the urethra at the neck 
of the bladder and is composed of two lobes which embrace, 
and form a continuous mass with, the paired lobe of (4) the 
dorsal prostate. Although the dorsal and lateral prostatic 
lobes are separate entities (Price and Williams-Ashman, 196I1 
Price, 1963f Pranks, 19671 Jesik et al., 1982), they are 
often referred to collectively as the "dorsolateral* prostate 
(Hebei and Stromberg, 1976) because of their close proximity.
On the basis of the site of origin of the prostatic
— 29 —
primordia and the anatomical position of the tubules,
Price (1963) proposed the following (Table 1.1) homologies
between the rat prostatic complex and the human prostate,
as described by Lowsley (1912).
Table 1.1 Homologies between the prostatic lobes in the
rat and man
Rat
Anterior prostate 
Lateral prostate 
Dorsal prostate 
Ventral prostate
Man
Middle (or medium) lobe 
Lateral lobes
Dorsal (or posterior) lobe
Since the rat ventral prostate and the anterior lobe of the 
human prostate differ in their site of origin from the 
ventral wall of the urethra, relative to the openings of 
the ejaculatory ducts and prostatic utricle, Price (1963) 
concluded that the two lobes are not homologous. However, 
in view of the current controversy surrounding the regional 
morphology of the normal human prostate, which includes a 
general tendency to deny the significance of Lowsley’s 
(1912) concept of lobation in the adult gland (McNeal, 1972, 
1980a), it appears that such interspecies comparisons 
require further clarification.
While the various segments of the rat prostatic 
complex are structurally similar in that they are all 
composed of tubuloalveolar glands, lined with a single 
layer of secretory,epithelium and separated by fibromuscular 
stroma, the histological characteristics of each segment 
differ, as does the chemical composition of the segments
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and their secretions (Moore et al., 1930; Price and 
Williams-Ashman, 19611 Brandes, 1966, 1974aj Mann, 1954, 
1964, 1974j Aumuller, 1979). However, as in the majority 
of experimental studies of the rat prostate, the ventral 
prostate (Plate 1.1) is the subject of the present 
investigation and will therefore be considered in greater 
detail.
The normal histology of the adult rat ventral prostate 
was described by Moore et al. (1930) and has been discussed 
in extensive reviews by Franks (196*7), Cavazos (1975), 
Aumuller (1979) and Jesik et al. (1982). The glandular 
alveoli and ducts are lined with straight or slightly folded 
simple columnar epithelium and are separated by fine strands 
of fibromuscular stroma. In contrast to the human prostate, 
the interacinar tissue in the rat ventral prostate is very 
sparse and consists primarily of fibroblasts, with some 
smooth muscle cells (Flickinger, 1972). Undifferentiated 
cells are also present in the stromal tissue of the rat 
ventral prostate (Flickinger, 1972), whereas few comparable 
cells are evident in the stroma of the human prostate 
(Spring-Mills and Hafez, 1980). Stereological analyses 
have shown that the interacinar tissue comprises about 25% 
of the total volume of the rat ventral prostate (Bartsch, 
1977; Bartsch and Rohr, 1982), whereas in the normal human 
prostate, stromal tissue occupies 45 to 555% of the gland 
(Bartsch et al., 1979; ' Bartsch and Rohr, 1982). As in the h 
prostate, however, the glandular epithelium in the rat
* ventral prostate is composed of tall secretory cells which 
line the lumina and small, non-secretory basal cells wedged 
between the secretory epithelium and the basement membrane. 
In the rat ventral prostate, a typical secretory epithelial
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Plate 1,1 Transverse section through the proximal part of the 
urethra and the prostate gland of a sexually- . 
mature (4-6 months old) albino rat. The ventral 
prostate is composed of two distinct lobes (VP) which 
embrace the ventrolateral.aspects of the urethra (U) 
and are separated by the dorsolateral prostate (DIP) 
and fibromuscular tissue which lies ventral to the 
urethra. Haematoxylin & Eosin, X20.
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cell is columnar in shape, contains a large round or oval, 
"basal nucleus with one or two prominent nucleoli, and 
exhibits a distinct clear (ie. negatively-stained) zone 
in the supranuclear cytoplasm, which corresponds with the 
position of the Golgi apparatus (Moore et al,, 1930),
Ultrastructural studies have shown that the distribution of 
organelles in the secretory cells of the rat ventral prostate 
is similar to that in the human, although the rat exhibits 
more extensive development of the endoplasmic reticulum and 
Golgi apparatus (Harkin, 1957i 1961? Brandes and Groth, 1961? 
1963? Brandes, 1966, 1974a? Helminen and Ericsson, 1970J 
Cavazos, 1975? Aumuller, 1979). Also, the merocrine mode 
of secretion appears to be the primary form of protein 
release in the rat ventral prostate (Flickinger, 197^). 
Histochemically, the secretory epithelium exhibits positive 
acid phosphatase activity (Brandes et al., 1962? Brandes,
1963» 1966? Muntzing, 1972? Paris and Brandes, 1974? Brandes 
and Kirchheim, 1977)» "but the intensity of the reaction is 
considerably less than in the human prostate (Brandes, 1966? 
Muntzing, 1972). However, as in the human prostate, the 
intracytoplasmic distribution of acid phosphatase in the rat 
ventral prostate is both lysosomal and secretory (Vanha- 
Perttula et al., 1972? Helminen et al., 1975> Tenniswood 
et al., 1976).
Advancing age in the rat, like in the human, is 
accompanied by morphological changes in the prostate which 
show marked individual variability (Mainwaring and Brandes, 
197^? Burek, 1981). While some areas of the gland may 
exhibit atrophic changes, characterized by dilated alveoli 
lined with flattened epithelium, other regions of the 
epithelium appear hyperplastic and still others appear
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normal. Glandular atrophy is also accompanied by decreased 
secretory activity and often the alveolar lumina contain •1$
concretions which resemble the corpora amylacea of the aged y
human prostate, but without the characteristic laminations 
(Burek, 1981). The most striking age-related change in the 
ultrastructure of the rat ventral prostate is a progressive i
accumulation of pigment granules, which show characteristics 
of both lysosomes and lipofuscin pigment (Harkin, 1957# 196li 
Brandes, 1963# 1966; Mainwaring and Brandes, 1974). With 
increasing age these deposits become abundant particularly 
in the supranuclear and basal regions of the cell, and in 
rats greater than two years of age they may occupy a large 
proportion of the cytoplasm (Mainwaring and Brandes, 1974),
Arcadi (1959) reported a similar accumulation of PAS-positive 
granules in the prostate glands of aging rats, Histochemical 
studies have further shown that, with age, the distribution 
of acid phosphatase activity in the secretory epithelium of 
rat ventral prostate also becomes concentrated in the 
supranuclear region (Brandes, 1963, 1966> Paris and Brandes,
1974; Mainwaring and Brandes, 1974).
1.2 INTRODUCTION TO THE ANDROGENS
While the rat and human prostate glands exhibit distinct 
morphological, biochemical and pathological differences, both 
organs share a common dependence upon androgens for their 
normal development and growth, and for the maintenance of 
their structural and functional integrity. Moreover, it is 
this basic similarity which has been exploited in the 
widespread use of normal rat prostate as a model organ in 
prostate research.
Androgens (Greek "andros", male) have classically been
- 35 -
defined as steroid hormones which are capable of stimulating
the development of male secondary sex characteristics. All 
native androgens are 19-carbon (C%%) steroid hormones and 
have a common basic molecular structure (Fig. 1.1) consisting 
of a 17-carbon tetracyclic skeleton, the cyclopentanoperhydro­
phenanthrene nucleus, with two angular methyl groups which 
contribute carbon atoms 18 and 19# respectively. Individual 
androgen molecules differ from each other in the structure 
and spatial arrangement of their polar substituents.
1.2.1 Androgen Biosynthesis and Transport
Androgen biosynthesis in the male adult occurs 
primarily in the testis and, to a limited extent, in the 
adrenal cortex. The principal testicular androgen is 
testosterone and it accounts for more than 95% of the total 
testosterone in normal adult men, the remainder being derived 
from peripheral metabolism of other testicular or adrenal 
steroids (Lipsett, 1975).
The biosynthesis of testosterone has been discussed in 
comprehensive reviews by Eik-Nes (1975b) and Ewing and Brown 
(1977). Briefly, testosterone is synthesized from 
cholesterol in the interstitial cells of Leydig under the 
direct stimulation and control of LH (lutenizing-hormone), 
a gonadotrophic hormone secreted by the anterior pituitary 
in response to the hypothalamic gonadotrophin, LH-RP 
(lutenizing-hormone releasing factor). Testosterone 
biosynthesis is primarily regulated by a negative feedback 
system whereby the level of circulating testosterone controls 
the secretion of LH-RP which, in turn, regulates the release 
of LH from the anterior pituitary. However, other factors
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Fig, 1,1. The basic molecular structure of androgens 
indicating the carbon-atom numbering system used for 
steroid hormones. The rings of the cyclopentano- 
perlydrophenanthrene nucleus are designated A, D, C, D. 
Carbon-atoms at positions 18 and 19 are derived from 
angular methyl groups.
~ 37 -
which include age» light, season, temperature and diet, 
and which are often species-specific, also influence the 
secretory activity of the hypothalamus and testis (Price
and Williams-Ashman, 1961).
Testosterone gains access to the systemic circulation
via the spermatic veins and is transported either in the
form of complexes with plasma binding proteins or in the 
free (unconjugated) form (Jung et al,, 1975; Eik-Nes, 1975b; 
Mainwaring, 1977; Menon and Walsh, 1979). 1n human plasma, 
the majority of circulating testosterone is bound to a high 
affinity ^-globulin, known- as TEBG>(testosterone-estradiol 
binding globulin; also designated as SHDG, sex hormone 
binding globulin or SDP, sex steroid binding plasma protein) 
and with lower affinity to transcortin (CDQ, corticosteroid 
binding o^-globulin) and plasma albumin (Jung et al,, 1975i 
Menon and Walsh, 1979). Free testosterone represents less 
than 10e of the total plasma concentration (Mawhinney and 
Delis, 1976). 1n the rat, however', TEDG is absent (Jung et 
al., 1975; Mainwaring, 1977) and plasma testosterone binds 
primarily to the corticosteroid binding globulin, CDG
(Mainwaring, 1977).
At present, the process by which testosterone enters 
androgen-dependent target organs, such as the prostate, is
incompletely understood, but it is believed to be by passive, 
or possibly facilitated, diffusion of the free steroid (Eik- 
Nes, 1975b; Moore and Wilson, 1975f Mainwaring, 1977; Aumuller, 
1979; Farnsworth, 1980). Hence, 1t is the free moiety of 
testosterone which appears to assume biological importance
at the cellular level. The association of testosterone with 
plasma binding proteins may, therefore, be more important in 
regulating the amount of free testosterone available to
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target organs, rather than as a mechanism of androgen transport 
(Lasnitzki and Franklin, 1972j Eik-Nes, 1975^? Lasnitzki, 1976). 
Furthermore, these binding proteins may serve to prevent 
indiscriminate androgenization and to protect the hormone from 
premature destruction by peripheral metabolic processes 
(Maimwairiing, 1977)-
1.2.2. Testosterone Metabolism in the Prostate
In both the rat ventral prostate and the human prostate 
gland, testosterone is subjected to extensive metabolism (Fig.1.2) 
(Farnsworth and Brown, 1963? Ofner, 1968; Bruchovsky and Wilson,
1968a, 1968b; Anderson and Liao, 1968? Siiteri and Wilson, 1970;
Ofner et al. , 197^? Moore and Wilson, 1975? Wilson, 1975; Eik-Nes 
1975a? Mainwaring 1977? Aumuller 1979). The major intracellular 
metabolite, 5<nedihydrotestosterone, is formed by a rapid and 
irreversible reaction catalyzed'by the membrane-bound enzyme, 
5<c^-r^e^c^i^<^'base (NADPH-depenrent-ee-3-ket08terohi-5a—oxidooeducatse). 
Since this metabolite is, itself, a potent androgen and the 
principal steroid retained by prostate cell nuclei (Bruchovsky 
and Wilson, 1968a, 1968b; Anderson and Liao, 1968? Tveter and 
Attramadal, 1969? Tveter and Aakvaag, 1969? Fang et al,, 1969?
Sar et al., 1970), it is generally agreed that 5e3•dihydro- 
testosterone is the "active" form of testosterone in the prostate.
According to the current model for the mechanism of action 
of androgens proposed by Mainwaring (1977), the androgenic effect . 
of testosterone is mediated by a sequence of molecular events 
which are related to the intracellular metabolism of testosterone 
and the presence of specific androgen receptor proteins (Liao et 
al., 1975? Liao, 1976, 1977? Mainwaring, 1977? Ahmed et al., 1979a, 
1979b? Aumuller, 1979? Rennie and Bruchovsky, 198O), This model 
presumes that* (1) after entering the cell, testosterone is converted.
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Fig. 1.2 Pathways of testosterone metabolism in the prostate.
a = 5a-reductase j b = 3<o-hhdroxysteroid dehydrogenase; 
c = 17^-hydroxysteroid dehydrogenase (Farnsworth, 1980.
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to 5<-dihydrotestosterone, thereby minimizing the
intracellular concentration of testosterone and maintaining 
the downhill gradient for the diffusion of testosterone into 
the target cell, (2) 5#-dlhydrotestosterone is selectively 
hound with high affinity to a cytoplasmic receptor protein,
(3) the resultant complex, after undergoing an activation 
step which modifies its stereochemical configuration, is 
translocated to the nucleus where it is hound to nuclear 
acceptor proteins and (4) binding of this complex presumably 
activates metabolic processes (transcription, translation,
DNA synthesis and mitosis) responsible for the androgenic 
response. This model has gained wide acceptance through 
the discovery of cytoplasmic and nuclear androgen receptor 
proteins, which are physiochemically similar in both the 
rat and human prostate glands (Liao et al., 1974, 1975>
Liao, 1976, 1977; Karr and Sandberg, 1979; Aumuller, 1979; 
Rennie and Bruchovsky, 1980; Farnsworth, 1980; de Voogt,
1982), However, the mechanism by which nuclear binding of 
the 5o-dihydrotestosterone complex activates the metabolic 
events involved in the androgenic response is, as yet, 
unknown.
1.2.3 Effects cf Androeen Deprivation and Replacement on~the ~ ’ Rat ~ jrostate
While the isolation and identification of testosterone 
did not occur until 1935 (David et al., 1935), the fundamental 
relationship between the testis and the structural and 
functional status of the prostate was recognized as early as 
1792 by John Hunter (1792) in his classic description of 
post-castration atrophy in the male accessory sex glands.
The cytologic effects of castration were first studied by
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Moore et al. (1930) in the rat prostate, and while only the *
ventral prostate will be considered here, castration induces 
similar retrogressive changes throughout the various segments 
of the rat prostatic complex (Moore et al,, 1930; Price and 
Williams-Ashman, 1961; Cavazos, 1975; Aumuller, 1979). Within 
four days of castration the secretory epithelium in the rat 1A
ventral prostate is reduced in height and the supranuclear 
clear zone disappears. This is accompanied ty a reduction 
in the size of the glandular alveoli and the more prominent 
appearance of the interacinar tissue. On subsequent days 
these changes become more pronounced and by ten days the 
Golgi apparatus begins to fragment. At twenty days post- Mg
castration atrophy is maximali the secretory epithelium is 
a fraction of its normal height, the basement membrane has 
disappeared, epithelial cell nuclei are pyknotic and lack • 
nucleoli, the Golgi apparatus is reduced to granules and the 
glandular alveoli are shrunken, while the proportion of 1
stromal tissue appears to have increased (Moore et al., 1930). 
Korenchevsky and Dennison (1935) suggested that the increase 
in stromal tissue following castration may only be apparent 
with respect to reductions in the proportion of other tissue 
components. However, more recent histoquantitative analyses 
have shown that the volume of interacinar tissue does i
increase, while that of the epithelium and lumen decrease 
(Arvola, 1961; Romppanen et al., 1980; Huttunen et al., 1981).
Post-castration atrophy is also associated with <
extensive alterations in the fine structure of the secretory 
epithelium of the rat ventral prostate (Harkin, 1957» 1961;
Brandes et al., 1962; Brandes and Groth, 1964; Brandes, 1966,
1974b; Helminen and Ericsson, 1971; Kerr and Searle, 1973;
Cavazos, 1975; Brandes and Kirchheim, 1977; Aumuller^, 1979).
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Within 24 to 48 hours of castration, the rough endoplasmic 
reticulum undergoes transient dilation (Harkin, 1957) 
followed by gradual collapse and fragmentation of the 
extensive system of cisternae. Subsequently, the degenerate 
rough endoplasmic reticulum, as well as the Golgi apparatus, 
mitochondria, ribosomes and secretory vacuoles, become 
sequestered in autophagic vacuoles, resulting in the 
progressive depletion of subcellular organelles (Brandes, 
1974b; Brandes and Kirchheim, 1977), Histochemical studies 
have also shown that a marked shift in the intracytoplasmic 
distribution of acid phosphatase activity accompanies 
involution of the glandular epithelium (Brandes, 1966, 1974b; 
Brandes and Kirchheim, 1977), In contrast to the diffuse 
distribution of acid phosphatase positive granules in the 
secretory epithelium of normal rat ventral prostate, enzyme 
activity appears in the form of large conglomerates in 
castrated animals. Localization of acid phosphatase activity 
within the autophagic vacuoles of atrophic prostatic 
glandular epithelium (Helminen and Ericsson, 1971) implicates 
the participation of lysosomal enzymes in the degradation 
process (Helminen and Ericsson, 1971i Brandes, 1974b; Paris 
and Brandes, 1974).
Depletion of the cytoplasmic organelles in castrated 
rat ventral prostate is accompanied by a rapid decline in 
RNA and protein synthesis, with resultant loss of secretory 
activity, and is presumably responsible for marked reductions 
observed in epithelial cell-size (Brandes, 1966, 1974b; 
Helminen and Ericsson, 1971). DeKlerk and Coffey (1978) have 
shown that in rat ventral prostate, castration induces an 85% 
decrease in epithelial cell size, as well as a 92% reduction 
in total epithelial cell number'. Similarly, Lesser and
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Bruchovsky (1973) demonstrated an 85% reduction in the 
number of nuclei isolated from rat ventral prostate l4 
days after castration, indicating that post-castration 
regressign of the prostate is associated with significant 
cell loss. Morphological studies have further shown that 
castration-induced involution of the rat prostate is 
accompanied by extensive epithelial cell loss through 
apoptosis (Kerr et al., 1972; Kerr and Searle, 1973;
Stiens and Helpap, 1981). Concomitant with reductions in 
both epithelial cell. • size and number in castrated rat 
ventral prostate is a cessation of cell renewal (Tuohimaa 
and Niemi, 1974; Tuohimaa, 1980). Within 24 hours of 
castration, DNA synthesis declines dramatically and by day 
6 reaches a negligible level (Lesser and Bruchovsky, 1973; 
Bruchovsky et al., 1975; Bruchovsky and Lesser, 1976). 
Grossly, these changes in cell size and number are reflected 
by a marked decrease in tissue mass. Following castration, 
the rat ventral prostate rapidly atrophies and within two 
weeks represents only a small fraction of its original 
weight (Burkhart, 1942; Saunders, 1963; Coffey et al., 1968; 
Lesser and Bruchovsky, 1973; Kerr and Searle, 1973; Tuohimaa 
and Niemi, 1974; Bruchovsky et al., 1975; Tuohimaa, 1980; 
Huttunen et al., 1981 ; Ehrlichman et al., 1981),
Early experimental studies on androgen replacement 
therapy clearly demonstrated that post-castratlon atrophy 
of the rat prostate is prevented or rapidly repaired by the 
administration of bull testis extracts or exogenous 
testosterone (Moore et al., 1930; Moore and Price, 1938). 
Moore and colleagues found that prostate glands from 13 to 
100 day castrated rats were histologically indistinguishable 
from the normal intact gland within 20 days of androgen
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treatment* Later, Burkhart (1942) studied the earliest 
histologically detectable effects of testosterone on 
castrated rat prostate and showed that increases in both 
epithelial cell size and mitotic activity were evident
within two days of androgen treatment. Epithelial cell 
hypertrophy and enlargement of the cell nuclei were detected
23 hours after testosterone stimulation, while increases in 
mitotic activity were observed after 35 hours and reached 
maximum levels at about 43 hour’s. Subsequent studies have 
shown that the first biochemical manifestation of androgen 
action in castrated rat ventral prostate is a rapid increase 
in RNA and protein synthesis, which follows within a few 
hours of hormonal stimulation (Coffey et al,, 19681 Coffey, 
1974; Mainwaring, 1977; Aumuller, 1979). Evidence of 
restitution of the ultrastructural and functional integrity 
of castrated rat prostate also become apparent within 24 
hours of testosterone treatment (Brandes, 1974b). In 
contrast, the effect • of androgens on prostatic DNA synthesis 
in the castrated rat is a late event characterized by a 
latent period of 24 to 48 hours, which is followed * by a 
surge of DNA synthetic activity that peaks on day 3 to 4 
and, thereafter, declines despite the continued 
administration of testosterone (Coffey et al., I968j Lesser 
and Bruchovsky, 1973» Coffey, 1974; Coffey and Sloan, 1975; 
Mainwaring, 1977; Tuohimaa, 198O). The latent period, 
known as the "pre-replicative phase" (Alison and Wright, 1981), 
represents the time interval during which androgen-induced 
RNA and *protein synthesis occur, and which appear to be 
necessary for the initiation of DNA synthesis and subsequent 
mitosis (Mainwaring, 1977). However, the Induction of 
prostatic DNA synthesis and cell division are refractory to
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androgen stimulation unless sensitized by declining cell 
number and, hence, are dependent upon the time elapsed 
between castration and the onset of hormonal stimulation 
(Bruchovsky et al., 1975; Bruchovsky and Lesser, 1976;
Alison et al,, 1976; Alison and Wright, 1979a, 1981; 
Tuohimaa, 1980). Furthermore, the velocity and magnitude 
of the proliferative response are directly related to the 
time elapsed since castration (Alison et al,, 1976; • Alison 
and Wright, 1979a, 1981; Tuohimaa, 1980), as well, as 
dependent upon the dose and potency of the androgen 
administered and the duration of the treatment (Saunders, 
1963; Robson et al., 1965; Lesser and Bruchovsky, 1973* 
Tuohimaa and Niemi., 1974; Osterberg and Tuohimaa, 1975; 
Bruchovsky et al., 1975; Bruchovsky and Lesser, 1976; 
Tuohimaa, 198O),
The effect of androgens on prostatic DNA synthesis 
in the castrated rat is typical of many mammalian systems 
of induced-growth in that all exhibit common, characteristic 
phases which have been depicted in Baserga's (1969, 1971) 
classical model of the cell cycle (Fig. 1.3) (Carter et al., 
1972; Coffey, 1974; Coffey and Sloan, 1975). Following 
stimulation, the first stage of the cell cycle, termed GAP 1 
or Gp occurs and is characterized by rapid RNA and protein 
synthesis. Subsequently, the period of DNA synthesis, 
designated S phase, ensues and represents the time interval 
during which the cell duplicates its total DNA content. 
Cessation of DNA synthesis is followed by a third period, 
known as GAP 2 or Gg* and is marked by a series of 
biochemical events, notably RNA and protein synthesis, 
which appear to be necessary for the cell to traverse G« 
and enter mitosis, or M phase, which ultimately produces
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Fig. 1.3 The cell cycle. GQ = resting phasei G- = pre- 
replicative phase, S = DNA synthesis, C2 = post 
replicative phaser M = mitosis.
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two daughter cells (Baserga, 1969» 1971# 1976). After
mitosis a daughter cell may remain in the cell cycle or 
leave the cycle to enter a population of non-proliferating 
cells. Such "decycling* cells may either (a) differentiate 
irreversibly, function and eventually die, (b) undergo 
immediate necrosis, or (c) enter a state of proliferative 
rest, termed Gq, and from which they may return to the cell 
cycle (Aherne et al., 1977).
In the normal, adult animal the prostate is a 
proliferatively quiescent tissue since most cells are in 
Gq (Alison et al., 1976; Alison and Wright, 1979a, 1979b,
1981). However, after a period of androgen deprivation 
caused by castration, the administration of exogenous 
androgens stimulates a transitory increase in prostatic 
DNA synthesis and cell division. According to Tuohimaa 
(1980), the administration of androgens to castrated rodents 
has a dual effect on the cell proliferation kinetics of the 
prostate. First, androgens reduce the size of the non­
proliferating (Go) cell population, resulting in an increased 
growth fraction as new cells are recruited into the cell cycle 
(Alison and Wright, 1979a, I98I). Second, androgens enhance 
the velocity of cell cycling, leading to a shortening of all 
phases of the cell cycle (Tuohimaa and Niemi, 1968, 1974; 
Tuohimaa, 1980), However, despite continued androgen 
administration, hormone-induced prostatic cell proliferation 
is a transitory event which ceases once pre-castration 
cellularity has been restored (Bruchovsky et al,, 1975; 
Bruchovsky and Lesser, 1976; Alison et al,, 19761 McHanwell 
et al.# 1976; Alison and Wright, 1979a, 1981; Tuohimaa, 1980), 
Tissue-specific growth inhibitors, such as "chalones* 
(Bullough, 1965; Bullough et al., 1967), have been considered 
as a possible growth-limiting mechanism in the prostate
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(Bruchovsky et al., 1975> Bruchovsky and Lesser, 1976, Tuohimaa, 
1980). Theoretically, the amount of the inhibitor produced by 
the normal number of cells would be sufficient to prevent cell 
proliferation, whereas a reduction in cell number would allow 
the prostate to regenerate until normal cellularity was restored 
(Bruchovsky; et al., 1975f Bruchovsky and Lesser, 1976). 
Alternatively, physicochemical interactions between the fibro- 
muscular stroma and the epithelium may be responsible for the 
regulation of prostatic growth (Franks et al,, 19701 Miintzing 
and Murphy, 1977l Miintzing et al. , 1979i Miintzing, 1980)., 
Miintzing (1980) proposes a mechanism whereby the rate of collagen 
synthesis controls the amount of stromal tissue which, in turn, 
determines the rate of epithelial cell proliferation. The 
hypothesis is further supported by recent evidence indicating 
the importance of epithelial and stromal interactions during 
embryogenesis of the prostate (Lasnitzki and Mizuno, 1979» 1980j 
Cunha and Lung, 1979b, 198O» Bard et al., 1980).
The rapid and dramatic response of the rat prostate to 
androgen deprivation and replacement has resulted in its use 
both as a classical androgen bioassay and an experimental model 
for studying androgen-induced growth of the prostate. While 
cell renewal in the prostate is clearly dependent upon 
androgenic stimulation, the hormonal mechanisms involved in the 
regulation of prostatic growth are poorly understood. Insight 
into the factors controlling prostatic DNA synthesis is, 
however, essential since this represents the uncontrolled 
element which produces abnormal, hyperplastic growth in the 
human prostate. The rate of ‘DNA synthesis in castrated rat 
ventral prostate thus provides a useful parameter for assessing 
the effects of hormones on prostatic growth (Coffey et al., 19681 
Coffey, 1974i Coffey and Sloan, 1975)* In addition, this model 
has been extended to provide a method of assaying the anti­
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proliferative potency of antiandrogenic compounds using androgen
induced DNA synthesis as an index of prostatic growth (Carter 
et al., 1972; Sufrin and Coffey, 1973, 1975; Sloan et si., 1975)
1.3 INTRODUCTION TO ORGAN , AND CELL CULTURE
Organ culture, defined as "the maintenance or growth
of tissues, organ primordia or the whole or parts of an organ 
in vitro in a way that may allow differentiation and 
preservation of the architecture and/or function" (Federoff,
1967), provides a strategy for investigating the direct 
effects of hormones and chemotherapeutic agents on prostatic 
growth. More than 50 years ago, Fell and Robison (1929) 
developed the classical organ culture technique, whereby 
fragments, or explants, of-organs were grown on the surface 
of a coagulum of plasma and embryo extract. Hoover use of 
the plasma clot method was largely replaced during the 1950*s 
through the development of synthetic fluid media (Trowell,
1955, 1959; Waymouth, 1959, 1965» Paul, 1975) and since then, 
organ culture methoddkgy has undergone numerous modifications 
due to the increased application of this technique to a 
variety of specialized tissues and biomedical problems (Foley 
and Epstein, 1964; Fell, 1964, 1976; Easty, 1970; Baulieu et 
al., 1975; Hodges, 1976; Balls and Rao, 1980; Lieber and 
Veneziale, 1980). Current organ culture procedures primarily 
employ the basic technique introduced by Trowell(1954, 1959), 
whereby a platform of perforated metal, known as a "grid", is 
used to support the tissue explants at the interface between 
the fluid medium and gaseous atmosphere of the culture vessel.
Organ culture offers several advantages for the study of 
hormone-dependent tissues, such as the prostate (Lasnitzki, 
1974). In contrast to in vivo experiments, the endocrine
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environment of the tissue can be precisely defined and
easily manipulated. Hence, in the isolated organ the
direct effect of a single hormone, or the interaction of 
several compounds, can be studied under controlled and 
easily reproducible experimental conditions, which are 
devoid of systemic effects. Organ culture also preserves 
the architecture of the tissue, thereby enabling histological 
analyses of the various tissue components and their 
relationships, as well as permitting correlations between 
morphological and biochemical parameters. Preservation of 
the histological architecture may be of particular significance 
with respect to the prostate as interactions between the 
epithelium and stroma appear to play an important role in the 
normal development, growth and function of the gland (Franks 
et al., 1970; Franks, 19771 Muntzing and Murphy, 19771 
Muntzing et al., 1979; Lasnitzki and Mizuno, 1979, 1980;
Cunha and Lung, 1979b, 1980; Muntzing, 1980; Bard et al., 1980)
Clearly, organ culture is well-suited to studies of 
human tissue and, undoubtedly, the ideal model for prostatic 
cancer would utilize tissue of human origin, however, several 
factors limit the realization of this goal (Franks, 1977; 
Merchant, 1979, 1980; McNeal, 1980b). First, human prostatic 
tissue, particularly normal tissue, is not readily available 
in any quantity. While surgical intervention is relatively 
common in the ' treatment of BPH, use of the transurethral 
resection (TUB) procedure provides only a limited amount of 
tissue which is suitable for culture. Radical prostatectomy 
is a considerably less common therapeutic measure for 
treatment of BPH, or prostatic cancer, hence such tissue is 
rarely available. Secondly, the human prostate gland, even 
in its ' normal state, is a heterogeneous organ and this
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variability is further accentuated by morphological
changes due to aging and/or the development of BPH or
prostatic cancer. Hence, the acquistion of replicate
tissue samples is very difficult , particularly if the
specimens are obtained by TUR. Thirdly, the time elapsed 
between procurement of the tissue and establishment of the 
culture may be of critical importance since the prostatic 
secretion contains a high concentration of enzymes, notably 
proteases* which may affect tissue viability. Finally, 
prostatic cancer is usually only detected in its advanced 
stages when the tumour has quite likely undergone considerable 
variation and selection and, therefore, may not be 
representative of the original tumour. Moreover, Merchant 
(1979) has stressed that the prior therapeutic history of the 
patient may also influence the tumour response in vitro.
Use of normal animals, of similar age and physiological 
status, as a source of prostatic tissue eliminates some of 
the problems and variables associated with human prostatic 
tissue and can provide valuable insight into the actions of 
hormones and chemotherapeutic agents on the prostate. During 
the past 30 years, the extensive work of Use Lasnitzki on 
normal rodent prostate in organ culture has clearly demonstrated 
the value of this experimental system for investigations into 
the effects of hormones, vitamins, chemotherapeutic agents and 
carcinogens on prostatic tissue (Lasnitzki, 1951» 1954• 1955» 
1962, 1963. 1964, 1965b, 1970a, 1970b, 1974, 1975» 1976> 
Lasnitzki and Robel, 1969> Lieber and Veneziale, 1980), Organ 
culture studies of normal rat ventral prostate have shown that 
the tissue remains androgen-dependent and responsive in vitro.
In the absence of androgens, the tissue undergoes regressive 
changes similar to post-castration atrophy in vivo 1 the
- 53 -
alveoli shrink, epithelial height is reduced, the supranuclear 
clear zone disappears, there is a loss of epithelial folding, 
secretory activity is diminished or absent and the proportion 
of stromal tissue increases (Lasnitzki, 1974), Ultrastructural 
alterations in the secretory epithelial cells are also similar 
to those observed in vivo following castration. Within two 
days of culture in androgen-free medium the rough endoplasmic 
reticulum collapses, the Golgi apparatus becomes disorganized 
and the luminal microvilli disappear. By four days, the |
rough endoplasmic reticulum is markedly reduced, secretory 
vacuoles are absent and autophagic vacuoles appear throughout 
the cytoplasm (Gittinger and Lasnitzki, 1972, Lasnitzki, 1974,
1975» 1976i Ichihara, 1976, 1977)• Biochemical studies have 
also shown that the acid phosphatase activity in rat ventral 
prostate cultured in testosterone-free medium is greater than 
that in freshly excised tissue or in explants treated with 
testosterone (Lasnitzki et al., 1966). This increased acid 
phosphatase activity in androgen-free cultures, along with 
the development of autophagic vacuoles, is consistent with the 
hypothesis that castration-induced involution of the prostate
i
in vivo is associated with lysosomal enzymes (Lasnitzki, 1975).
The addition of testosterone to organ culture media has
a well-documented effect on the maintenance of cytodifferentiation 
and stimulation of epithelial cell proliferation in normal rat 
prostate (Lasnitzki, 1965b, 1970a, 1970b, 1974, 1975, 19761 
Baulleu et al., 1968a, 1968b, 1969> Robel et al., 1971 > Gittinger 
and Lasnitzki, 19721 Johansson and Niemi, 1975l Johansson, 19761 
Ichihara, 1976, 19771 Lieber and Veneziale, 19801 Sandberg and 
Kadohama, 1980). Rat ventral prostate in organ culture 
concentrates testosterone from the medium (Lasnitzki, 1971,
1974, 1976f Lasnitzki et al,, 1974) and studies of testosterone
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metabolism in vitro have shown that it is similar to the 
in vivo conversion of testosterone to various 5oedndrostane 
derivatives, notably 5«-dihydrotestosterone (Baulieu et al., 
1968a, 1968b, 1969; Robel et al., 1971, 1975; Lasnitzki, 1971, 
1974, 1976i Johansson, 1976). Furthermore, organ culture 
studies on the effects of testosterone and its metabolites on 
rat prostate strongly suggest that the androgenic action of 
testosterone is mediated via its intracellular metabolites 
(Baulieu et al., 1968a, 1968b, 1969; Robel et al., 1971; 
Gittinger and Lasnitzki, 1972; Lasnitzki, 1970a, 1970b, 1971,
1974, 1975, 1976). While all the metabolites exhibit some 
degree of androgenic activity, 5<c-dihycd'otestosterone is the 
most potent in stimulating epithelial cell proliferation, 
whereas 5c-e~idros8suie-d3e» 17^-diol effectively maintains 
cytoplasmic differentiation and secretory activity, but does 
not induce epithelial hyperplasia (Baulieu et al., 1968a, 1968b, 
1969; Robel et al., 1971; Lasnitzki, 1970a, 197<0b, 1971, 1974,
1975, 1976). Thus, Baulieu et al. (1968a, 1968b, 1969) 
suggested that 5o-dihhdrotesto8terone may be responsible for 
the regulation of cell proliferation in the rat prostate, while 
cytodifferentiation and secretory function are maintained by 
5a5dulibostaae-d/3,17/-dhol. As the human prostate exhibits a 
similar pattern of testosterone metabolism to that of the rat, 
experimental studies of rat ventral prostate in organ culture 
may, therefore, be considered relevant to the human gland and 
can provide a valuable reference for the interpretation of 
hormonal responses in the human prostate (Lasnitzki, 1977; 
Tuohimaa, 1980).
While the effects of testosterone and its metabolites
on differentiation and proliferation in cultured rat prostate 
have been well-defined qualitatively, few studies have
- 55 -
attempted to quantitate the proliferative response to androgen 
stimulation and, among those which have, the results are often 
conflicting. These inconsistencies have generally been attributed 
to variations in the composition of the culture medium. With 
few exceptions, organ culture studies of rat prostate routinely 
employ media containing serum and, less frequently insulin, yet 
both of these substances are known to influence the proliferative 
activity of rat prostate in vitro and its response to androgen 
stimulation (Lasnitzki and Franklin, 1972, 19751 Johansson and 
Santti, 19731 Johansson, 1975f Donaldson and Thomas, 1976). 
Consequently, the full potential of this system has not been 
realized primarily because the design of an organ culture 
environment is multifaceted and, as yet, there is no uniformity 
in the composition of organ culture media or the experimental 
procedure employed. Therefore, in an attempt to establish an 
in vitro model for studying the direct effects of hormones and 
chemotherapeutic agents on prostatic growth, the present study 
investigated the proliferative activity of normal rat ventral 
prostate in chemically-defined organ culture using the 
incorporation of 5- E1-iodo-2•-deoxyuridine (12^I-UdR) to 
monitor DNA synthesis.
The y-emitting radioisotope, 12^I-UdR, is a specific 
precursor of DNA (Hughes et al., 1964-) which has been widely 
used in kinetic studies of prostatic tissue in organ culture 
(Littlewood et al., 197^1 Shipman et al., 19751 Donaldson and 
Thomas, 1976| Riches et al., 1976a, 1976b, 1982? Mistry et al. , 
1982) and has proven a useful alternative to [jraethy 1-^hJ- 
thymidine (^H-TdR) for monitoring cell proliferation (Riches 
et al., 1976a, 1976b). Although 12^I-UdR can be both radiotoxic 
and cytotoxic, it is unlikely that such effects are significant 
at low doses in short-term studies (Riches et al., 1976a).
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Moreover, reutilization problems inherent with the use of ^H-TdR 
(Maurer, 1981) are reduced with 12%-UdR (Dethlefsen, 1971» 1974) 
and it has the advantage over ^-emitting radionucleotides in that 
DNA synthesis can be monitored in whole tissues without
histoquantitation, extensive biochemical processing or destruction 
of the tissue sample (Riches et al., 1976a). Simply washing the 
tissue with 70% alcohol removes 98 to 99% of the unbound 
radioactivity (Fidler, 19701 Micklera, 1972). Furthermore , 
fixation in alcoholic Bouin’s fluid does not alter the 12^I-UdR 
activity in cultured prostatic tissue (Riches et al., 1976a,
1976b), thus ^^^I-UdR uptake can be monitored in fixed tissue 
which may be subsequently processed for histological, histochemical 
or histoquantitative analyses.
In the present study, the initial objective was to 
characterize the proliferative activity of young adult rat 
(4 to 6 months old) ventral prostate in chemically-defined organ 
culture, both in the presence and absence of testosterone, using 
the ^2^1-UdR labelling technique. This parameter was then 
correlated with the histological response of the tissue, which 
was also compared with the distribution of ^H-TdR labelling in 
autoradiographs. The specificity of 12^I-UdR uptake was 
further verified by comparing 12^I-UdR activity in whole explants 
with that of DNA biochemically extracted from replicate explants.
Variations in organ culture media (ie. + serum and/or 
insulin) and methodology were also investigated for their effect 
on the proliferative activity of rat ventral prostate and its 
response to testosterone stimulation. Since the age of the 
tissue is also known to influence the response of rodent prostate 
to testosterone (Franks, 1959a» Lasnitzki, 1954, 1974), the 
proliferative activity of aged ( > 12 months old) rat ventral 
prostate was compared with that of younger tissue.
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The established method of quantitative organ culture 
was then used to compare the proliferative response of young 
adult rat ventral prostate to testosterone with that of its
major metabolites, 5<c-dihhdrotestosterone, androstenedione, 
androstanedione and 5a/-androstane-30,l70-diol. The proliferative 
response to 5ao-ihydro0estosterone was also compared with that of 
its epimer, 5/-dihhdrotestosterone. The 12^I-UdR data were 
then correlated with the histological response of the tissue.
Quantitative organ culture was also used to investigate 
testosterone-induced DNA synthesis in rat ventral prostate 
as a potential model for evaluating the antiproliferative 
actions of oestrogens, antiandrogens and hormone-cytotoxic 
agents. Using optimal and minimal testosterone concentrations 
for maximal 12^I-UdR uptake, the inhibitory effects of 
cyproterone acetate and rhethylstilboestrol were investigated 
on the testosterone stimulated response. Similarly, the effects 
of Estracyt (estramustine phosphate disodium and estramustine 
phosphate), and its metabolite, estramustine, were compared 
with that of their carrier-hormone, oestradiol-^^. The effects 
of estramustine phosphate, estramustine and oestradiol-l?^ on 
the proliferative response stimulated by testosterone were also 
compared in the presence and absence of foetal calf serum, as 
per H/isaeter (1975b). The ^^i-udR results were also compared 
with the histological response of the tissue.
While organ culture provides the initial step in determining 
the effects of hormones and chemotherapeutic agents on prostatio 
tissue in vitro, it has become increasingly apparent that to 
further define the actions of these compounds it is necessary 
to obtain pure populations of prostatic cell types for
experimental manipulation. Thus, the specific effects of such
compounds could be correlated with the responses of individual
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cell types. Cell culture, defined as "the in vitro study of J
disaggregated cells** (Federoff, 1967)• provides an ideal <
method for studying cellular and metabolic processes of the -7
two major cell fractions of the prostate, namely the epithelium 
and stroma, in a controlled environment. Separation of these 
different cell types should also permit investigation of their 
intercellular relationships by recombination of cell populations 
(Chevalier et al., 1980). Furthermore, the development of cell 
cultures of normal prostatic epithelium could serve as a model 
system for studies on carcinogenesis, as well as for the 
screening and assessment of chemotherapeutic agents which may be 
of potential value in the clinical management of prostatic 
cancer (Franks, 1977, McLimans et al., 1977, Merchant, 1979,
Webber, 1978, 1979, 1980), However, in order to develop such a 
model system it is first necessary to isolate pure populations 
of viable prostatic epithelial cells and confirm their epithelial x 
origin, as well as to determine their nutrient requirements and 
growth potential in vitro. Hence, prostate cell culture research I 
has been primarily concerned with the development of methods for 
the isolation, characterization and culture of prostatic 3
epithelial cells.
Most primary cell cultures of prostatic epithelium have
.■1been established from outgrowths ef tissue explants (Stonington 
and Hemmingsen, 1971, Schroeder et al., 1971, Webber et al.,
197^, Lewis and Kaack, 1980j Malinin et al., 1980j Clarke and 
Merchant, 1980j Lewis et al., 1981) or from aggregates of 
epithelial cells derived from enzymatically (Stone et al., 1976> 
Burleigh et al., 1980i Douglas et al., 198O1 Webber, 1979, 1980) 
or mechanically (Franks et al., 1970, Lechner et al., 1978) 
dissociated tissue. However, the efficacy of such procedures in
removing stromal cells, in particular fibroblasts, from "purified* §
4
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epithelial cell fractions is questionable. Hence,-several 
studies have investigated the use of density gradients for 
the isolation of epithelial cells from suspensions of 
enzymatically-dissociated tissue (Dow and Pretlow, 1975i Helms 
et al., 1976| Pretlow et al., 1977; Chevalier et al., 1980; 
Rubenstein and Anderson, 1980; Clark et al., 1982),
In an attempt to establish a rapid, yet simple and reliable, 
method of obtaining pure populations of viable epithelial cells 
from normal rat ventral prostate, the present study investigated
ithe use of discontinuous Percoll- density gradients. Cytological 
examination and the histochemical demonstration of acid 
phosphatase activity were used to identify cells of epithelial 
origin. Since the demonstration of formalin-resistant acid 
phosphatase activity in human prostatic epithelium has been used 
as a histochemical marker to characterize isolated or cultured 
prostatic epithelial cells (Stonington et al., 1975)# the 
formalin sensitivity of this enzyme in cryostat sections of rat 
ventral prostate was compared with that of human BPH in order 
to evaluate this method as a means of identifying epithelial 
cells derived from rat prostate. A preliminary evaluation of 
the growth potential of isolated rat ventral prostatic 
epithelial cells in vitro was also investigated using eee^-udR 
uptake and the incorporation of %H-TdR coupled with 
autoradio graphy.
CHAPTER 2
MATERIALS AND METHODS
— 6l —
2.1 ORGAN CULTURE
2.1.1 Animals
Male adult albino rats derived from the Wistar strain 
were used as tissue donor’s. The animals were categorized
according to age into one of the following groups :
1, Young sexually mature rats from 4-6 months of age 
and ranging in weight from 300-500g,
2. Retired breeding rats more than 12 months of age 
and weighing 650-800g.
The animals were housed in a temperature (20-22°C) and light 
(12h light/l2h dark) controlled environment, and were 
maintained on BP No.l small laboratory animal diet and tap 
water ad libitum.
2.1.2 Organ Culture Technique
The basic organ culture technique used was similar to
the method described by Trowell (1954, 1959) and included 
modifications by Riches et al.(1973). The animals were 
sacrificed by ether anaesthesia and the ventral lobes of the 
prostate were aseptically removed. The tissue was rinsed and 
decapsulated in RPMI l640 tissue culture medium (Flow 
Laboratories Ltd.) supplemented with 1Q""m HEPES (N-2- 
hydroxyethyl-piperazine-N*-2-ethane sulphonic acid), 50/ig ml"1 
kanamycin (Flow Laboratories Ltd.) and 40ig ml"1 gentamicin 
(Roussel Laboratories Ltd.), To minimize trauma and avoid 
regenerative hyperplasia, the tissue was gently teased 
(Lasnitzki, 1965a) into 2mm1 fragments with syringe needles 
(N0.25G). Four explants were placed onto a moistened square 
of cellulose acetate membrane filter (0.4^5/rm Millipore filter;
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Oxoid Ltd.) mounted on a stainless steel grid in a 30mm
plastic Petri dish (Sterilin Ltd.). In designated cultures
the explants were placed either directly onto the grid or
onto the bottom of the culture dish. Waymouth’s MB 752/1
tissue culture medium (Flow Laboratories Ltd.) containing
50/ug ml” kanamycin, 40,ug ml” gentamicin and 2mM L-glutamine
(Flow Laboratories Ltd.) was dispensed in 3ml aliquots such
that the medium formed a meniscus with the undersurface of
the grid. Appointed cultures received antibiotic and 
-1L-glutamine supplemented medium containing 3^g ml bovine 
insulin (Sigma Chemical Company Ltd.) and/or foetal calf 
serum (Flow Laboratories Ltd.) at concentrations of 5» 10 or 
20%. The culture dishes were randomly arranged in 90mm 
plastic Petri dishes (3 or 4,30mm dishes per 90mm dish) and 
stacked in McIntosh and Fildes jars lined with paper towel 
dampened with double distilled water. The jars were flushed 
with 95% oxygen and 5% carbon dioxide for 3° minutes at a 
flow rate of 150cc minute”1> then sealed and incubated at 
37°C for a period of 4-6 days. Unless otherwise stated, the 
medium was renewed every second day and the jars regassed.
2.1.3 Androgens
—22.4 x 10” M solutions of the following androgens 
(Sigma Chemical Company Ltd.) were prepared and serially 
diluted in absolute ethanol (Aristar gradej British Drug 
House Ltd.). Directly before use the alcohol solutions 
were diluted lilO with Waymouth’s medium such that the 
addition of 50//1 to 3ml of culture medium produced the 
desired final concentrations. Control cultures received 
an equal volume of absolute ethanol diluted 1:10 with
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Waymouth’s -medium.
1) Testosterone Fig. 2.1 Sigma T-1500
2) 5oK-ihyddotestosterone Fig. 2.2 Sigma A-838O
3) Androstenedione Fig. 2.3 Sigma A-9630
4) Androstanedione Fig. 2.4 Sigma A-8255
5) Aniooseane-30,17^-diol Fig. 2.5 Sigma A-7630
6) 5/5-^^^ oo te s t os terone Fig. 2.6 Sigma E-5376
2.1.4 Hormone-Cytotoxic Compounds
The following estramustine compounds were kindly 
supplied by AKTIEBOLAGET LEO Research Laboratories, Helsingborg, 
Sweden. With the exception of estramustine phosphate sodium 
(LS 299Z), the compounds were prepared as 1 x 10" M solutions 
in absolute ethanol and serially diluted such that the
addition of 10^1 to 3ml of culture medium produced the desired 
final concentrations. Following the same procedure, and in 
accordance with its physiochemical properties, estramustine 
phosphate sodium was prepared in 0.15M saline. Control 
cultures received equal volumes of either absolute ethanol 
or saline.
1) Estramustine phosphate sodium Fig. 2.7 LS 299Z
2) Estramustine phosphate Fig. 2e. LS 299
3) Estramustine Fig. 2,. LS 275
2.1.5 Oestrogens
_?1 x 10 M solutions of the following oestrogens
(Sigma Chemical Company Ltd.) were prepared and serially 
diluted in absolute ethanol such that the addition of 10^1 to 
3m1 of culture medium produced the required final concentrations.
1) Oestradiol-17^ Fig. 2.10 Sigma E-8875
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Fig. 2,1. Testosterone (MW 288.4)
4
Fig. 2.2. 5 az~dihydrotestosterone (MW 290.4)
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Fig. 2.5. Androstenedione (MW 286,4)
Fig. 2,4. Androstanedione (MW 288.4)
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OH
Pig. 2,5. Androstane-5yS ,17^ -diol (MW 292.5)
Pig. 2.6. 5 /-dih^dioOestosterone (MW 290,5)
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Pig. 2.7. Estramustine phosphate sodium (MW 564*39)
3
Pig. 2.8. Estramustine phosphate (MW 520.59)
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OH
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Fig. 2.9. Estramustine (MW 440)
OH
Pig. 2.10. Estradiol-17/3 (MW 272.4)
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Fig. 2.11, Diethylstilboestrol (MW• 268,$)
C«3
c=o
€T
5 
s O
Fig. 2.12. Cyproterone acetate (MW 416.9)
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2) Diethylstilboestrol Fig, 2,11 Sigma D-4628
2.1.6 Antiandrogens
Cyproterone acetate M20 (Fig. 2, 12) was kindly
supplied by Sobering AG Berlin/Bergkamen. West Germany. It
—2was prepared as a 1 x 10 M solution in absolute ethanol and 
diluted such that the addition of 10^1 to 3ml of culture 
medium produced the desired final concentrations. Control 
cultures received an equal volume of absolute ethanol.
2.1.7 ^^^I-UdR Labelling Technique
5_125iodo-2*-deoxxyiridine (12%-UdRj Specific activity 
50i mg" ) was obtained from - • the Radiochemical Centre,
Amersham, England. The isotope was diluted to a concentration 
of lO^uCi ml" in RFMI 1640 culture medium supplemented with 
50/ug ml" kanamycin and %Op,g ml" gentamicin. Each culture 
received luCi of ^UUjuudR per 5ml of Waymouth's medium, and 
unless otherwise stated., the labelling period was 24h, The 
explants were fixed in alcoholic Bouin's fluid, removed from 
the Millipore filters and washed in three changes of 70% 
alcohol during the next three days to remove any unbound 
isotope (Riches et al,, 1976a), Incorporation of 12Ui-udR 
was determined using as LKB Wallac 1275 MiniGamma Counter, 
Groups of four explants, immersed in 70% alcohol., were counted 
for 10 minutes and the data adjusted for background radiation 
and decay of the isotope. The explants were then blotted on 
filter paper and weighed on a Sartorius 2434 balance. Results
-jwere expressed as counts per minute per milligram (CPM mg) 
of fixed tissue.
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2.1.8 DNA Extraction
Isolation of DNA (deoxyribonucleic acid) from %%%I~UdR 
labelled explants was performed using the method of Bonting 
and Jones (1957). Explants were transferred to ice cold 5%
TCA (trichloroacetic acid) and the Millipore filters removed, 
The tissue was washed in three changes of cold 5% TCA during 
a 60 minute period, then rinsed twice in 0,15M saline, The 
wet weight of the tissue (2 explants per group) was determined 
using a Sartorius 2434 balance, Explants used for the 
extraction of DNA were homogenized in IN NaOH for 60 minutes 
at 37°C, DNA was precipitated using 10% TCA and centrifugation 
at 1500rpm for 10 minutes, The precipitate was washed with 
5% TCA and counted for 20 minutes in a IN Intertechnique CG30 
Gamma Counter, Replicate explants were fixed in Bouin's fluid 
and counted as whole explants, The results were expressed as 
counts per minute per milligram (CPM mg” ) of wet tissue,
2.1.9 Histology and Histoquantitation •
Histological sections were prepared of the explants 
and biopsy specimens of fresh tissue (control before 
explantation), Fixed tissue was dehydrated in an ascending 
series of alcohol (75-100%), cleared in chloroform and 
embedded in paraplast, Sections were cut on a rotary 
microtome at Sfjm and were stained using Erhlich's haematoxylin 
and 0,5# aqueous eosin, or the periodic-acid Schiff method 
with Mayer's haemalum as a nuclear counterstain (Pearse, 1968),
Histoquantitative measurements of epithelial height 
were determined using a Reichert-Jung Microstar 120 light 
microscope equipped with a Reichert-Jung MOP-1 console,
Sections were examined using the X40 objective and epithelial
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height jum) was measured at 5 random sites in 30 alveoli.
The results have been expressed as the mean height t s.a.m. 
(standard error of the mean).
2.1.10 %H-TdR•Labelling and Autoradiography
[methyli-H]~thymidine (%I-TdRj Specific activity
5Ci mmole”1) was obtained from the Radiochemical Centre,
Amersham, England. The isotope was diluted to a concentration
of 20iCi ml” in RPMI l640 culture medium supplemented with 
—1 —150/ug ml” kanamycin and 40/ig ml” gentamicin. Each culture 
received 1/u.Cl of %{.-TdR per ml of culture medium for a 
labelling period of 18h. The explants were fixed in Bouin's 
fluid and subsequently washed in three changes of 701 alcohol. 
Histological sections were prepared using the previously 
described (section 2,1,9) method of dehydration, embedding 
and sectioning.
Autoradiographs were prepared using the liquid 
emulsion coating technique described by Kopriwa and Leblond 
(1962). The slides were coated with Ilford Nuclear Research 
G5 emulsion and air dried overnight. As a control measure 
of background radiation, clean glass slides were prepared 
as autoradiographs. The slides were stored in light-proof 
boxes, containing silica gel, for 7-10 days at 4°C. 
Autoradiographs were developed using Kodak D19b High Contrast 
Developer (20*0) for 5 minutes, then rinsed in distilled water 
and fixed in Kodak Acid Fixer, Sections were post-stained 
with Mayer's haemalum and 0,5# aqueous eosin.
Kodak D19b High Contrast Developer was prepared as
follows I
Sodium carbonate (anhydrous) 24,Og
- 73 -
Sodium sulphite (hydrous) 72. Og
Hydroquinone (Quinol) 4,4g
Potassium bromide 2,0g
Metol l.lg
Distilled water 500ml
Statistical Methods
125I-UdR Data
In each experiment, 12 or 16 explants were randomly 
allocated per treatment group and comprised three or four 
replicate cultures. Graphical presentation of the data 
represents results from replicate (n>3) experiments 
calculated as treatment meants.e.m. Variation among the 
treatments was determined using a two-way analysis of 
variance (with replication) and differences between individual 
treatment groups were determined using Duncan’s Multiple 
Range comparison of means test,
2,2 HISTOCHEMICAL LOCALIZATION OF ACID PHOSPHATASE ACTIVITY
2,2,1 Tissue
Fresh specimens of ventral prostate were removed from 
young adult (4-6 months old) and retired breeding (>12 months. 
old) rats derived from the Wistar strain. Biopsies of liver 
and kidney were also excised from young adult rats. Human 
benign prostatic hyperplasia (BPH) specimens obtained by 
transurethral resection were kindly supplied by Mr, J.P.A,
Weaver, Consultant Urologist, Dundee Royal Infirmary,
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2.2.2 Acid Phosphatase Staining of Cryostat Sections j
Tissue specimens were quenched in a C02 expansion 
freezer and transferred to a Slee Type HRM cryostat (-20°C). 
Sections were cut at Q/um and mounted on glass coverslips.
The method used for the histochemical demonstration of acid 
phosphatse activity was similar to the procedure described 
by Carson (1973)• Replicate cryostat sections were fixed in 
either cold acetone (15 minutes) or 10^ neutral formalin 
(5h and 2^-h) or were air dried without fixation. Sections 
were stained in the substrate (Napthol AS-MX phosphate;
Sigma Chemical Company Ltd.) and dye (Fast Garnet GBC 3
diazonium salt; Sigma Chemical Company Ltd.) solution for |
- /60 minutes at room temperature. Mayer’s haemalum was used J
as a nuclear counterstain and the coverslips were mounted onto
S»'A
glass slides with glycerine jelly. Control sections were 2'•H
incubated in either substrate or dye alone. Acid phosphatase 
activity was determined by the presence of a red, granular 
pigment. (
2.3 CELL CULTURE
12.3.1 Animals
Male adult Wistar-derived rats age 2-3 months and•
weighing 200-250g were used as tissue donors. The animals
were housed as described in section 2.1.1.
2.3.2. Tissue Disaggregation
The method used for the disaggregation of rat ventral
prostate was similar to the technique described by Rubenstein
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and Anderson (1980), Ventral prostate glands were aseptically 
removed from three animals by ether anaesthesia. The tissue 
was rinsed and decapsulated in pre-warmed (37*G) HEPES- 
buffered RPMI 1640 culture medium supplemented with 50IU ml” 
benzylpenicillin and 50/ug ml“ streptomycin sulphate (Flow 
Laboratories Ltd.), The tissue was pooled and transferred to
6ml of RPMI 1640 medium (37*G) containing 2mM L-glutamine,
—1 —150IU ml benzylpenicillin, 50ug ml streptomycin sulphate, 
20# calf serum (Flow Laboratories Ltd.) and 0,1# collagenase 
(Clostridium histolyticum; Sigma Chemical Company Ltd,), The 
tissue was rapidly minced with scissors and then incubated at 
37°C for 60 minutes. During the incubation period the tissue 
was mechanically disrupted by frequent pipetting into a 1ml 
syringe and in the last 5 minutes, 0.1ml of 0,4# DNase 
(Deoxyribonuclease I; Sigma Chemical Company Ltd.) was added 
(Clark ' et al,, 1982). The homogenate was filtered through 
a nylon sieve (20^m; Begg Cousland Ltd,) and the cells were 
harvested in a bench centrifuge at lOOOrpm for 10 minutes.
The cells were washed in cold (4°C) RPMI 1640 culture medium 
containing 2mM L-glutamine, 501U ml” benzylpenicillin,
5Q/U ml” streptomycin sulphate and 20# calf serum (hereafter 
referred to as "medium"). The cells were then harvested in 
an MSE Chilspin refrigerated centrifuge (Fisons Ltd,) for 
10 minutes at lOOOrpm and resuspended in 1ml of cold medium.
2.3,3 Isolation of Rat Prostatic Epithelial Cells
Discontinuous density gradients were prepared by 
nlayering Percoll (Pharmacia Fine Chemicals AB) solutions 
of the following densities into a 10ml conical centrifuge 
tube (Sterilin Ltd,)1
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1.02. g ml"1 TOP
1.04 g ml”1
1.06 g ml"*!
1.08 g ml"1
1.10 g ml"1 CUSHION
Percoll solutions of the appropriate densities were prepared
using either 1.5M saline or 10X concentrated RPMI 1640
culture medium (Flow Laboratories Ltd.) such that the
individual bands of the gradient were alternately coloured 
Rand easily distinguished. The following formula (Percoll 
Methodology and Applications, 1980) was used to prepare the 
necessary solutionsi
y p-O-lPto-O.9 
Po-1
Percoll (undiluted) ml
the final solution ml
where VQ = volume of 
V = volume of
•i
p = desired density of the final solution g ml
Pq = density of undiluted Percoll (1.133) g ml"1
P±0 ” density of 1.5M saline (1.055) g ml”1
or density of 10X RPMI (1.057) g ml"1
Since the refractive index of Percoll is directly proportional 
to density, an Abbe *60* refractometer (Bellingham Stanley Ltd.) 
was used to verify the densities of the prepared solutions.
The cells obtained from the tissue disaggregation, 
suspended in 1ml of medium, were gently layered onto the top 
of the gradient and then separated by isopycnic centrifugation 
in the Chilspin centrifuge for 25 minutes at 1500rpm. Using 
a Pasteur pipette, the individual cell bands were serially 
removed from the top of the gradient and then washed three 
times in cold medium to remove any Percoll.
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2.3.4 Characterization of Isolated Rat Prostatic Epithelial Cellsl|
Cytological examination of each cell fraction was 
performed using cytocentrifuge (Shandon Southern Instruments 
Ltd.) preparations. Aliquots (0.2ml) of each cell fraction 
were centrifuged onto glass slides for 5 minutes at 400rpm.
The slides were air dried, fixed in methanol and stained using 
a modified Jenner-Giemsa technique (Thomas, 1971). Morphological 1 
assessment of the cells indicated that the fraction removed 
from the 1.04 g ml” interface contained mainly epithelial cells.
The histochemical demonstration of acid phosphatase 4
was used to identify cells of epithelial origin. Replicate 
cytocentrifuge preparations of the epithelial-enriched fraction 
were fixed in cold acetone or 10# neutral formalin for 1 minute 
or were air dried without fixation, and were then stained for 
acid phosphatase (as described in section 2,2,2).
Epithelial cell viability was determined using the 
trypan blue dye exclusion method. An aliquot of the cell
. suspension was diluted 4*1 with trypan blue (0,2#) and the
j
fraction of the cells excluding the dye were counted using an 
improved Neubaur haemocytometer,
d
2.3.5 Cell Culture and Labelling (12^I-UdR| %H-TdR) Methods
Similar to Rubenstein and Anderson (1980), cells
derived from the epithelial-enriched fraction were cultured
in HEPES-buffered RPMI 1640 medium supplemented with 2mM 
-1 -1L-glutamine, 50IU ml benzylpenicillin, 50ig ml streptomycin 
sulphate, 3ig ml" bovine insulin, 10# calf serum and 4 x 10"?M
<
testosterone.
Short term monolayer cell cultures were prepared by
6 * plating 10i cells in 5ml of medium into 50ml plastic tissue J
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culture flasks (Sterilin Ltd.). The cultures were then 
incubated at 37°C in a humidified air and 5# incubator. 
After one week the cells were stained using either the 
Jenner-Giemsa technique (as described in section 2.3.4) or 
the acid phosphatase staining technique (as described in 
section 2.2.2).
111l-UdR Labelling
"Nuclon” microtest plates (96 flat bottom wells;
K 4Gibco Europe Ltd.) were inoculated with 5 x 10 cells per 
well and incubated at 37°G in a humidified air and 5# COi 
incubator for 9 days. Every second day six replicate wells 
were labelled with O.liCi of H1l-UdR for 24h. The cells 
were then trypsinized (2.5# trypsin; Sigma Chemical Company 
Ltd.) and collected onto fibre filter discs using a Titertek 
(Skatron AS) cell•harvester. The filter discs were dried 
and counted in the LKB Wallac 1275 MiniGamma Counter for 
5 minutes to determine H1l-UdR uptake. The results have 
been expressed as counts per minute (CPM).
iH-TdR Labelling
Coverslip cultures were prepared using "Multidish" 
culture plates (24 wells; Flow Laboratories Ltd,) lined with 
round, plastic Thermanox coverslips (13mm; Lux Scientific 
Corporation). Each plate was inoculated with 1o1 cells per 
well and incubated in a humidified air and 5# COi incubator 
at 37°C for 9 days. Every second day, four replicate cultures 
were labelled with 0,2iCi of %H-TdR for 18h and then fixed in 
acetic ethanol.. The coverslips were mounted onto glass slides 
with glycerine jelly and prepared as autoradiographs using 
the liquid emulsion coating technique (as described in section 
2.1,10), The slides were post-stained with Mayer's haemalum
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and 0,5# aqueous eosin. Replicate cultures were stained 
for acid phosphatase activity (as described in section 2,2,2).
CHAPTER 3
EXPERIMENTAL PROCEDURE AND RESULTS
— 8l
3.1 PROLIFERATIVE RESPONSES OF RAT EETRAAL PROSTATE IN
ORGAN CULTURE
The proliferative activity of rat ventral prostate in
organ culture was monitored using the incorporation of
111l-UdR as a measure of DNA synthesis. H1l-UdR uptake has
been expressed as:
_____ 111l-UdR uptake of treatment group (CPM mg"1) 1
12< 1 ' 1l-UdR uptake of non-supplemented control (CPM mg )
such that the incorporation of H1l-UdR by the unsupplemented 
control equals 100 CPM mg“ .
Results are presented asgraphs and photomccrogaaphs 
which are located at the end of section 3.1.
3.1.1 Proliferative Resatnhehs'OhTesOosOerone in YoungAdult Rat Ventral Prostate ' &
111l-UdR Results
The proliferative activity of young adult (4-6 months 
old) rat ventral prostate cultured in chemically-defined 
medium, in the absence and presence of testosterone 
(4xlO"9 to 4x10""%!), during a four day culture period is 
shown in Fig. 3.1. Testosterone supplements were added on 
day 0 • and replenished following the medium change on day 2, 
Replicate cultures were labelled each day with H1l-UdR for 
24h. Cultures treated with 4x10"1, 4x10"®, 4x10"? and 
4x10“%M testosterone showed similar stimulation of H1l-UdR 
uptake with time, whereas 4x10""m testosterone was markedly 
inhibitory, H1l-UdR uptake in testosterone-free control 
cultures gradually decreased with time.
Using the same procedure and a six day culture period,
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Fig;. 3.2 illustrates the pattern of the proliferative 
response to 4 x 10”?M testosterone. 12^I-UdR uptake
in testosterone-stimulated cultures reached peak 
activity on day 4 and declined thereafter. The 
incorporation of 12^I-UdR in testosterone-free control 
cultures remained relatively constant throughout the 
culture period.
As shown in Fig. 3.3» 12^I-UdR uptake in cultures
treated with 4 x 10”?M testosterone increased linearly
during the final 24h of a four day culture period.
222i-udR was added at the onset of day 4 and replicate
cultures were harvested at four hourly intervals. By
comparison with the testosterone treated cultures,
122^i-UdR uptake in the control cultures showed only a 
slight increase during day 4,
The relationship between testosterone concentration
and 222i-udR uptake on day 4 is shown in Fig. 3.4*.
During the four day culture period, testosterone was
added on day 0 and renewed on day 2. Testosterone
concentrations ranging from 4 x 10“2 to 4 x 10""Ml showed
similar stimulation of 222i-udR uptake, with maximal
incorporation occurring at 4 x 10"? and 4 x 10~^M.
—10Concentrations of testosterone less than 4 x 10“ M 
were not stimulatory and 4 x 10"^M was inhibitory.
Using the same procedure, the inhibitory effect of 
high concentrations of testosterone was investigated 
further (Fig. 3«5)« Optimal stimulation of 222^-UdR 
uptake, as shown in Fig. 3,4,.was maintained in 
cultures treated with 0,5 x 10"2, 1.5 x 10"2 and 
2.0 x 10"-M testosterone. The onset of the inhibitory 
response occurred at 2.5 x 10"2%i testosterone.
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The relationship between 12^I-UdR uptake on day 4 
and testosterone concentration was compared in whole 
explants and DNA extracted from replicate cultures 
(Fig. 3.6). Irrespective of testosterone concentration, 
12%-UdR uptake was equivalent in whole explants and 
corresponding DNA precipitates.
The temporal requirement for testosterone (4 x 
in relation to maximum 12^I-UdR uptake on day 4 is shown 
in Fig. 3*7. Testosterone was available for the following 
time intervals during the four day culture periods (1) the 
first 24h, (2) the second 24h, (3) the first 48h, (4) the 
final 48h or (5) the entire 96h. After treatment with 
testosterone, the explants were rinsed in Waymouth’s 
medium and transferred to-new grids and Petri dishes 
containing testosterone-free medium. Regardless of the 
period of availability, 12^I-UdR uptake was maximal 
when testosterone was present during the first 48h of 
the culture period. The addition of testosterone after 
this time reduced the magnitude of the stimulatory 
response on day 4.
The effect of delaying the introduction, of 
testosterone on the pattern of the proliferative 
response is shown in Fig. 3.8. Cultures were incubated 
with 4 x 10“?M testosterone for either the entire six 
day culture period (by addition on day 0, 2 and 4) or 
the final 96h (by addition on day 2 and 4). Each day 
replicate cultures were labelled with 12^I-UdR for 24h, 
Despite the delay in the introduction of testosterone, 
peak activity still occurred on day 4, but the magnitude 
of the response was markedly reduced.
Using a four day culture period, the effects of
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5# foetal calf serum and/or insulin (3/Wg ml ) on the 
mncocptratmtn of H1l-UdR were investigated in cultures 
maintained in the absence and presence of testosterone 
(4 X 10"? and 4 x 10"%M) (Fig. 3.9). Testosterone was 
added on day 0 and replenished following the medium 
change on day 2. Treatment with 4 x 10"?M testosterone 
produced maximal H1l-UdR uptake under all conditions, 
whereas 4 x 10"^M testosterone was consistently least 
effective. The presence of foetal calf serum did not 
significantly (p>0,05) alter the responses observed in 
the serum-free system. However, the presence of insulin 
stimulated an increase in the uptake of H1l-UdR by the 
testosterone-free control cultures and enhanced the 
stimulatory effect of 4 x testosterone. The
combination of foetal calf serum and insulin stimulated 
increases of similar magnitude in the H1l-UdR uptake of 
all cultures.
In order to determine optimal conditions for
125■1-UdR uptake, explants were grown on M^Mpo^ filter 
paper mounted on the grid, directly on the grid or 
submerged in chemically-defined medium (Fig. 3.10),
During the four day culture period, testosterone 
(4 x 10"?M) supplements were added on day 0 and 2, All 
cultures were submerged and labelled with H1l-UdR for 
the final 24h. Regardless of the experimental conditions, 
all cultures maintained in the presence of testosterone
exhibited a similar stimulatory response on day 4.
12511-UdR uptake in control cultures which had been 
submerged for four days was similar to that of testosterone 
treated cultures and was significantly (p<0.01) greater 
than the paper or grid controls.
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Histological Observations
The in vivo histological appearance of young adult 
rat ventral prostate, as shown in a fresh biopsy specimen 
(Plate 3.1), consists of glandular acini and ducts 
separated by thin strands of fibromuscular stroma. A 
single layer of straight or folded secretory epithelium 
lines the alveoli and ducts, and is composed of cuboidal 
or columnar epithelial cells that have a round basal 
nucleus, with a -conspicuous nucleolus, and exhibit a 
distinctive supranuclear clear zone. Eosinophilic or 
PAS-positive secretory material is often observed as a 
thin film in the alveolar lumina and at the apical 
surface of the epithelial cells. Occasionally, small 
round basal cells are seen* wedged between the secretory 
epithelium and the basement membrane.
Ventral prostatic tissue cultured for four days in 
non-supplemented chemically-defined medium underwent 
epithelial atrophy (Plate 3«2). The histological 
architecture of the tissue was maintained but most alveoli 
were dilated and lined with flattened epithelial cells. 
Residual secretory material was present in some alveolar 
lumina, but evidence of active secretion was usually 
absent. Alveolar epithelium located at the peripheral 
edges of the explants.often exhibited regions of epithelial 
hyperplasia, which appeared as small epithelial outgrowths 
or a piling up of cells into the lumen. In these alveoli, 
the lumina usually contained extruded epithelial cells and 
cellular debris. The content of fibromuscular stroma 
appeared to vary'between explants, but never deviated 
markedly from that seen in'the in vivo controls.
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As shown in Plate 3.3» supplementation of the 
culture medium with 4 x 10 M testosterone did not 
prevent the occurrence of epithelial atrophy observed 
in the non-supplemented controls. Most alveoli were 
lined with flattened epithelial cells and secretory 
activity was diminished or absent. Similar results
were observed in cultures treated with 4 x 10“ and
1 o .4 x 10“ M testosterone. However, cultures treated with 
4 x 10“9, 4 x 10“®, 4 x 10“? or 4 x 10“%M testosterone 
were histologically similar to the in vivo controls in 
that epithelial height and secretory activity were 
maintained. Varying degrees of epithelial hyperplasia 
were also observed, but was most prominent at the 
higher testosterone concentrations. In cultures treated 
with 4 x 10“%M testosterone (Plate 3.4), the secretory 
epithelium of centrally located alveoli was well- 
maintained, while peripheral alveoli usually exhibited 
some degree of epithelial hyperplasia. Treatment with 
4 x 10”?M testosterone appeared to promote epithelial 
cell proliferation throughout the explant (Plate 3.5). 
Regions of well-maintained and hyperplastic epithelium 
often occurred within the same alveolus, but in the 
hyperplastic areas, epithelial height and secretory 
activity were not usually maintained and the lumen often 
contained extruded cells. Changes in the appearance of 
the epithelium in relation to testosterone treatment 
were also reflected in measurements of epithelial 
height (Table 2.1).
Treatment with 4 x 10“%M testosterone appeared to 
have a cytotoxic effect on the tissue (Plate 3.6), In
the majority of explants the epithelium was necrotic and
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Table 2.1 Average epithelial height . (ur + s.e.i.) of young
adult rat ventral prostate in vivo and in vitro.
BIOPSY 4 --JDAY ORGAN CULTURE
Control Testosterone
4x10“12M 4x10“%M 4x10“?M
17.12+ 9.01+ 10.54+ 15.35+ 16.85+
0.42 0.31 0.47 0.50 0.61
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the lumina were occulded with cellular debris. Fibro- 
muscular tissue was scarce and often appeared as only a 
few isolated fibroblasts.
Autoradiographic localization of %H-TdR incorporation 
correlated well with the histological appearance of 
111l-UdR labelled explants. In four day cultures 
maintained in non-supplemented medium, %H-TdR labelling 
was primarily associated with epithelial outgrowths at 
the periphery of the explants (Plate 3.7). However, in 
cultures treated with 4 x 10"?M testosterone, %H-TdR 
labelling was homogeneously distributed throughout the 
tissue and was predominantly associated with the basal 
regions of the alveolar epithelium (Plate 3.8), Cultures 
treated with 4 x 10“%M testosterone were almost entirely 
necrotic and showed no evidence of %H-TdR labelling.
Cultures maintained in testosterone-free medium 
supplemented with either 5# foetal calf serum or insulin 
(3/Ug rl."1) underwent epithelial atrophy similar to those 
explants grown in non-supplemented chemically-defined 
medium. However, the presence‘of insulin appeared to 
enhance the proliferative activity of epithelial cells 
located at the periphery of the explants. Cultures 
maintained in the presence of both insulin and serum 
exhibited similar peripheral epithelial hyperplasia, 
but the remainder of the tissue appeared well-maintained 
and resembled cultures which had been treated with 
optimal concentrations of testosterone.
The histological appearance of cultures treated 
with 4 x 10"?M testosterone were similar whether the 
explants were grown in chemically-defined medium or 
media supplemented with insulin and/or foetal calf
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serum. Most alveoli exhibited regions of well-preserved 
secretory epithelium and areas of hyperplastic growth.
Treatment with 4 x 10”^M testosterone remained 
cytotoxic in the presence of insulin, but in media 
containing foetal calf serum the severity of the 
cytotoxic response was marginally reduced as some 
alveoli were partially maintained. However, in the 
presence of insulin, foetal calf serum and 4 x 10“%M 
testosterone most explants were well-maintained and 
indistinguishable from those which had been treated 
with optimal concentrations of testosterone.
Cultures maintained in chemically-defined medium 
either on Millipore filter paper or directly on the 
grid were histologically similar. Those cultured in 
the absence of testosterone underwent epithelial 
retrogression, whereas treatment with 4 x lO^M 
testosterone maintained the secretory epithelium and 
promoted epithelial cell proliferation. In contrast, 
the secretory epithelium in explants cultured by 
submersion was sloughed into the lumen, often in long 
continuous segments, irrespective of the presence or 
absence of testosterone. The extruded epithelium was 
replaced by two to three irregular layers of crowded, 
round basal cells. With the exception of the 
perialveolar stroma, the interacinar tissue in these 
cultures often appeared hypocellular.
3.1.2 Proliferative Responses to Testosterone and its Metabolites in Young Adult' Rat Ventral Prostate
Using the 12^I-UdR labelling technique, the
proliferative response of cultured rat ventral prostate
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to testosterone stimulation was compared with that of
its major metabolites. Explants were cultured on
Millipore filter paper supported on stainless steel
grids in chemically-defined medium and were treated
with testosterone, 5<c--ihyyd“oteetosterone,
androstanedione, androstenedione, androstane-3/, 17^5-diol
or 5/3dihyyrotestosterone at concentrations of 4 x 10“u,
4 x 10“? or 4 x 10“%M. Androgen supplements were added
on day 0 and replenished on day 2 following the medium 
. 12^change, Cultures . were labelled with ui~udR for the 
final 24h of a four day culture period.
125I-UdR Results
The proliferative responses to testosterone and 
5to-ihydrotestosterone (Fig;. 3*11) were not significantly 
different (p>0.05). Concentrations of 4 x 10”u and 
4 x 10“?M testosterone or 5u-dihydro0et0osterone 
significantly stimulated UUUi-udR uptake (p<0.01), 
whereas at 4 x 10“%M these androgens were both equally 
inhibitory. However, in contrast to 5aodihyd^otestotterone 
its epimer 5/3dihydrotestostertne did not stimulate 
UUUl-UdR uptake at any of the concentrations used .
(Fig. 3.12).
As shown in Fig. 3.13» the proliferative responses 
to testosterone, androstanedione and androstenedione 
were all similar, whereas a^rosta^^/M^S-diol 
elicited & different pattern of response. Testosterone, 
androstanedione and androstenedione significantly 
(p<0.01) stimulated 12Ui~udR uptake at concentrations 
of 4 x 10“9 and 4 x 10“?M, and were all equally
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inhibitory at 4 x 10"%M, In contrast, 4 x 10“%^I 
androstane-3*,17/-diol did not stimulate the
incorporation of 12*I-UdR, whereas 4 x 10“? and
4 x 10"%M were both marginally stimulatory.
Histological Observations
The histological appearance of cultures treated
with 5<a-dihydrotestosterone, androstanedione or
—9 —7androstenedione at concentrations of 4 x 10", 4 x 10"? 
and 4 x 10 %M resembled cultures which had been 
treated with equimolar concentrations of testosterone.
At 4 x 10"%M all of these androgens were markedly 
cytotoxic, whereas at concentrations of 4 x 10"? and 
4 x 10"%M the secretory epithelium was well-maintained 
and epithelial cell proliferation was stimulated 
(Plate 3.9), Unlike these androgens, 4 x 10"%M 
androstane-3/»» 17/3-diol was not cytotoxic (Plate 3.10),
At concentrations of 4 x 10"* and 4 x 10"?M, androstane- 
3*»17/-diol fully maintained the height and secretory 
activity of the alveolar epithelium without promoting 
pronounced epithelial hyperplasia. At 4 x 10 
androstane-3j»17/-diol was inactive and epithelial 
atrophy occurred.
In contrast to 5<o-dihydrotestosterone, treatment 
with 5/--ihyyrotestosterone (Plate 3*11) was ineffective
at all concentrations used and the cultures resembled
those which had been maintained in androgen-free 
medium.
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3.1*3 Proliferative Responses to Testosterone in Ventral Prostate from Retired' Breeding '' Rats
Using the previously established method of 
quantitative organ culture (as described in section 
3,1,2), the proliferative response to testosterone was 
monitored in ventral prostatic tissue from retired 
breeding rats (> 12 months old).
12^I-UdR Results
The relationship between testosterone concentration 
and iI-UdR uptake following four days of organ culture 
is shown in Fig. 3,14, Unlike the testosterone dose- 
response curve for young adult rat ventral prostate 
(Fig.. 3*4), 111l-UdR uptake in cultures of older prostatic 
tissue showed only a slight increase following treatment 
with 4 x 10“2, 4 x 10“ and 4 x 10“?M testosterone, and 
both 4 x 10“ and 4 x 10“%M testosterone were inhibitory.
Using a six - day culture period, Fig, 3*15 illustrates 
the pattern of the proliferative response to 4 x 10“?M 
testosterone in aged rat ventral prostate. In contrast 
to young adult rat ventral prostate (Fig, 3*2), Ull-UdR 
uptake in older prostatic tissue followed a similar 
pattern both in the presence and absence of testosterone. 
Maximum Ull-UdR uptake occurred on day 4 to 5 and the 
testosterone stimulated response was not significantly 
different (p> 0.05) from that observed in the control.
Histological Observations
Macroscopically, ventral prostate from retired 
breeding rats appeared larger than that from younger
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animals and explantation required greater force. As 
shown in Plate 3.12, the in vivo (control before 
explantation) histological appearance of aged rat 
ventral prostate was highly variable. Many alveoli 
were dilated and lined with flattened epithelial cells, 
while others exhibited typical folded columnar epithelium, 
but often both types of epithelium were present within 
a single alveolus. Secretory activity was absent in 
regions of atrophic epithelium and the lumina often 
contained small, eosinophilic concretions.
In contrast to young adult rat ventral prostate, 
aged tissue cultured either in the absence (Plate 3*i3) 
or presence of x testosterone (Plate 3«i^)
exhibited similar histology. In most explants 
degenerative changes were evident in the interacinar 
tissue, which included loss of the perialveolar stroma, 
as well as the basement membrane of the alveolar 
epithelium, resulting in the epithelium having an 
irregular appearance which was further distorted by 
regions of hyperplastic growth. Treatment with higher 
concentrations of testosterone (4 x 10~^ and b x 10”?M) 
had a cytotoxic effect on both the epithelium and 
stroma, similar to that observed in younger tissue 
treated with x 10~^M testosterone.
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Fig. 3.1 Incorporation of 12^I-UdR by explants of young adult
rat ventral prostate cultured in chemically-defined
medium for up to four days in the absence (Control)
0 8and presence of testosterone (4 xlO" , 4 x 10" ,
4 x 10-7f x and 4 x 10“^M).
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Fig. 3,2 Incorporation of 12^I-UdR by explants of young adult 
rat ventral prostate cultured in chemically-defined 
medium for up to six days in the absence (Control) 
and presence of testosterone (4 x
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Fig. 3.3 12^I-UdR uptake during the final 24h of a four day
culture period by explants of young adult rat ventral 
prostate maintained in chemically-defined medium in
the absence (Control) and presence of testosterone 
(4 X 1Q-7M).
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Fig. 3.4 Incorporation of 12^I-UdR by explants of young adult
rat ventral prostate following four days of organ
culture in chemically-defined medium in the absence
(■, medium only; □ , medium and alcohol diluent) and 
—12 —11presence of testosterone (4 x 10 , 4 x 10 ,
4 x 10“10, 4 x 10”9, 4 x 10”®, 4 x 10”7, 4 x 10"6 
and 4 x 10”^M).
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Fig. 3.5 Incorporation of 12^I-UdR by explants of young adult 
rat ventral prostate following four days of organ 
culture in chemically-defined medium in the absence 
(■» medium only; o, medium and alcohol diluent) and
presence of testosterone(0,5 x 10"^, I.5 x 10“^#
2*0 x 10“5, 3.0 x 10-5, 3.5 x iq-5 and 4 x lO^M).
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Fig. 3.6 Incorporation of 12^I-UdR in whole explants and DNA 
extracted from replicate cultures of young adult rat 
ventral prostate following four days of organ culture
in chemically-defined medium in the absence and 
presence of 4 x 10“^* 4 x 10“^, 4 x 10"? and 
4 x 10"*M testosterone (T).
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Fig. 3.7 Incorporation of ' 12^I-UdR by explants of young adult 
rat ventral prostate following four days of organ 
culture in chemically-defined medium in the absence
and presence of 4 x 10~?M testosterone. "TIME* 
represents the time interval during which testosterone 
was present in the medium. ’CONTROL' represents
cultures which were maintained in medium only, or in
medium supplemented with the alcohol diluent
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Fig. 3.8 Incorporation of 12^I-UdR by explants of young adult 
rat ventral prostate cultured in chemically-defined 
medium for up to six days in the absence and presence 
of testosterone. Testosterone was present for either 
the entire culture period (A), or only the final 96h 
(A), ’Control* represents cultures that were 1
maintained in testosterone-free medium.
DAYS IN CULTURE
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Fig. 3.9 Effects of insulin (3/t/g ml*1) and/or 5% foetal calf 
serum (PCS) on the incorporation of 12^I-UdR by 
explants of young adult rat ventral prostate following 
four days of organ culture in the absence (Control) 
and presence of testosterone (4 x 10“? and x 10“^M).
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Pig. 3.10 Incorporation of 12^I-UdR by explants of young 
adult rat ventral prostate following four days of 
organ culture on Millipore filter paper (PAPER), 
directly on the grid (GRID) or submerged in 
chemically-defined medium (BOTTOM), either in the 
absence (Control) or presence of testosterone 
(4 x 10"7M).
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Pig. 3.11 Incorporation of 12^I-UdR by explants of young
adult rat ventral prostate following four days of 
organ culture in chemically-defined medium in the 
presence of testosterone (T) and 5<c-dDiydro- 
testosterone (DHT) at concentrations of 4 x 10"^,
4 x 10-' and 4 x 10"*M. Androgen-free control 
cultures are represented by ■» medium only, and □, 
medium supplemented with the alcohol diluent.

Fig. 3.12
®4j
I
12^ - Incorporation of ^I-UdR by explants of young 
adult rat ventral prostate following four days of 
organ culture in chemically-defined medium in the i
presence of 5c-dihhdrotestosterone (DHT) and f
5j5-dihydrotestosterone (5/3-DHT) at concentrations |
of 4 X 10"9, i x lOT? and 4 x Androgen-
free control cultures are represented by ■» medium ;
£only, and □, medium supplemented with the alcohol JI
diluent. 3
-.4
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Fig. 3,13 Incorporation of 12^I-UdR by explants of young adult 
rat ventral prostate following four days of organ 
culture in chemically-defined medium in the presence 
of testosterone (T), androstanedione (A-3»17-dione), 
androstenedione (A^-A-3,1?-dione) and androstane-3^» 
17^3-diol (A-3/3»17/$-diol) at concentrations of 
4 x 10"9, 4 x 10"7 and 4 x 10"*M. Androgen-free 
control cultures are represented by ■» medium only,
and □, medium supplemented with the alcohol diluent.
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Fig. 3,14 Incorporation of 12^I-UdR by explants of ventral 
prostate from retired breeding rats following four 
days of organ culture in cheraically-defined medium 
in the absence (m, medium only; □» medium and 
alcohol diluent) and presence of testosterone 
(4 x 10-12, 4 x 10-1°, 4 x 10“9, 4 x 10-8, x 10­
4 x 10“8 and 4 x I0“4m).
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Fig, 3,15 Incorporation of XXXj-udR by explants of ventral 
prostate from retired breeding rats cultured in 
chemically-defined medium for up to six days in 
the absence (Control) and presence of 4 x 10~?M 
testosterone.
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Plate 3.1 Alveoli in a fresh-fixed biopsy specimen'of 
young adult rat ventral prostate showing 
actively secreting columnar epithelium, 
Haematoxylin & Eosin. X400.
Plate 3.2 Alveoli in a similar explant of young adult rat 
ventral prostate cultured for - four days in non- 
supplemented, chemically-defined medium, showing 
low atrophic epithelium and absence of active 
secretion. Haematoxylin & Eosin. X400.
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Plate 3.3 Alveoli in a similar explant cultured for four
days in chemically-defined medium supplemented 
—12with 4 x lO M testosterone showing reduced
epithelial height and lack of fresh secretion, 
typical of androgen-free control cultures. 
Haematoxylin & Eosin. X4QQ.
Plate 3,4 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x lO~°M testosterone showing well- 
maintained, actively secreting columnar epithelium, 
typical of the control before explantation (Plate 3«l)* 
Haematoxylin & Eosin. X400.
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Plate 3.5 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 1Q~?M testosterone showing actively 
secreting columnar epithelium and regions of 
epithelial hyperplasia, Haematoxylin & Eosin. 
X400,
Plate 3.6 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10"% testosterone showing extensive 
necrosis of the alveolar epithelium and absence 
of fibromuscular stroma. Haematoxylin & Eosin. 
X400.
A
1
*'v J* • . * '
JmL K • .':? ’ « «• u • . * »:* *..*> »-*5 •
*• 1 V s ’ <*> T• *•<•w, . w•. \hV,.«x
------- - - • • -
— 130 —
Plate 3,7 Autoradiograph of an explant of young adult rat 
ventral prostate cultured for four days in non- 
supplemented, chemically-defined medium showing 
the predominance of ^H-TdR labelling over 
outgrowths of peripherally-located alveolar 
epithelium. Mayer’s haemalum & Eosin. X400.
Plate 3*8 Autoradiograph of a similar explant cultured for
four days in chemically-defined medium supplemented 
with 4 x 10"?M testosterone showing the distribution 
of ^H-TdR labelling over basal regions of the • 
alveolar epithelium. Mayer’s haemalum & Eosin. X400.
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Plate 3.9 Alveoli in an explant of young adult rat ventral 
prostate cultured for four days in chemically- 
defined medium supplemented with 4 x 10~?M 
5a~dihydrotestosterone. showing well-maintained 
columnar epithelium and regions of hyperplastic 
growth. Haematoxylin & Eosin. X400.
Plate 3»10 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10~’M androstan-333,17j-diol» showing 
well-maintained. actively secreting columnar 
epithelium. Haematoxylin & Eosin. X400.
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Plate 3.11 Alveoli in a similar explant cultured for four
days in chemically-defined medium supplemented 
with 4 x 10"?M 5/3-dihydrotestosterone, showing 
low atrophic epithelium typical of androgen- 
deprived cultures, Haematoxylin & Eosin, X400.
Plate 3*12 Alveoli in a fresh-fixed biopsy specimen of 
ventral prostate from' a retired breeding rat 
(> 12 months old), showing the heterogeneity 
of the alveolar epithelium and presence of 
concretions in the lumina, Haematoxylin & 
Eosin. X200,
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Plate 3.13 Alveoli in a similar explant of aged rat ventral
prostate cultured for four days in non-supplemented, 
chemically-defined medium, showing irregularity of 
the alveolar epithelium, some regions of epithelial 
hyperplasia and degeneration of the fibromuscular ' 
stroma, Haematoxylin & Eosin, X400.
Plate 3*14 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10"?M testosterone, showing the same 
irregular appearance of the alveolar epithelium 
and degeneration of the stroma as seen in non- 
supplemented, control cultures of aged rat 
ventral prostate. Haematoxylin & Eosin. X400.
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3.2 EFFECTS OF CHEMOTHERAPEUTIC AGENTS oA THE PROLIFERATIVE
RESPONSE OF RAT VENTRAL PROSTATE TO TESTOSTERONE
STIMULATION IN ORGAN CULTURE
Quantitative organ culture was used to evaluate the 
effects of antiandrogens, oestrogens and hormone-cytotoxic 
agents on testosterone-induced DNA synthesis in young 
adult rat ventral prostate. Explants were labelled with
12^I-UdR for the final 24h of a four day culture period
12^and ^I-UdR uptake has been expressed as:
STIMULATION _ 12^I-UdR uptake of treatment group (CPM mg"1)____
INDEX uptake of testosterone control (CPM mg"1)
such that the stimulation index of the testosterone control 
equals 1.0.
Results are presented as graphs and photomicrographs 
which are located at the end of section 3.2.
3,2.1 Effects of Cyproterone Acetate, Diethylstilboestrol, 
Oestradiol-17" and Estramustine Compounds on the
Proliferative Response to 4 x 1O""m Testosterone
12^I-UdR Results
The effect of cyproterone acetate at concentrations of 
4 x 10“2, 4 x io~7 and 4 x 10~2 on the proliferative 
response stimulated by 4 x 10~?M testosterone is shown 
in Fig, 3,16, Testosterone and cyproterone acetate were 
added simultaneously on day 0 and replenished, following 
the medium change, on day 2. Treatment with 4 x 10"2 and 
4 x 10~?M cyproterone acetate did not significantly reduce 
(p >0,05) the stimulatory effect of testosterone, whereas 
4 x 10~"m was significantly inhibitory (p<0.01).
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Using the same procedure, the effect of 
diethylstilboestrol on the testosterone-induced response 
was investigated (Fig. 3.17). Similarly, concentrations 
of 4 x 10"^ and 4 x 10~?M diethylstilboestrol did not 
reduce the stimulatory response to testosterone, but at 
4 x 10"-% it was significantly inhibitory (p<0.01).
The influence of oestradiol-175, estramustine (LS 275), 
estramustine phosphate (LS 299) and estramustine phosphate 
sodium (LS 299Z) on the testosterone stimulated response 
were compared using the same procedure (Fig. 3*18). At 
4 x 10~9 and 4 x 10“?M oestradiol-175 significantly 
(p <0.05) reduced the testosterone effect, and at 4 x 10"^M 
was markedly inhibitory (p<0,0l). 1n contrast, the 
estramustine compounds exhibited a similar effect at all 
concentrations used 'and were consistently less effective 
than oestradiol-775 in reducing the testosterone stimulated 
response.
The effects of the estramustine compounds and 
oestradio-1775 at 4 x 10~^M were compared both in the 
absence and presence of 4 x 10~?M testosterone (Fig. 3,19), 
The estramustine compounds all had a similar effect in the 
presence of testosterone and were not significantly 
different (p»-0.05) from the testosterone control. However, 
oestradiol-175 had a significant (p<0.01) inhibitory 
effect on the testosterone response. 1n the absence of 
testosterone, there was no significant difference (p >0,05) 
between the estramustine compounds, oestradiol-175 and the 
non-supplemented control.
The influence of oestradio-1775 and the estramustine 
compounds (4 x 10"5m) on the stimulatory effect of 
testosterone (4 x 10“?M) was then investigated with respect
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to the time at which the drugs and testosterone were 
added. In Fig. 3.20, testosterone was added only on 
day 0 and the estramustine compounds and oestradiol-l7g 
were introduced on day 2 following renewal of the culture 
medium. The three estramustine compounds showed the 
same response and were not significantly different 
(p >0.05) from the testosterone control, whereas 
oestradiol-173 significantly inhibited (p<0.01_) 
testosterone stimulation.
In Fig. 3.21, the estramustine compounds and 
oestradiol-17g were added only on day 0 and testosterone 
was introduced following the medium change on day 2.
The estramustine compounds all exhibited the same 
response and were not significantly different (p>0.05) 
from the testosterone control. However, oestradiol-l^g 
had a significant (p<0.01) inhibitory effect on the 
testosterone-induced response.
Histological . Observations
The histological appearance of young adult rat 
ventral prostate cultured for four days in the presence 
of 4 x 10~?M testosterone (Plate 3.15) resembled those 
cultures which had been treated with testosterone and 
either 4 x 10“7 or 4 x 10"?M cyproterone acetate 
(Plate 3*16). In most alveoli the secretory epithelium 
was well-maintained and areas of epithelial cell 
proliferation were evident. In contrast, treatment 
with 4 x 10"7m cyproterone acetate appeared to have a 
cytotoxic effect on both the stromal and epithelial 
components of the tissue (Plate 3.17). Most of the
*
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alveolar epithelium was necrotic# the lumina were filled
with cellular debris and often only "shadows" of former 
alveoli were observed. Stromal tissue was either scarce
or absent.
. -7Cultures which were treated with 4 x 10 'M 
testosterone alone (Plate 3.18) or in combination with 
4 x 10“2, 4 x 10~7 or 4 x 10“%J estramustine phosphate 
sodium, estramustine phosphate (Plate 3*19) or 
estramustine (Plate 3»20) were all histologically 
similar# showing good maintenance of the alveolar 
epithelium and secretory activity. In contrast# 
treatment with either 4 x 10“' or 4 x 10“'m oestradiol-173 
caused slight regressive changes and 4 x 10"%M 
oestradiol-173 caused extensive epithelial necrosis 
and stromal tissue was virtually absent (Plate 3*21). 
Similarly, treatment with the synthetic oestrogen, 
diethylstilboestrol, at 4 x 10“%I was cytotoxic, but 
at lower concentrations it was inactive.
Cultures treated with the estramustine compounds 
(4 x 10“%)) in the absence of testosterone underwent 
epithelial retrogression similar to that which occurred 
in non-supplemented control cultures. However, treatment 
with oestradiol-173 remained cytotoxic in the absence of 
testosterone.
Cultures treated with the estramustine 'compounds 
(4 x 10“%)) either 48h before or after the introduction 
of 4 x 10"?M testosterone were all well-maintained and 
histologically similar to the testosterone control, 
whereas treatment with 4 x 10oestradiol-173 was 
consistently cytotoxic.
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3,2.2 Effects of Cyproterone Acetate, Oestradiol-17fl 
and Estramustine Compounds on the Proliferative
Response , to . 4 x 10“%/I Testosterone
111l-UdR Results
The effect of cyproterone acetate at concentrations 
of 4 x 10“1, 4 x 10"? and 4 x 10"%/I on the response 
stimulated by 4 x 10"%M testosterone is shown in Fig. 3.22. 
Testosterone and cyproterone acetate were added on day 0 
and replenished on day 2 following the medium change. 
Cyproterone acetate at 4 x 10"%M did not significantly 
reduce (p>0.05) the stimulatory effect of testosterone, 
whereas higher concentrations (4 x 10"? and 4 x 10"%)) 
were increasingly inhibitory.
Using the same procedure, the influence of 
estramustine phosphate sodium, estramustine phosphate, 
estramustine and oestradiol-111 on the testosterone
response were compared (Fig. 3.23). At 4 x 10"1 and
—74 x 10"?M, all the estramustine compounds elicited a 
similar response and only marginally reduced the 
stimulatory effect of testosterone, whereas at 4 x 10"^M 
all the compounds were significantly inhibitory (p<0.01). 
In contrast, oestradiol-171 significantly inhibited 
(p<0.01) the testosterone stimulated response at all 
concentrations used.
The inhibitory effects of oestradiol-175 and the 
estramustine compounds (4 x 10"%)) were investigated 
with regard to the time at which the drugs and testosterone 
were introduced. In Fig, 3.24, 4 x 10"%M testosterone was 
added only on day 0 and addition of the drugs followed the 
medium change on day 2. All the estramustine compounds
— ' .14-3 —
reduced the testosterone response equally, but oestradiol-173 
was the most effective inhibitor. By comparison with Fig.
3,23, delaying the onset of the drug addition appeared 
to reduce the magnitude of the inhibitory effects elicited
by each compound.
In Fig;, 3*25» the estramustine compounds and 
oestradiol-173 were added on day 0 only and testosterone 
was introduced on day 2. The estramustine compounds all 
had an equal, and marked, inhibitory effect on the 
testosterone stimulated response, but oestradio-1173 
remained the most potent inhibitor. By comparison with 
Fig, 3.23, pre-treatment with the drugs did not appear to 
increase the magnitude of the inhibitory effects of any 
of the compounds. .
Histological Observations
The histological appearance of rat ventral prostate 
cultured for four days in the presence of 4 x 10“%M 
testosterone alone (Plate 3*22) or in combination with 
an equimolar concentration of cyproterone acetate were 
similar, showing good preservation of the tissue.
However, treatment with 4 x 10“?m cyproterone acetate 
(Plate 3.23) caused marked reductions in epithelial 
height and secretory activity in most alveoli. Treatment 
with 4 x 10"%M cyproterone acetate had a cytotoxic effect 
on both the stroma and alveolar epithelium, similar to 
that shown in Plate 3«i1*
In contrast, cultures treated with 4 x 10“%M 
testosterone alone (Plate 3*24) or in combination with 
either 4 x 10“' or 4 x 10“?m estramustine phosphate
sodium, estramustine phosphate or estramustine were all
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histologically similar and well-maintained. However, in 
cultures treated with the estramustine compounds at a 
concentration of 4 x 10"^M, most alveoli were dilated 
and lined with flattened epithelium. Epithelial folding 
was markedly reduced and secretory activity was diminished 
or absent (Plate 3.25). Unlike the estramustine compounds, 
however, treatment with either 4 x 10"7 or 4 x 10"?M 
oestradiol-7?S» in the presence of 4 x 10"^M testosterone, 
caused severe epithelial atrophy and necrosis (Plate 3.26), 
and 4 x 10"7%i oestradiol-775 was cytotoxic.
Pre-treatment with the estramustine compounds 
(4 x 10~^ivi) for 48h before the addition of 4 x 10"^M 
testosterone caused epithelial retrogression, similar to 
that shown in Plate 3.25» whereas extensive epithelial 
and stromal necrosis occurred in cultures treated with 
4 x 10oestradiol1775.
Cultures treated with the estramustine compounds 
(4 x 10"%) 48h after the introduction of testosterone 
(4 x 10"7%^) were histologically similar to the 
testosterone control, whereas treatment with 4 x 10"-% 
oestradiol-175 remained cytotoxic.
3.2,3 The Influence of Serum and the Effects of Oestradiol-775 
and the Estramustine Compounds on the Proliferative
Response to 4 x 10" M Testosterone
127I-UdR Results
The effects of estramustine phosphate, estramustine 
and oestradiol-175 on the proliferative response stimulated 
by 4 x 10"^M testosterone were compared in the presence
and absence of 5% foetal calf serum (Fig. 3.26). Testosterone
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(4 x 10" ^M) and the drugs (4 x lO"%M) were added on day 0 
and neither the medium nor the supplements were renewed 
during the four day culture period (H/isaeter, 1975b'). In 
the serum-free system, there was no significant difference 
(p> . 0.05) between the response of cultures treated with 
the estramustine compounds and the testosterone control, 
whereas treatment with oestradiol-17/ was significantly 
inhibitory (p<0.01). In contrast, all the drugs exhibited 
comparable responses and were significantly inhibitory 
(p< 0.05) in serum-supplemented medium.
Using the same procedure, the inhibitory effects of 
estramustine phosphate, estramustine and oestradiol-17/3 
were compared in the absence and presence of 5» 10 and 
20% foetal calf serum (Fig. 3.27). In the serum-free 
system, neither of the estramustine compounds had a 
significant inhibitory effect on the testosterone stimulated 
response, whereas oestradiol-17/3 was significantly 
inhibitory (p*0,0l). However, in the presence of 5* 10 
or 20% foetal calf serum, the estramustine compounds and 
oestradiol-173 were all equally inhibitory. By comparison 
with the serum-free system, it appeared that the presence 
of serum enhanced the inhibitory effects of estramustine 
phosphate and estramustine, whereas it decreased the 
inhibitory action of oestradiol-17/.
Histological Observations
The histological appearance of cultures maintained 
in serum-free medium supplemented with 4 x 10"^M 
testosterone alone (Plate 3.27) or in combination with 
4 x 10"%M estramustine phosphate (Plate 3.28) or
estramustine were all well-preserved, whereas treatment
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with 4 x 10"^M oestradiol-173 was cytotoxic (Plate 3.29).
-6In contrast, only cultures treated with 4 x 10 %
testosterone were well-maintained in the presence of 5/ 
foetal calf serum (Plate 3-30)* Treatment with testosterone 
and 4 x 10”"m estramustine phosphate (Plate 3,31) or 
estramustine in serum-supplemented medium caused epithelial 
retrogression which was ■ frequently accompanied by necrosis. 
However, in serum-supplemented cultures treated with 
testosterone and 4 x 10”-Sl oestradio-1173 most of the 
alveoli were dilated and lined with flattened, non­
secreting epithelial cells (Plate 3-32)- The effects of 
oestradiol-173 and the estramustine compounds on cultures 
maintained in medium containing higher concentrations of 
foetal calf serum (10 and 20%) were similar to that 
observed in the presence of 5% foetal calf serum.
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Fig, 3.16 Effects of 4 x 10"9, 4 x 10"? and 4 x 10“"%
cyproterone acetate on the 4 x 10"?M testosterone-
stimulated response of rat ventral prostate on day 
4 following organ culture in chemically-defined 
medium, Non-supplemented control cultures are 
represented by ■, medium only, and □, medium
containing the alcohol diluent.
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Fig. 3.17 Effects of 4 x 10"%, 4 x 10"? and 4 x 10""m
diethylstilboestrol on the 4 x 10"?M testosterone- 
stimulated response of rat ventral prostate on day 
4 following organ culture in chemically-defined 
medium. Non-supplemented control cultures are 
represented by ■ , medium only, and □, medium 
containing the alcohol diluent.
Concentration of Diethylstilboestrol 
(moles litre"1)
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Fig. 3.18 Effects of estramustine phosphate sodium (LS 299Z),
estramustine phosphate (LS 299) t estramustine (LS 2?5) 
and oestradiol-l?% (E2~l7%) on the 4 x 10"?M
testosterone-stimulated response of rat ventral 
prostate on day 4 following organ culture in 
chemically-defined medium. Non-supplemented control 
cultures are represented by ■* medium only and O, 
medium containing the alcohol diluent.
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Fig. 3.19 Proliferative responses of rat ventral prostate 
on day 4 following organ culture in chemically- 
defined medium supplemented with 4 x 10~^M 
estramustine phosphate sodium (LS 299Z)t 
estramustine phosphate (LS 299)» estramustine 
(LS 2?5) or oestradiol-17y3 (E2~17/5) in the absence 
(CONTROL) and presence of 4 x 10“?M testosterone.
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Fig. 3.20 Proliferative responses of rat ventral prostate on
day 4 ' of organ culture in chemically-defined medium 
following treatment with 4 x 10”?M testosterone for 
the first 48h and 4 x lO’^M estramustine phosphate 
(LS 2992), estramustine phosphate (LS 299), estramustine 
(LS 275) or oestradiol—173 (E^-l?^) during the final 
48h. ’Control’ represents non-supplemented cultures.
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Fig. 3.21 Proliferative responses of rat ventral prostate on 
day 4 of organ culture in chemically-defined medium 
following treatment with 4 x 10"^M estramustine 
phosphate sodium (LS 299Z)# estramustine phosphate 
(LS 299)» estramustine (LS 275) or oestradiol-1?^ 
(E2-1?y) during the first 48h and 4 x 10~?M 
testosterone for the final 48h. "Control* 
represents non-supplemented cultures.
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Fig. 3.22 1 Effects of 4 x 10“^, 4 x 10“* and 4 x 10”%M
cyproterone acetate on the 4 x 10“%M testosterone- 
stimulated response of rat ventral prostate on day 
4 following organ culture in chemically-defined 
medium. Non-supplemented control cultures are 
represented by ■* medium only and □» medium 
containing the alcohol diluent.
Concentration of Cyproterone acetate
-j
(moles litre1)
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Fig, 3.23 Effects of 4 x 10”^, 4 x 10”? and 4 x 10”%M
estramustine phosphate sodium (LS 299Z)» estramustine 
phosphate (LS 299), estramustine (LS 275) and 
oestradiol-17^ (E2~17y3) on the 4 x 10”%M testosterone 
stimulated response of rat ventral prostate on day 4 
following organ culture-. in chemically-defined medium. 
Non-supplemented control cultures are represented by 
■t medium only and □, medium containing the alcohol 
diluent.
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Fig. 3,24 Proliferative responses of rat ventral prostate on 
day 4 of organ culture in chemically-defined medium 
following treatment with 4 x lO~^M testosterone for 
the first 48h and 4 x 10“^M estramustine phosphate
sodium (LS 299Z)» estramustine phosphate (LS 299)» 
estramustine (LS 275) or oestradiols/^ (E^-l/^) 
during the final 48h. ’Control’ represents non- 
supplemented cultures.
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Fig. 3*25 Proliferative responses of rat ventral prostate on 
day 4 of organ culture in chemically-defined medium 
following treatment with 4 x 10~*M estramustine 
phosphate.sodium (LS 2992)» estramustine phosphate 
(LS 299)» estramustine (LS 275) or oestradiol-l7/3 
(Eg-17/3) for the first 48h and 4 x 10"^M testosterone 
during the final 48h. ’Control* represents non- 
supplemented cultures.
cr-q 94x10 M Testosterone 
□ Control
DRUGS 
4X10 5M — — LS 299 LS299Z LS 2 75 E2-17B
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Fig. 3.26 Effects of 4 x lO'^M estramustine phosphate (LS 299)» 
estramustine (LS 275) and oestradiol-17y5 (Eg-l?^) on 
the 4 x 10”bM testosterone-stimulated response of rat
ventral prostate on day 4 of organ culture in the 
absence and presence of 5% foetal calf serum (FCS).
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Fig. 3.27 Effects of 4 x 10“""m estramustine phosphate (LS 299)»
estramustine (LS 275) and oestradiol-173 (Eg-l?^) onzthe 4 x 10 M testosterone-stimulated response of rat 
ventral prostate on day 4 of organ culture in the 
absence and presence of foetal calf serum (5» 10 and
20#).
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Plate 3.15 Alveoli in an explant of young adult rat ventral 
prostate cultured for four days in chemically- 
defined medium supplemented with 4 x 10~?M 
testosterone. showing well-maintained columnar
' epithelium and areas of epithelial cell
proliferation. Haematoxylin & Eosin. X400.
Plate 3.16 Alveoli in a similar explant cultured for four
days in chemically-defined medium supplemented
—7 7with 4 x 10 testosterone and 4 x 10“?M
cyproterone acetate. showing close resemblance
to the testosterone control culture (Plate 3.15)
Haematoxylin & Eosin. X400.
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Plate 3.17 Alveoli in a similar explant sultured for four 
days in chemically-defined medium supplemented 
with 4 x 10”?M testosterone and 4 x 10“^M 
cyproterone acetate, showing widespread necrosis
of the alveolar epithelium and fibromuscular 
stroma. Haematoxylin & Eosin. X200.
Plate 3,18 Alveoli in an explant of ' young adult rat ventral 
prostate cultured for four days in chemically- 
defined medium supplemented with 4 x 10"?M
testosterone, showing well-maintained, actively 
secreting columnar epithelium and evidence of
epithelial cell proliferation. Haematoxylin & 
Eosin. X400.
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Plate 3.19 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 X testosterone and 4 x 10"^M
estramustine phosphate (LS 299)» showing the 
same well-preserved columnar epithelium as seen 
in the testosterone control culture (Plate 3,18). 
Haematoxylin & Eosin. X400.
Plate 3*20 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10"^M testosterone and 4 x 10“^M 
estramustine (LS 275), also showing close 
resemblance to the testosterone control culture 
(Plate 3.18). Haematoxylin & Eosin. X400.
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Plate 3*21 Alveoli in a similar expXant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10"?M testosterone and 4 x 10”^M
oestradiol-i?^, showing extensive necrosis of 
the alveolar epithelium and fibromuscular stroma, 
Haematoxylin & Eosin. X200.
Plate 3*22 Alveoli in an explant of young adult rat ventral 
prostate cultured for four days in chemically- 
defined medium supplemented with 4 x 10“^M 
testosterone, showing well-maintained columnar
epithelium and evidence of epithelial cell 
proliferation. Haematoxylin & Eosin. X400,
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Plate 3.23 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10“^M testosterone and 4 x 10"^M 
cyproterone acetate, showing reduced epithelial
height and lack of fresh secretion, typical of 
androgen-deprived cultures. Haematoxylin & 
Eosin. X400.
Plate 3.24 Alveoli in an explant of young adult rat ventral 
prostate cultured for four days in chemically- 
defined medium supplemented with 4 x 10“'M 
testosterone, showing well-preserved columnar 
epithelium and areas of epithelial hyperplasia. 
Haematoxylin & Eosin. X400.
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Plate 3.25 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10”?M testosterone and 4 x 10"?M 
estramustine phosphate (LS 299)» showing.low 
cuboidal epithelium and reduced secretory 
activity, typical of androgen-deprived cultures. 
Haematoxylin & Eosin. X400,
Plate 3.26 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10“?M testosterone and 4 x 10"?M 
oestradiol-1?#, showing atrophic alveolar 
epithelium and necrosis of the fibromuscular 
stroma, Haematoxylin & Eosin. X200.
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Plate 3.27 Alveoli in an explant of young adult rat ventral
prostate cultured for four days in chemically- 
defined medium supplemented with 4 x 10“^M 
testosterone, showing well-maintained, actively 
secreting columnar epithelium. Haematoxylin & 
Eosin. X400.
Plate 3.28 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10“^M testosterone and 4 x
estramustine phosphate (LS 299)» showing close
resemblance to the testosterone control culture 
(Plate 3.27). Haematoxylin & Eosin. X400.

- 185 -
Plate 3.29 Alveoli in a similar explant cultured for four 
days in chemically-defined medium supplemented 
with 4 x 10”%M testosterone and 4 x
oestradiol-17%» showing extensive necrosis of 
the epithelium and stromal tissue. Haematoxylin 
& Eosin. X200.
Plate 3.30 Alveoli in an explant of young adult rat ventral 
prostate cultured for four days in semi-defined 
medium (5% foetal calf serum) supplemented with 
4 x 10“%M testosterone, showing well-maintained, 
actively secreting columnar epithelium. 
-Haematoxylin & Eosin. X400.
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Plate 3*31 Alveoli in a similar explant cultured for four 
days in semi-defined medium (5% foetal calf 
serum) supplemented with 4 x 10“^M testosterone 
and 4 x 10“%M estramustine phosphate (LS 299)» 
showing marked degeneration and necrosis of 
the alveolar epithelium. Haematoxylin & Eosin. 
X400.
Plate 3.32 Alveoli in a similar explant cultured for four 
days in semi-defined medium {5% foetal calf 
serum) supplemented with 4 x 10“testosterone 
and 4 x 10"%M oestradiol-l?3» showing severe
atrophy of the alveolar epithelium and absence 
of secretory activity. Haematoxylin & Eosin. 
X400.
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3.3 HISTOCHEMICAL DEMONSTRATION OF ACID PHOSPHATASE ACTIVITYIN '' HUMAN '' BENIGN ' PROSTATIC HYPERPLASIA (BPH) AND RAT '
VENTRAL PROSTATE
Acid phosphatase activity in fresh-frozen sections of 
human BPH was localized in the alveolar epithelium and 
stained bright red when using the azo-dye, Fast Garnet GBC 
(Plate 3«33)« The intensity of the reaction was similar 
when the cryostat sections were air-dried without fixation 
or were fixed for 15 minutes in either cold acetone or 
10% neutral formalin. Following incubation in 10% neutral 
formalin for 24h the acid phosphatase reaction remained 
positive, but the intensity of the reaction was reduced 
(Plate 3.34).
Acid phosphatase activity in cryostat sections of 
immature (4 weeks old) and' young adult (4 to 6 months old) 
rat ventral prostate was localized in the alveolar 
epithelium but, unlike human BPH, the reaction was much 
less intense (Plate 3*35)* Sections air-dried without 
fixation or fixed in either cold acetone or 10% neutral . 
formalin for 15 minutes all exhibited reactions of similar 
intensity. However, after incubation in 10% neutral 
formalin for 5h, acid phosphatase activity was no longer 
demonstrable in prostatic tissue from either immature or 
young adult rats (Plate 3.36). Similar results were 
observed in cryostat sections of liver and kidney obtained 
from young adult rats.
Unlike young adult rat ventral prostate, acid 
phosphatase activity in cryostat sections of ventral « 
prostatic tissue from retired breeding rats (> 12 months 
old) was localized in discrete clumps throughout the 
alveolar epithelium (Plate 3-37). The distribution and
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intensity of the reaction were similar whether the sections 
were air-dried without fixation or fixed for 15 minutes in 
either cold acetone or 10% neutral formalin. Furthermore, 
acid phosphatase activity in aged rat ventral prostate 
persisted following 5% of formalin treatment and the 
intensity of the reaction was not altered (Plate 3.38 b
Control sections incubated in either the substrate 
(napthol AS-MX phosphate) or dye (Fast Garnet GBC) alone 
did not exhibit any staining reaction.
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Plates 3*33 - 3*38 are cryostat sections of fresh 
biopsy specimens of human BPH and rat ventral prostate 
stained for acid phosphatase in a solution of Napthol 
AS-MX phosphate and Fast Garnet GBC diazonium salt for 
60 minutes at room temperature. Mayer’s haemalum was 
used as a nuclear counterstain.
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Plate 3.33 Human BPH showing intense acid ' phosphatase 
staining in the alveolar epithelium. 
Acetone fixation. X160.
Plate 3*34 Section of the same BPH specimen showing a 
positive, but reduced, reaction for acid 
phosphatase following fixation in 10% 
neutral formalin • for 24h. Xl60,
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Plate 3.35 Young adult rat ventral prostate showing acid
phosphatase staining in the alveolar epithelium. 
Acetone fixation. Xi60.
Plate 3*36 Section from the same specimen of rat ventral
prostate showing the absence of acid phosphatase 
activity after fixation in 10% neutral formalin
for 5h. Xi60,
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Plate 3*37 Ventral prostate from a retired breeding rat 
showing clusters of acid phosphatase activity
in the alveolar epithelium. Acetone fixation.
X160.
Plate 3.38 Section of the same tissue specimen showing a 
similar acid phosphatase reaction after 5h 
fixation in 10% neutral formalin. Xi60.
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3.4 ISOLATION, CHARACTERIZATION AND CULTURE OF EPITHELIAL
CELLS FROM RAT VENTRAL PROSTATE
Disaggregation of rat ventral prostate by enzymatic 
and mechanical disruption provided cell suspensions with 
S 66% viability, as indicated by the exclusion of trypan 
blue dye. Microscopic examination of the cell suspension 
following the 60 minute incubation period indicated that 
the tissue was almost completely digested, with only a 
few small clusters of undissociated epithelial cells 
present. Passage of the cell suspension through a 20^m 
nylon sieve left no residue behind. Extension of the 
digestion period to 90 minutes did not further disrupt 
the undissociated fragments but appeared to have a 
damaging effect on the cell membranes as cytoplasmic 
protrusions were observed on the external surfaces of 
many cells.
Centrifugation of the cell suspension through a 
discontinuous Percoll density gradient (1.02 - l.lOg ml“%) 
yielded a reproducible pattern of three visible fractions 
(Fig. 3.28). Fraction 1 sedimented slightly into the 
1.02g ml layer, had a flocculant appearance and consisted 
predominantly of cell debris (Plate 3*39), Fraction 2 
appeared as a dense band at the 1.04g ml" interface and 
consisted primarily of large, round nucleated cells, some 
of which retained the characteristic appearance of 
prostatic epithelial cells (Plate 3.4-0), Fraction 3 
formed a broad band which occurred between the 1.06 and 
l.OBg ml" layers and contained many erythrocytes along 
with some small and large, round nucleated cells (Plate 
3.41).
On the basis of cell morphology, it appeared that
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Fraction 2 was the epithelial cell enriched band. The 
histochemical demonstration of acid phosphatase activity 
in cells derived from Fraction 2 was further indicative 
of their epithelial origin (Plate 3.42). The intensity 
of the acid phosphatase staining reaction remained the 
same whether the cytopreparations were fixed in cold 
acetone or 10% neutral formalin (1 minute) or were air- 
dried without fixation. Epithelial cell viability was 
> 73%, as indicated by the exclusion of trypan blue, and 
between 3.4 to 4.23 x 10% viable epithelial cells were 
isolated from each cell suspension.
A preliminary investigation of the growth potential 
of isolated prostatic epithelial cells 3n vitro showed 
that within one week cells.derived from Fraction 2 
generated numerous colonies of cells which retained 
histochemically demonstrable acid phosphatase activity. 
Coverslip cultures of isolated prostatic epithelial cells 
labelled with %H-TdR showed that labelling was absent 
during the first day of the culture period but 
progressively increased with time in culture (Plate 3*43). 
Furthermore, replicate cultures indicated that positive 
acid phosphatase activity was retained for at least nine 
days in culture.(Plate 3*44). In contrast, suspension 
cultures of isolated prostatic epithelial cells showed 
that maximum nnnj-UdR uptake occurred during the first 
three days of the culture period and rapidly declined 
thereafter (Fig. 3.29).
200
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Fig. 3,28 Distribution of cells from 
enzymatically dissociated rat ventral 
prostate on the discontinuous Percoll
density gradient.
1
2
3
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Fig. 3.29 Incorporation of %%%I-UdR by cells derived from
Fraction 2 and maintained in suspension cultures 
(microtest plates) for up to nine days in RPMl 
1640 medium supplemented with 10% calf serum,
insulin (3y/g ml"%) and 4 x 10~?M testosterone.
600-
500'
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Plate 3.39 Microscopic appearance of a cytocentrifuge 
preparation of Fraction 1 showing primarily 
cellular debris. Jenner-Giemsa. X200,
Plate 3*%0 Microscopic appearance of a cytocentrifuge
preparation of Fraction 2 showing large, round 
nucleated cells, one of which (arrow) demonstrates 
the typical columnar shape of a prostatic epithelial 
cell with a negatively stained supranuclear zone. 
Jenner-Giemsa. X400.
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Plate 3.41 Microscopic appearance of a cytocentrifuge 
preparation of Fraction 3 showing many red 
blood cells and some large, round nucleated 
cells, Jenner-Giemsa. X400.
Plate 3.42 Photomicrograph of a cytocentrifuge preparation
of cells derived from Fraction 2 showing positive 
acid phosphatase activity. Napthol AS-MX phosphate 
and Fast Garnet GBC diazonium salt. Xi60.
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Plate 3,43 Autoradiograph of a primary monolayer culture
generated by cells derived from Fraction 2 and 
labelled with ^H-TdR after four days of culture. 
Haematoxylin & Eosin. X400.
Plate 3,44 Photomicrograph of a primary monolayer culture 
generated by cells derived from Fraction 2 and 
stained for acid phosphatase after four days of 
culture. Napthol AS-MX phosphate and Fast Garnet 
GBC diazonium salt. X160.
__
CHAPTER 4
DISCUSSION
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In the present study, incorporation of the thymidine
analogue, 12^I-UdR, has been used to monitor the
proliferative activity of normal rat ventral prostate
in vitro with the aim of establishing a model.system to 
study the effects of hormones and chemotherapeutic.agents 
on prostatic growth. Riches et al. (1976a) demonstrated 
the use of ^^^I-UdR labelling as a quantitative means of 
monitoring DNA synthesis in organ cultures of prostatic 
tissue, without histoquantitatlon or biochemical extraction 
procedures. Results of the present study have further shown 
that good correlation exists between the 12^I-UdR activity 
monitored in whole explants of cultured rat ventral prostate 
and DNA biochemically extracted from replicate explants, 
thus confirming that the isotope is preferentially incorporated 
into DNA and that the activity monitored in whole explants 
reflects the ^^^I-UdR uptake associated with the nuclear 
fraction.
As the ^I-UdR labelling technique permits correlation 
of radioactive uptake with histological analysis of the 
tissue sample, the initial objective of the present study was 
to characterize the proliferative activity of cultured rat 
ventral prostate both quantitatively and qualitatively. The 
results have shown that in androgen-free, chemically-defined 
organ culture, the proliferative activity of young adult rat 
ventral prostate gradually declines with time in culture. 
Similar results have also been shown for rat prostate 
maintained in chemically-defined (Johansson,-1975> Donaldson 
and Thomas, 1976) and semi-defined (ie. serum-supplemented) 
(Shipman et al., 1975I Riches et al., 1976b) androgen-free 
media. However, Simnett and Morley (1967) reported that 
mitotic activity in the mouse (6, l4, 24 and 44 weeks old)
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coagulating gland increased significantly following four
days of organ culture in chemically-defined T8 medium and jj
suggested that this response may be due to the isolation of 4
the tissue from growth-inhibiting factors present in vivo .'
However, Muntzing and colleagues (Muntzing and Murphy, 1977$ 
Muntzing et al*» 1979; Mintzing, 1980) contend that there is 
little experimental evidence to confirm the existence of a 
prostatic chalone in rat ventral prostate. Implantation of 
atrophied ventral prostatic tissue from inbred, orchnectomnzed 
rats into the ventral prostate of normal, inbred rats caused 
the DNA content of the gland to increase considerably above 
normal values. This suggests that there is no soluble growth 
inhibitor diffused in the normal prostate in a sufficient
amount to prevent epithelial cell proliferation (Mnntzing
al. , 1979), Since rat ventral prostate does not proliferate 
in androgen-free culture medium, it seems unlikely that a 
mitotic inhibiting factor present in vivo is lost as a result 
of dissection trauma or during organ culture of the prostate.
Alternatively, inherent differences between the ventral 
prostate and the coagulating gland may be responsible for 
differences in the pattern of proliferative activity in vitro j
-J*(Donaldson and Thomas, 1976). The rat coagulating gland,
unlike the ventral prostate, undergoes epithelial hyperplasia 
in androgen-free organ culture (Lasnitzki, 1974). In vivo |
studies have also shown that while cell renewal ceases in rat 
ventral prostate following castration, a low level of mitotic 
activity is retained in the coagulating gland (Tuohimaa and |
Niemi, 1974; Tuohimaa, 1980), However, the coagulating gland
ais a more androgen-sensitive target organ than the ventral 
prostate and, therefore, this residual mitotic activity in vivo
may be related to the action of adrenal androgens (Tuohimaa, 1980)$
%4
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In contrast to Simnett and Morley (1967), Franks (1961,
1963) attributed increased epithelial cell proliferation in 
cultured mouse prostate to the presence of insulin in T8 
medium. The latter contains a high concentration of insulin 
(50/ug ml~ Trowell, 1959) and, as will be discussed later,
insulin has a well-documented stimulatory effect on the 
proliferative activity of rodent prostate in organ culture.
Retrogressive changes resembling those of post-castration 
atrophy in vivo have been described in both mouse (Lasnitzki,
1951, 195^4, 1955, 1963, 1974; Lieber and Veneziale, 1980) and 
rat (Lasnitzki, 1965b, 1970a, 1970b, 1974, 1975, 1976; Lasnitzki, 
et al., 1966; Lasnitzki and Robel, 1969; Gittinger and Lasnitzki, 
1972; Johansson and Niemi, 1975; Feyel-Cabanes et al., 1978, 1980; 
Lieber and Veneziale, 1980; Sandberg and Kadohama, 1980) prostate 
maintained in androgen-free organ culture. The tall, folded 
columnar epithelium of the intact rat ventral prostate decreases 
in height, the supranuclear clear zone disappears, secretory 
activity is diminished or absent and the content of fibromuscular 
stroma increases (Lasnitzki, 1974). Similar changes in the 
epithelium of rat ventral prostate have been shown in the 
present study and differences between the epithelial height of 
intact and cultured prostatic tissue clearly demonstrate the 
retrogressive effect of androgen deprivation. The histological 
response of the tissue to androgen withdrawal also correlates 
well with the progressive decrease observed in Ull-UdR uptake.
However, in contrast to the previously mentioned in vivo 
and in vitro studies of the effects of androgen deprivation on 
rat prostate, the present results did not show a marked 
increase in the content of fibromuscular stroma. Likewise,
Riches it al. (1976b) were unable to demonstrate a significant 
increase in the proportion of interacinar tissue in rat prostate
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cultured for four days in androgen-free, semi-defined medium. 
Lasnitzki (1964, 1974) reported that stromal growth in rat 
ventral prostate maintained in androgen-free, semi-defined 
medium is much less pronounced than that in completely natural 
medium. This suggests that the latter may contain growth 
promoting factors which specifically affect the stromal 
element. Webber (1974, 1978) has also shown that the use of 
horse serum in cultures of normal, sexually-immature human 
prostate favoured epithelial cell proliferation, whereas foetal 
bovine serum stimulated growth of fibroblasts, thus suggesting 
that the type of serum used may selectively enhance proliferation 
of a particular cell type. Franks (1959b, 1961, 1963) also 
showed that the transfer of hyperplastic explants of mouse 
prostate from serum-free medium to culture medium containing 
20 to 40% human adult male serum causes selective degeneration 
of the hyperplastic epithelial cells. This further suggests 
that serum supplements may contain growth regulatory factors 
which are cell-specific.
However, marked increases in stromal growth have also been 
reported in cultures of rat ventral prostate maintained in 
chemically-defined medium for six days (Feyel-Cabanes et al.,
1978, 1980). Possibly, the amount of stromal tissue observed 
in explants of rodent prostate is related to the duration of 
the culture period. Johansson and Niemi (1975) reported that 
rat ventral prostate cultured for two days in semi-defined 
medium closely resembled the in vivo control, whereas a marked 
increase in the content of fibromuscular stroma was evident 
after six days of culture. Furthermore, the present study has 
shown that %H-TdR labelling in four day cultures of rat ventral 
prostate maintained in chemically-defined medium was restricted 
to a few isolated fibroblasts and some small outgrowths of
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peripherally located epithelium» while Feyel-Cabanes et al.
(1980) found that in six day cultures of rat ventral prostate 
maintained in chemically-defined medium ^H-TdR labelling was 
heavily concentrated over perialveolar and interstitial 
fibroblasts.
However, Lasnitzki and Robel (1969) have also emphasized 
that the retrogressive changes observed in cultured rat ventral 
prostate often vary between groups of animals. In some glands, 
epithelial atrophy is accompanied by increased stromal growth, 
whereas in others the effect is confined to regression of the 
alveolar epithelium. Thus, differences in the content of 
fibromuscular stroma may not necessarily be directly related 
to variations in the experimental conditions.
The addition of testosterone to organ culture media has a 
well-defined effect in preventing epithelial retrogression in 
rodent prostate (Lasnitzki, 195^» 1955» 1963, 1965b, 1970a, 1970b, * 
197^, 1975» 1976; Lieber and Veneziale, 1980 j Sandberg and 
Kadohama, 1980). Testosterone maintains the height and secretory 
activity of the epithelium, suppresses stromal growth and 4
stimulates epithelial cell proliferation (Lasnitzki, 197M- f
However, the proliferative response of rat prostate to testosterone
■4stimulation in organ culture has most frequently been assessed on 4 
the basis of histological criteria, as few studies have attempted
to quantitate the response. Lasnitzki (1970b) demonstrated that 
35 x 10”^M testosterone stimulated a marked increase in the 
■^H-TdR labelling index and grain count of rat prostate cultured 
in semi-defined medium. Johansson and Santti (1973) reported 
that testosterone activated the incorporation of labelled DNA 
precursors in rat ventral prostate cultured for two to four days 
in chemically-defined medium. Johansson and Niemi (1975) showed 
significant increases in the incorporation of labelled thymidine
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(^H-TdR and ^C-TdR) and the %H-TdR labelling index of rat
ventral prostate following eight days of organ culture in 
-1 -6semi-defined medium supplemented with ml“ (3»5 x 10" M) 
testosterone. In contrast, Lasnitzki (1979) demonstrated that 
Jug ml"1 (1.04 x 10"*M) testosterone did not stimulate %H-TdR 
uptake in rat prostate cultured for four to six days in semi­
defined medium. However, Johansson (1975) showed that 
testosterone concentrations ranging from 10"1 to 10"1m in 
chemically-defined medium stimulated significant increases in 
^H-TdR incorporation in four day cultures of rat ventral prostate, 
but 10"^M was inhibitory. Similarly, Johansson and Niemi (1975) 
showed that 0.003^ ml" (1.04 x 10" °M) testosterone had a 
marked stimulatory effect on the incorporation of %H-TdR by 
cultures of rat ventral prostate maintained in chemically-defined 
medium for four days. Donaldson and Thomas (1976) have also 
shown marked stimulation of H^I-UdR uptake on day 4 in cultures 
of rat ventral prostate maintained in the presence of insulin 
(3/ug ml"1) and testosterone (10"?M) in serum-free medium. In 
contrast, H/isaeter (1975h) was unable to demonstrate any 
stimulation in the Incorporation of %H-TdR by rat ventral 
prostate following three days of organ culture in semi-defined 
medium containing 4 x 10"1m testosterone.
Results of the present study are in good agreement with 
those of Johansson (1975) and indicate that the proliferative 
response of rat ventral prostate to testosterone stimulation 
in chemically-defined medium is dose-dependent, with testosterone 
concentrations ranging from 4 x 10"1 to 4 x 10"1m inducing 
maximal H1l-UdR uptake, while higher concentrations 
( >2.5 X 10"1m) exert an inhibitory effect. The pattern of the 
proliferative response following stimulation with an optimal 
concentration of testosterone (4 x 10"?M) shows that a lag
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phase of approximately 48 hours precedes the onset of DNA
synthesis, which reaches peak activity on day 4 of the culture 
period and declines thereafter, despite the eonttnutd pressnnc 
of testosterone. Stimulation with W^m testosterone has p een 
shown to elicit a comparable pattern of ^H-TTId uptate 1 n 
cultures of rat ventral prostate maintained in caemncally-deiinep 
medium (Johansson, 1975)* A similar pattern of proliferative 
activity has also been observed in the accessory sex glands of 
castrated rodents treated with exogenous testosterone (Coffey et 
al,, 1968j Carter et al., 1972; Lesser and Bruchovsky, 1973>
Sufrin ' and Coffey, 1973; Coffey, 1974; Ttohimaa and Niemi, 1974; 
Bruchovsky et al., 1975; Bruchovsky and Lesser, 1976; Alison et 
al., 1976; Ttoaimaa, 198O; Alison and Wright, 1979&, 1981). The 
similarity between the proliferative response to testosterone 
in vivo and in chemically-defined organ culture indicates that 
testosterone alone is capable of promoting cell proliferation 
in the prostate, suggesting that other hormonal or non-hormonal 
factors present in vivo may serve only to modify the testosterone 
response. The rapid decline observed in the proliferative 
activity of cultured rat ventral prostate following the transitory 
surge of testosterone-induced DNA synthesis on day 4 is also 
remarkably similar to the in vivo response, which strongly 
suggests the presence of a specific mitotic inhibitory system. 
While the present study does not permit any conclusion regarding 
the nature of the growth-limiting mechanism, the results do 
indicate that prostatic growth is regulated by locally active 
factors which remain functional in organ culture. Furthermore, 
since the suppression of proliferative activity both in vivo 
and en vitro occurs despite the continued administration or 
presence of testosterone, it appears that the initial stages of 
the proliferative response are androgen-dependent, whereas the
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latter stages of the response are independent of androgenic 
stimulation.
In vivo studies have also shown that in castrated rat •>
ventral prostate, the surge of proliferative activity usually
fr
observed three to four days after the onset of testosterone 
treatment can be suppressed by the simultaneous administration 
of either protein synthesis inhibitors, such as cycloheximide 
or puromycin, or the antiandrogen,.cyproterone acetate, with 
testosterone during the 48 hour latent period preceding DNA 
synthesis. However, delaying the onset of these inhibitors 
beyond this time is completely ineffective in blocking DNA i
synthesis, thus suggesting that androgen-mediated events V
necessary for the induction of the proliferative response occur i 
during the latent period (Carter et al., 1972j Sufrin and 
Coffey, 1973i Coffey, 1974; Mainwaring, 1977). Similarly, ?
the present study has shown that the addition of testosterone j
(4 x 10~?M) within the first 48 hours of the culture period t
elicits maximal proliferative activity on day 4, whereas the 
addition of testosterone after this time diminishes the f
magnitude of the response# Delaying the onset of testosterone 
does not, however, shift the day of peak activity but, rather*, 
shortens the duration of the latent period. Results of the 
present study have also shown that the addition of testosterone 
only during the first 24 hours, the second 24 hours or the 
first 48 hours evokes an increase in DNA synthesis on day 4 
which is of equivalent magnitude to the response elicited when | 
testosterone is present for the entire culture period. Similarly,| 
Lesser and Bruchovsky (1973) demonstrated that in vivo a single 
androgen injection is capable of stimulating a marked increase 
in DNA synthesis in castrated rat ventral prostate. These 4
results suggest that either androgens are very long lived in
'34
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prostatic tissue (Lesser and Bruchovsky, 19731 Bruchovsky
et al., 1975) or» more likely, that proliferation, once
initiated, can proceed without further hormonal stimulation 
(Coffey, 1974).
In contrast to the present study, in vivo studies have 
shown that the magnitude of the proliferative response to 
androgen stimulation in the accessory sex glands of castrated 
rodents increases with time after castration (Osterberg and 
Tuohimaa, 19751 Alison and Wright, 1979&» 19811 Tuohimaa,
1980) and it has been suggested that this increased proliferative 1 
activity is a reflection of the cell production required to 
restore pre-castration cellularity of the gland (Alison and 
Wright, 1979a> 1981). However, in vivo studies have also 
shown that the response to androgen treatment In the accessory 
sex glands of castrated rodents becomes more rapid as the time 
interval between castration and the onset of androgen 
administration increases (Saunders, 1963J Osterberg and 
Tuohimaa, 1975f Bruchovsky and Lesser, 1976j Alison et al.,
19761 Alison and Wright, 1979a, 198lj Tuohimaa, 1980). Alison 
and Wright (1981) have suggested that as the period of androgen 
deprivation increases in castrated animals, cells of the 
accessory sex glands may move at a "shallower level within GQW, 
resulting in a more rapid induction of DNA synthesis and, hence, 
shortening of the pre-replicative phase, once the androgenic 
stimulus is introduced.
The dose-dependent effect of testosterone on ^^^I-UdR 
uptake in cultured rat ventral prostate correlated well with 
the histological response of the tissue. Treatment with 
4 x 10~12 to 4 x -(;es^og-(;erone chemically-defined
medium was insufficient to completely prevent the occurrence 
of epithelial atrophy associated with androgen deprivation.
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Similarly, Feyel-Cabanes et al. (1978) reported that
testosterone concentrations > 10*^^ are required in chemically- 
defined medium to maintain rat ventral prostate in a state 
comparable to the normal, intact gland. The present results 
have further shown that testosterone concentrations ranging 
from 4 x 10“e to 4 x 10“ejM maintained the secretory epithelium 
and promoted epithelial cell proliferation, particularly at the 
higher concentrations. Lasnitzki and Franklin (1972) and 
Kadohama et al, (1977) also reported that in chemically-defined 
organ cultures of rat prostate, testosterone concentrations 
ranging from 5 x 10“e to 5 x 10^^ are capable of providing 
good maintenance and stimulating epithelial cell proliferation.
In the present study, the proliferative effect of testosterone 
(4 x 10“7M), and the extent of the response, was further 
illustrated by the homogeneous distribution of %H-TdR labelling, 
which was associated primarily with the basal regions of the 
glandular epithelium. H/isaeter (1975b) has shown a similar 
distribution of %H-TdR labelled epithelial cells in the basal 
regions of alveoli in explants of rat ventral prostate cultured 
for four days in the presence of 4 x 10“e^ testosterone.
Results of the present study have also shown that treatment 
with high concentrations of testosterone (4 x 10"^) in 
chemically-defined medium has a marked cytotoxic effect on rat 
ventral prostate, which is presumably responsible for the 
dramatic decrease observed in eee-j-udR uptake. Similarly, 
Kadohama et al, (1977) found that treatment with 5 x 10“^ 
testosterone had a severe deleterious effect on rat ventral 
prostate cultured in chemically-defined medium. Lasnitzki (1965a) 
has suggested that non-specific cytotoxicity associated with the 
use of high hormone concentrations in vitro may be related to 
the concentration of the hormone per se, rather than to its
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physiological function.
Apart from the concentration of testosterone * variations 
in organ culture media and methodology can also influence the 
proliferative activity of prostatic tissue in vitro. Merchant 
(1979) has emphasised the lack of uniformity in prostate 
culture media, particularly with respect to serum supplementation. 
In organ culture studies of rodent prostate, foetal calf, calf, 
horse or human serum are frequently incorporated into culture t
media, generally in concentrations ranging from 5 to 20$.
However, serum supplements often have the disadvantage of being 
the source of pathological contaminants and of introducing 1
biologically active substances, such as hormones, into culture 
media. Furthermore, the identification and concentration of 
such compounds is unknown and can vary greatly between batches 
of serum (Taylor, 197*H Sato, 1975l Hodges, 1976> Stiles et al., 
1981). Clearly, the introduction of unknown types and quantities t 
of hormones through serum supplementation is of particular 
significance in studies attempting to define the hormone- «
dependence of organs, such as the prostate. In addition, most 
sera also contain steroid hormone binding proteins, notably 
TEBG, which may influence the biological action of testosterone 
in vitro by limiting the amount of free or unbound hormone 
available to the tissue (Lasnitzki and Franklin, 19721 Sandberg 
and Kadohama, 1980). Undoubtedly, the biological effects of 
serum will be influenced by the age, sex, species and physiological 
state of the donor, however, as most commercially obtained sera 
are pooled some of these factors are unknown or ill-defined.
In the present study, the addition of 5% foetal calf serum 
to the culture medium did not alter the proliferative response 
of rat ventral prostate to testosterone x 10"^M) stimulation
or the response of testosterone-free cultures, as compared with
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the serum-free system. However, in contrast, H/fisaeter (1975b) 
was unable to demonstrate testosterone (4 x 10“#M) stimulation 
of %--TdR uptake in rat ventral prostate cultured in medium 
containing 5% foetal calf serum and suggested that endogenous 
androgens present in the serum supplement may have been 
responsible for masking the stimulatory effect of testosterone. 
These contrasting results may, however, be attributed to 
variations in the hormone content of different batches of 
commercially prepared foetal calf serum (Esber et al., 1973).
Unlike organ culture studies which have used high 
concentrations of testosterone (> 10“#M) in semi-defined 
media and shown good maintenance of rat prostate (Lasnitzki, 
1965b, 1970a, 1970b, 197-4, 1975, 1976i Lasnitzki et al., 19661 
Baulieu et ai.» 1968b; Lasnitzki and Robel, 1969; Robel et al., 
1971), the present results have shown that treatment with 
4 x 10“%M testosterone in the presence of 5% foetal calf serum 
remains cytotoxic, although the severity of the toxic effect 
is marginally reduced compared to the serum-free system. In 
medium containing 10# calf serum, Johansson and Niemi (1975) 
found that testosterone concentrations S lOO^eg rr“* (3.5 % 10“%M) 
also produced a non-specific cytotoxic effect in cultures of 
rat prostate. Differences between the effects of high 
concentrations of testosterone on rat prostate in organ culture 
may, therefore, be related to the serum supplement,and-, in 
particular, the steroid hormone ' binding capacity of the serum 
used. Lasnitzki and Franklin (1972) demonstrated that the 
uptake of ^H-testosterone by rat ventral prostate in organ 
culture is inversely related to the concentration of serum 
used and is significantly lower in , the presence of human 
pregnancy serum, which contains high levels of TEBG. Furthermore 
Lasnitzki et al, (1974) showed that in medium containing 5# horse
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serum, testosterone concentrations >3.5 x 10“%M are required 
to produce an intracellular concentration of testosterone in
rat ventral prostate which equals or exceeds that of the
—9medium, whereas in serum-free medium 1.9 x 10 testosterone
is sufficient. Hence, supraphysiological concentrations of
testosterone are routinely used in serum supplemented media
in an attempt to overcome the effect of hormone binding
proteins. Yet, physiological concentrations of testosterone 
—fi(rat plasma testosterone approximates 10Mj Johansson, 1975) 
have been shown to effectively maintain rat ventral prostate 
cultured in either semi-defined (Johansson and Niemi, 1975) 
or chemically-defined (Lasnitzki and Franklin, 1972f Feyel- 
Cabanes et al., 1978, 1980) medium. The present results 
have also shown that physiological concentrations of 
testosterone are sufficient to maintain rat ventral prostate 
in short-term, chemically-defined organ culture. Thus it 
appears that serum is not essential for the in vitro culture 
of rat prostate and its elimination from culture media may 
well allow more precise definition of the effects of testosterone
Variations in the proliferative activity of rodent prostate 
in organ culture have also been attributed to the presence of 
insulin in some culture media (Franks, 1961, 1963; Donaldson 
and Thomas, 1976). Although insulin has been implicated as an 
essential factor for the culture of rodent prostate (Franks,
196If lostroh, 1971)» it also has a well-defined stimulatory 
effect on the proliferative activity of rat ventral prostate 
in vitro (Johansson and Santti, 1973f Johansson, 1975f Donaldson 
and Thomas, 1976) and has been reported to act synergistically 
with testosterone in rodent prostate organ culture (Lostroh,
1968, 1971 I Santti and Johansson, 1973f Johansson and Santti, 
1973f Ichihara et al., 1973f Fuller et al., 1974; Johansson,
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1975» 1976; Edwards et al., 1976; Ichihara, 1977).
Results of the present study have also shown that
supplementation of chemically-defined medium with insulin 
(jug ml”1) stimulates an increase in the proliferative activity 
of testosterone-free cultures of rat ventral prostate. The 
histological response of these cultures indicated that the 
proliferative activity occurred in the peripherally-located 
alveolar epithelium, thus suggesting that insulin may promote 
post-traumatic regenerative hyperplasia. In contrast, Franks 
(1961) reported that the majority of alveoli in cultures of 
mouse prostate maintained in T8 medium showed evidence of 
epithelial hyperplasia. However, the stimulatory effect of 
insulin on the proliferative activity of rat ventral prostate 
in chemically-defined organ culture is dose-dependent
(Johansson, 1975; Donaldson and Thomas, 1976) and since T8 
medium contains a high insulin content, these contrasting 
results may be related to differences in the concentration of 
insulin present in the medium.
Similar to previous studies (Johansson and Santti, 1973; 
Johansson, 1975; Donaldson and Thomas, 1976), the present 
results have also demonstrated that the presence of insulin 
in the culture medium augments the proliferative effect of 
testosterone (4 x 10“%M) on rat ventral prostate. However, 
treatment with 4 x 10“%M testosterone remains inhibitory in 
insulin-supplemented medium. Similarly, Fuller et al.>(1974)
reported that insulin (0.3 and 3,0fug ml”1) enhances the
7 —8stimulatory effect of 10and 10 M testosterone on the
l4 T *incorporation of labelled leucine ( C- or %H-leucine) and 
C--uridine into cultured rat prostate, whereas 10“Cj 
testosterone has an inhibitory effect. However, the histological 
results of the present study have shown that treatment with
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4 x 10“%M testosterone, either in the presence or absence
of insulin, is cytotoxic and presumably this accounts for
reductions observed in the uptake of labelled DNA, RNA and |¥
protein precursors. Moreover, these results emphasize the 
importance of correlating biochemical parameters with the 
histological response of the tissue. |
The present results have further shown that the 
combination of insulin with 5% foetal calf serum stimulates 
proportional increases in the proliferative response of rat 
ventral prostate, regardless of the presence (4 x 10“? or 
4 x 10“%)) or absence of testosterone. Histologically, the 
results also indicated that this combination of insulin and 
serum provides good maintenance and stimulates epithelial 
cell proliferation in cultured rat ventral prostate, 
irrespective of whether or not testosterone is present. This 
suggests that insulin and serum may have a synergistic effect 
on rat prostate which is independent of testosterone, although 
it is possible that this effect is due to the synergistic 
action of insulin with endogenous androgens present in the 
serum supplement (Sandberg and Kadohama, 1980). It is, however, 
difficult to rationalize the stimulatory effect of insulin and 
serum on cultures treated with testosterone concentrations i
which are known to be cytotoxic in chemically-defined organ |
culture (is. 4 x 10“%)) in terms of an enhanced testosterone 
response. ■
Although Insulin is known to exert a wide spectrum of <
effects on many cell types, the mechanism of action of this -
hormone remains unknown (Kahn et al., 1981). With regard to 
the prostate, Sandberg and Kadohama (1980) contend that insulin, | 
itself, has no effect in the absence of androgens and suggest 
that, in organ culture, insulin enhances the uptake or effects
•* w
— 225 "
of endogenous androgens present in the explants or serum 
supplement. It is, however, questionable whether the explants 
contain sufficient levels of endogenous androgens to account 
for the increased proliferative activity observed in insulin- 
supplemented, chemically-defined organ cultures of rat 
prostate and, in particular, for the dose-dependence of the 
insulin response. Moreover, Johansson and Santti (1973) 
reported that in chemically-defined organ cultures of rat 
ventral prostate, addition of the antiandrogen, cyproterone, 
inhibited testosterone-induced DNA, RNA and protein synthesis, 
but was less effective in suppressing the stimulatory effect 
of insulin on these parameters. This suggests that these 
hormones have different mechanisms of action in the prostate. 
Furthermore, Lasnitzki (197^^4) has reported that the stimulatory 
effect of Insulin on cultured rodent prostate is not due to 
increased testosterone uptake in the presence of insulin and 
Johansson (1976) has further shown that the rate of testosterone 
metabolism to 5o-dihydrotestosterone in cultured rat ventral 
prostate is not influenced by insulin. While insulin 
undoubtedly enhances the stimulatory effect of testosterone 
on rodent prostate In vitro, and in diabetic, castrated rats 
in vivo (Sufrin and Prutkin, 1974j Oksanen and Tuohimaa, 1975), 
it also appears that insulin may have a direct prostatic effect 
which is independent of androgens. Therefore, with regard to 
organ culture, studies which aim to investigate the androgen 
dependence of the prostate, clearly the addition of insulin and/ 
or serum to the culture medium complicates the interpretation 
of the response to androgen stimulation and deprivation. On the 
other hand, however, organ culture also provides an ideal method 
of studying interactions between testosterone and other hormonal 
or non-hormonal factors which may influence the effect of
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testosterone on the prostate in vivo.
In addition to the composition of culture media, the
present study has also shown that variations in organ culture 
methodology can Influence the proliferative response of 
prostatic tissue jn vitro. Rat ventral prostate cultured by 
submersion in non-supplemented, chemically-defined medium 
underwent a spontaneous surge of proliferative activity which 
greatly exceeded that of corresponding cultures maintained at 
the surface of the medium and masked the stimulatory response 
to testosterone (4 x 10“?M). Regardless of the presence or 
absence of testosterone, submerged cultures were histologically 
similar in that the amount of stromal tissue was reduced, while 
the secretory epithelium was sloughed into the lumen and 
replaced by irregular*, hyperplastic epithelium. In androgen- 
free, suspension cultures of human BPH, Webber et al. (1974) 
also reported hypocellularity of the stroma and degenerative 
changes in the secretory epithelium, which were accompanied 
by increased epithelial cell proliferation. By comparison, 
rat ventral prostate cultured at the gas-liquid interface of 
non-supplemented medium underwent epithelial atrophy typical 
of androgen deprivation, while similar cultures supplemented 
with testosterone (4 x 10“?M) were well-maintained and showed 
evidence of proliferative activity beneath the intact secretory 
epithelium. Differences between the histological response of 
tissue cultured at the surface of the medium and by submersion 
suggest that increased ^^I-UdR uptake in the latter is not 
due to increasing the surface area of tissue exposed to the 
isotope. Rather, it appears that the increased proliferative 
activity in submerged cultures may be a form of compensatory 
hyperplasia, which is independent of testosterone stimulation, 
and may result from the degenerative effect of the culture
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conditions on the secretory epithelium.
Variations in the proliferative activity of rodent prostate 
in organ culture can also be related to the age of the tissue. 
Burek (1981) has emphasized the lack of a universally acceptable 
definition of an "old" rat and has remarked that animals 
ranging from sexually-mature to thirty months of age have been 
classified as old, depending on the nature of the investigation. 
Yet, striking histological changes occur in the prostate glands 
of mice (Franks, 1959-, 19&7) and rats (Burek, 1981) during 
senescence. Unlike the tall, columnar epithelium typical of 
young, sexually-mature rodent prostate, the histological 
appearance of the alveolar epithelium in aged prostatic tissue 
is highly variable. In senescent rat ventral prostate much of 
the epithelium is atrophic, while other regions appear to be 
normal and still other regions are apparently hyperplastic 
(Burek, 1981). In the present study, similar age-related 
changes were observed in ventral prostate from retired breeding 
rats (>12 months old).
The similarity between age-associated prostatic atrophy 
and that which occurs following castration has prompted the 
widespread belief that androgen depletion may play a- ci?±l;:Lc&IL 
role in the onset of these morphological alterations (Mainwaring 
and Brandes, 1974). Although age-related changes in plasma 
testosterone levels have been extensively studied in the 
human male (Mawhinney and Belis, 1976, Voigt and Krieg, 1978; 
Menon and Walsh, 1979, Mann and Lutwack-Mann, 1981, Gupta, 1982), 
changes in plasma androgens in other species have received 
little attention. Lloyd (1972) has, however, reported that in 
the rat, blood testosterone levels increase nearly three-fold 
from tbree to seven months of age, but decrease approximately 
two-fold from seven to thirteen months. Thus, reductions in
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total plasma testosterone levels or, possibly, alterations 
in the testosteroneloestradiol ratio, may be responsible for
the onset of atrophic changes in the senile rat prostate.
While quantitative studies have not confirmed increased 
proliferative activity in aged rodent prostate (Mainwaring,
1967» Simnett and Morley, 196?! Donaldson and Thomas, 1976), 
histological indications of hyperplastic growth in the alveolar 
epithelium of senescent rodent prostate (Franks, 1959aj Burek, 
1981) are of particular significance since the normal, young 
adult gland rarely exhibits mitotic activity in vivo (Simnett 
and Morley, 1967; Tuohimaa and Niemi, 1968, 1974; Donaldson 
and Thomas, 1976). On the basis of such histological 
implications, Mainwaring and Brandes (1974) suggested that 
age-associated changes observed in the ultrastructure of the 
basement membrane in rodent prostate may disrupt normal 
physicochemical interactions between the glandular epithelium 
and stroma, thereby resulting in abnormal growth.
Age-associated changes in the response of rodent prostate 
to testosterone stimulation in organ culture have also been 
reported. Lasnitzki (1954, 1974) found that in cultures of 
young (4 to 5 weeks old) mouse ventral prostate, testosterone 
maintained structural differentiation and secretory activity, 
but caused epithelial hyperplasia in tissue from older (5 to 6 
months old) animals. However, Franks (1959a) reported that in 
cultures of prostatic tissue from old (8 months and 2 years old) 
mice, epithelial growth and secretory activity were less 
responsive to testosterone stimulation than in tissue from 
younger (5 to 6 months old) animals. This suggests that during 
senescence the prostate becomes less sensitive to testosterone. 
Mainwaring and Brandes (1974) have proposed that this decreased 
sensitivity to testosterone may be related to disruptions in the
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normal intracellular metabolism of testosterone caused by the 
degradation of important cytoplasmic organelles, notably 
ribosomes and mitochondria, with advancing age. Biochemical 
studies of the in vitro metabolism of testosterone in ventral 
prostatic tissue from young (3 months old) and old (> 12 months 
old) rats have shown that 5a-reductase activity is markedly 
lower in the latter (Shirnazaki et al., 1969; Nozu and Tamaoki, 
1974a; Mawhinney and Belis, 1976) and is accompanied by a 
significant reduction in the formation of 5a-dihydrotestosterone 
(Mawhinney and Belis, 1976). Lasnitzki (1976) also found that 
in organ cultures of ventral prostate from old (20 months old) 
rats the uptake of <d-testosterone and the formation of 
5ordihydrotestosterone was less than that in younger (2 months 
old) tissue. A profound decrease in cytoplasmic and nuclear 
androgen receptor content, accompanied by a diminished capacity 
to synthesize 5«-dihydroteetooterene, has also been reported in 
aging rat ventral prostate (Shain and Axelrod, 1973* Shain et al 
1977)# These results suggest that the reduced sensitivity of 
aged rat ventral prostate to testosterone may be related to 
important age-related changes in the ability of the tissue to 
accumulate, retain and/or metabolize testosterone.
Results of the present-study have also shown that the 
proliferative response of aged rat ventral prostate is less 
sensitive to testosterone stimulation at all concentrations 
which were effective in younger tissue. However, the results 
also showed that aged prostatic tissue cultured in the absence 
of testosterone undergoes a spontaneous surge of proliferative 
activity^ which may mask the effect of testosterone. Androgen- 
free cultures of human BPH also exhibit a similar burst of 
proliferative activity, which may be representative of a wound
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healing effect caused by dissection trauma (McMahon and Thomas, 
1973; Shipman et al., 1975; Donaldson and Thomas, 1976; Riches 
et al,, 1976b, 1982; Mlstry et al., 1982). However, in organ 
culture studies of rodent prostate, post-traumatic regeneration 
is usually associated with peripherally located alveolar 
epithelium (Franks, 1961, 1963; Lasnitzki, 1965b), whereas in 
the present study, cultures of aged prostatic tissue demonstrated 
irregular, hyperplastic epithelium throughout the explant, both 
in the presence and absence of testosterone. In addition, 
stromal tissue in these cultures showed marked degenerative 
changes. Since explantation of aged prostatic tissue required 
greater force than younger tissue, it is possible that the 
older tissue was subjected to greater trauma, which may 
further disrupt epithelial - stromal relationships in aged 
rodent prostate, thereby resulting in increased epithelial 
cell proliferation 3e vitro.
While the present study does not permit any conclusions 
with regard to factors which may be involved in the age- 
related decrease in sensitivity of rodent prostate to 
testosterone, it does demonstrate that the proliferative 
activity of aged rat ventral prostate maintained in androgen- 
free organ culture differs markedly from that of younger 
tissue and that aged prostatic tissue no longer remains clearly 
responsive to testosterone stimulation or deprivation. Organ 
culture studies of human BPH have experienced similar difficulty 
in establishing well-defined responses to either androgen 
stimulation or withdrawal (McMahon and Thomas, 1973; Harbitz, 
1973; McRae et al., 1973; Harbitz et al,, 1974; Lasnitzki' et al., 
1975; Donaldson and Thomas, 1976; Riches et al., 1976b, 1982; 
Lasnitzki, 1979; Mistry et al., 1982). While aged rat ventral 
prostate may be most representative of human BPH, the similarity
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between the response of aged rat prostatic tissue cultured in 
either the presence or absence of testosterone precludes its 
use as a suitable model for in vitro investigations of 
androgen-dependent responses in the prostate.
In normal young adult rat ventral prostate testosterone 
is subjected to extensive metabolism both in vivo (Bruchovsky 
and Wilson, 1968a, 1968b; Anderson and Liao, 1968) and in vitro 
(Baulieu et al., 1968a, 1968b, 1969; Robel et al., 1971, 1975).
Organ culture studies have shown that testosterone and its 
metabolites all promote varying degrees of epithelial cell 
proliferation, but the principal metabolite, 5o-dihydrotestosterone» 
is the most potent mitogenic agent, while 5#-androstane-30»1a6~diol 
provides good maintenance of the secretory epithelium but 
never induces marked epithelial hyperplasia (Baulieu et al,,
1968a, 1968b, 1969; Lasnitzki, 1970a, 1970b, 1971, 1974, 1975,
1976; Robel et al., 1971, 1975). Thus, Baulieu et al. (1968a,
1968b) suggested that the androgenic effect of testosterone 
in rat prostate is mediated via its intracellular metabolites 
and that 5c-dihydrotestosterone promotes cell proliferation 
while 5«eandotstane-3e»17/~<iiol functions in the maintenance of 
oytodiffeoentiation.
Few studies have attempted a quantitative comparison of 
the effects of testosterone and its metabolites on the proliferative 
activity of rat prostate in organ culture. However, Lasnitzki 
(1970b) demonstrated that 17.5 x 10“6M 5(-diilhiro0eetttterone 
stimulated marked increases in the %H-TdR labelling index
and grain count of rat prostate cultured in semi-defined
medium, whereas a higher concentration of testosterone 
(35 X 10“^M) was required to elicit a comparable response, 
and 5o-adrostane-3/3» 17/-diol was not stimulatory even at the 
highest concentration (70 x 10“6m). Lasnitzki (1979) also
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showed that 3eg ml"1 (1.04 x 10“%M) of eoedihydrotestosterone 
stimulated an increase in the %H-TdR labelling index of rat 
prostate cultured for four to six days in semi-defined medium, 
whereas an equivalent concentration of testosterone was
ineffective. In contrast, Johansson and Niemi (1975) demonstrate*;
1 6 ithat ljig ml (3.5 x 10 M) testosterone and 5<a-dihydroto3tosteron 
had similar stimulatory effects on the incorporation of labelled 3 
thymidine (^C-TdR or %H-TdR) in eight day cultures of rat 
ventral prostate maintained in semi-defined medium, whereas 
5o-androstane-3j, 17/3-diol elicited a weaker stimulatory response. 
Johansson and Niemi (1975) also showed that in chemically- ’
defined medium 0.003^5 ml" (1.04 x 10 M) testosterone or 
5narhhyrootesto8teoode stimulated similar increases in %H-TdR 
uptake in four day cultures of rat ventral prostate while 
5naadroostane-3/$, ^/-diol was less effective. Results of the 
present study have further shown that equimolar concentrations 
(4 x 10“9 or 4 x 10“?M) of testosterone, 5tf-darydroltstsoterone, 
adroostederiode and addoostaderhode all stimulated comparable 
increases in the uptake of e^j-udR by cultures of young adult 
rat ventral prostate maintained in chemically-defined medium 
for four days and that at 4 x 10"^m these androgens were all 
equally inhibitory. In contrast, 5e-adroostade-3e,17e-dhol was 
not stimulatory at 4 x 10"^M and at both 4 x 10"? and 4 x 10"-^M 
it induced marginal, yet comparable, increases in 12<e-UdR uptake!
The hiitollgiial rresits of'the present study correlated 4 
well witlx h hh incoloooratOon o o 1 ^I-UdR, dnd icatbig that at 
optimal concentrations testosterone, 5c*di•hyirr0estoltorone,
’ addoosOenerhone, and addolsOanedhone all preserved the 
secretory epithelium and promoted epithelial cell proliferation 1
to a similar extent. Likewise, Roy et al. (1972a) found that |
-6 .equimolar ccldendooaOhld 1 35 o 1 0 M) o f i estout erone,
- 233 -
androstenedione and androstanedione had similar effects on the 
induction of epithelial cell proliferation in cultures of rat 
ventral prostate maintained in semi-defined medium. Similarly, 
Johansson and Niemi (1975) reported that equivalent concentrations 
(0.02 to lO^g ml"11 6.9 x 10“^ to 3*5 x 10“%) of testosterone 
and 5<2-dihydrotestosterone had comparable effects on the 
maintenance of the alveolar epithelium and stimulation of 
epithelial cell proliferation in semi-defined organ cultures of 
rat ventral prostate. These results are, however, in contrast 
to earlier studies (Baulieu et al., 1968a, 1968b, 1969, Lasnitzki, 
1970a, 1970b, 1971» 197^» 1975» 1976, Robel et al., 1971» 1975) 
which indicated that 5c*-dihydrotestosterone was consistently 
more effective than either testosterone or androstanedione in 
promoting epithelial hyperplasia in cultures of rat prostate.
Results of the present study have also shown that, unlike 
testosterone, 5<2-dihydrotestosterone, androstenedione or 
androstanedione, treatment with x 10“% 5#*-androstane-3^,17^-dio; 
did not prevent the occurrence of epithelial atrophy associated 
with androgen deprivation, but at both 4 x 10”? and x 10“% 
it fully maintained the height and secretory activity of the 
epithelium without causing marked epithelial cell proliferation. 
Furthermore, among all the testosterone metabolites studied, 
only 5<*-androstane-3^,17^-diol was not toxic at 4 x 10“%, 
Similarly, Johansson and Niemi (1975) reported that, unlike 
testosterone and 5(^-dihydrotestosterone, low concentrations of 
5a-androstane-3/3» 17/3-diol (0.02 to O.fyxg ml”1, 6.9 x 10”® to 
3.5 x 10“%) were unable to prevent epithelial retrogression in 
semi-defined organ cultures of rat ventral prostate and that 
at high concentrations (^lOO^g ml”1, 3*5 x 10“%) both 
testosterone and 5<*-dihydrotestosterone became cytotoxic, 
whereas. 5<^-androstane-3/3> 17^-diol did not. However, in contrast
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to previous studies (Baulieu et al. , 1968a, 1968b, 19*69,
Robel et al., 1971; Lasnitzki, 1970a, 1970b, 1971, 1974, 1975, 1
1976) and the present results, Johansson and Niemi (1975) were 
unable to detect qualitative differences in the proliferative 
response of rat ventral prostate to stimulation with l0,eg ml"
(3*5 x 10"%M) testosterone, 5<3-dihh^c^x^c^o^<^£^1^<^)^‘fcerone or 
5o-androstane-3/3,17j-diol in semi-defined organ culture. On 
the basis of this observation, Johansson and Niemi (1975) 
contend that these steroids are qualitatively similar', despite 
clear differences between the biological effects of
5o-dndrostaned3^hl7/$.-diol and those of testosterone and
5#ddihydrotest08terone at both low (0.02 to 0.1/ig ml"1,
8 *7 16,9 x 10“ to 3.5 x 10"?M) and high concentrations (>l00/ug ml"1,
_ h.
3.5 x 10 M). They suggest that testosterone and its metabolites
activate a common biological mechanism, but with varying 
degrees of effectiveness. Variations in the androgenic effects 
of testosterone and its metabolites have been attributed to 
differences in their steric configuration, which may affect 
their binding affinity to receptors in the prostate (Saunders,
1963, Liao et al,, 1973, Mainwaring, 1977, Tuohimaa, 1980), Organ 
culture studies have shown that 5eddihyirotestosterone, unlike 
its epimer 5oedhhydrotestosterone, has no effect on the 
stimulation of cell proliferationor maintenance of rat prostate 
in vitro (Baulieu et al., 1968a, 1968b, Robel et al<, 1971). 
Similarly, the present study has shown that 5^diihyirotestosterone 
was inactive at all concentrations used, and was not cytotoxic 
at 4 x 10“%M. These results suggest that wlile the effect of 
different androgens may well vary with their configuration, 
the comparison of the effects of such stereoisomers is of 
limited value since, as Baulieu et el. (1968a) emphasize, 
5/-dihydrotestosterone is not a natural product of testosterone
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metabolism in the rat prostate. In errhOlod, direct correlations 
between the configuration of testosterone and its 5#-metabolites 
with the histological response of the prostate are of limited 
value in organ culture without consideration of their further 
metabolism within the target tissue.
In contrast to Johansson and Niemi (1975), Baulieu and 
colleagues CBaulieu et al., 1968a, 1968b, 1969; Robel et al.,
1971, 197^4, 1975) suggest that distinct biological responses 
of the rat prostate to testosterone are mediated by various 
active intracellular metabolites, whereby 5loa0hhdrotestosterode 
specifically controls cell proliferation and 5#-addros0adea 
3/5, ^/-diol maintains cytorlffeoedOleOion. The metabolism of 
testosterone to 5loa0hhdrotestosteoode in cultured rat prostate 
has been well doc•lmedOer (Baulieu et al. , 1968a, 1968bj Robel 
et al., 1971, 1975i laon^a^!, 1971, 1974, 1976, Johansson,
1976) and Roy et al. (1972a)-have further shown that both 
addoosOanerlode and addolstededhlne are converted to 
5<eaihydrolostsote^lde, whereas 5leaddrosOadea3e,t7/3“dllt is 
primarily converted to the weak androgenic steroid,
epladrolsteolde (Robel et al,, 1971, 1975; Roy et al., 1972b). 
This suggests that the proliferative ecOhvhOy ascribed to 
testosterone, addolsOededllde and anrrlsOaderhlne may be related 
to the intracellular formation of 5«-di^ihiyoteetooterode. The 
similarity between the proliferative responses of rat ventral 
prostate to OesOlsOeolde and these metabolites, as observed in 
the present study, strongly support this concept and, thus, 
corroborate the hypothesis that 5#edihyhyotesstoterone is 
responsible for cell proliferatim in rat prltOaOe. LatniOzkh 
(197^) has further suggested that the ability of 
5<coa0hydrotestosterone to preserve cytldlffeoentlatiod in 
cutOuoed- rat prostate may be related to the intracellular 
metabolism of 5<-d-dydro0oetolterlne to 5<eaadrostane-3y, 17e-Ohol
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However, it is not yet known if the amount of 5o•:androstaned 
3/,177-diol formed by the prostate is sufficient to be 
physiologically active (Lasnitzki, 1974) nor is its mode of 
action resolved (Robel et al,, 1974, Voigt et al., 1975f 
Lasnitzki, 1976). Evidence that 5<edndrosttne-3e•17/’-<iiol 
is capable of maintaining the cytoplasmic and secretory integrity 
of the rat prostate in organ culture, without causing pronounced 
epithelial growth or becoming cytotoxic at high concentrations 
does, however, suggest that it may have a specific biological 
function, as well as a distinct mechanism of action. However, 
evidence indicating that a small, but significant, amount of 
5a-dndrostaned3/,17/-diol is converted to jnedihydrotestosterone 
in the rat prostate suggests that 3#eandrostane-3 ^^p-diol may 
act partially via 5<-e-iy<yioteetosterone (Voigt et al., 1975,
Takyi et al., 1977). This may account for the marginal 
increase in proliferative activity observed at high concentrations 
of 5#dandrostaned3p,l70ddhol in organ culture.
Testosterone-stimulated DNA synthesis in the accessory sex 
glands of castrated rodents has been widely used to investigate 
the antiproliferative activity of chemotherapeutic agents 
(Carter et al., 1972, Sufrin and Coffey, 1973, 1975, Sloan et al., 
1975, Forsberg and H/isaeter, 1975, H/isaeter, 1975%, 1976b, 19771 
Alison and Wright, 1979c, 1980), Using a similar approach, the 
present study examined the effects of anthanirogens, oestrogens 
and hormone-cytotoxic compounds on the proliferative response 
induced by testosterone in organ cultures of young adult rat 
ventral prostate. Results of the present study have shown that 
treatment with testosterone (4 x 10“e to 4 x 10“%M) produces 
maximal increases (approximately 3-fold) in eeei-udR uptake on 
day 4 of the culture period, hence this time-point was chosen 
for investigation of the drug effects.
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The potent antiandrogen, cyproterone acetate, has been 
shown to effectively block testosterone-induced DNA synthesis 
in castrated rat ventral prostate in vivo (Carter et al. , 1972» 
Sufrin and Coffey, 1973, 1975; Coffey, 1974» Coffey and Sloan,
1975; Sloan et al., 1975) and is believed to exert its 
antiandrogenic effect primarily by direct competitive antagonism 
with androgens 'at the receptor level of the target tissue (Fang 
et al., 196*9; Fang and Liao, 1969, 1971; Belham and Neal, 1971; 
Walsh and Korenman, 1971; Liao et al., 1974; Neumann and Steinbeck, 
1974; Mainwaring, 1977; Menon and Walsh, 1979; Mittelman, 1979; 
Neumann et al., 1976, 1982). Investigation of the direct effect 
of cyproterone acetate on the proliferative response of rat 
ventral prostate to testosterone stimulation in chemically- 
defined organ culture therefore permits more precise insight 
into the mode of action of this compound in a system which is 
devoid of complicating systemic factors present in vivo. In the 
present study, the simultaneous addition of 4 x 10“e or 4 x 10“?M 
cyproterone acetate with 4 x 10“?M testosterone was found to have 
no effect on the stimulatory action of testosterone, whereas 
treatment with 4 x 10*^M cyproterone acetate had a pronounced 
inhibitory effect. The histological results paralleled the 
eeei-udR data, indicating that in cultures treated with 
concentrations of cyproterone acetate less than or equal to that 
of testosterone, the androgen effect predominated. In contrast, 
treatment with 4 x 10~^M cyproterone acetate caused extensive 
epithelial and stromal necrosis, indicative of a non-specific 
cytotoxic responses. As this response Is similar to that observed 
following treatment with high concentrations of testosterone 
(4 x 10~^m) in chemically-defined organ culture, inhibition of 
the testosterone-induced proliferative response by 4 x 10*^M 
cyproterone acetate cannot be directly attributed to specific
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antiandrogenie properties of the drug. Rather, it appears 
that the , cytotoxic response is due to the use of high 
concentrations of cyproterone acetate in vitro, In vivo 
studies have shown that in order to demonstrate antiandrogenie
effects of cyproterone acetate on testosterone-induced DNA 
synthesis in castrated rat ventral prostate, it is necessary 
to use the minimum dose of testosterone required for a maximum 
response and to administer at least a 30-fold excess of 
cyproterone acetate (Carter et al,» 1972f Sufrin and Coffey. 
1973l Coffey. 1974). Similarly, Neumann et al. (198O) showed 
a dose-dependent decrease in the seminal vesicle weight of 
normal male rats treated with increasing doses of cyproterone 
acetate (0.3 to lO.Omg/rat) and a 10-fold excess of the 
antiandrogen produces almost 100. inhibition of the androgen 
effect. Thus, using the minimum dose of testosterone required 
for a maximum response on day 4 (ie. 4 x 10“%w), the present 
results showed that treatment with 4 x 10“?M cyproterone acetate 
inhibited the testosterone-induced proliferative response and 
caused marked epithelial atrophy, resembling that observed in 
androgen-free control cultures. Likewise, Feyel-Cabanes et al. 
(1980) reported that in chemically-defined organ cultures of 
young adult rat ventral prostate, treatment with 1 x 10“^M 
cyproterone acetate in conjunction with 1 x 10“° to 4 x 10“%M 
testosterone markedly suppressed the androgenic effect. Since 
cyproterone acetate does not inhibit 5«-Teeuctase activity in 
rat prostate (Belham and Neal, 1971f Walsh and Korenman, 19711 
Liao et al,, 1974i Neumann and Steinbeck, 1974i Tveter et al.,
1980), these results tend to corroborate the hypothesis that 
cyproterone acetate acts via direct competitive antagonism 
with androgens at the receptor level of the prostate. In 
contrast, Rajalakshmi and Frasad (1976) found that long-term
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treatment of rats with cyproterone acetate resulted in marked 
suppression of 5^-dihydrotestosterone formation in the ventral 
prostate* thereby suggesting that the antiandrogen inhibits 
5cv-reductase activity. However* as 5^-reductase activity is 
dependent upon androgenic stimulation* chronic cyproterone 
acetate treatment may reduce the enzymatic activity not by 
enzyme inhibition but* rather* as a result of the castration- 
like changes induced (Tveter et al.* 1980),
Using the same procedure* the present study compared the 
effects of the hormone-cytotoxic agent* Estracyt (estraraustine 
phosphate disodium and estramustine phosphate) and its metabolite* 
estraraustine with that of their carrier-hormone* oestradiol-170, 
on the proliferative response to testosterone in cultured rat 
ventral prostate. The results have shown that treatment with 
oestradiol-170 was consistently more effective than either 
estramustine phosphate disodium* estramustine phosphate or 
estramustine in suppressing the testosterone-induced response.
The three estramustine compounds elicited similar responses 
under all experimental conditions and were only effective in 
reducing the proliferative response to 4 x 10"*^M testosterone at 
a concentration of 4 x 10*^M. The histological results further 
confirmed that only cultures treated with the estramustine 
compounds at 4 x 10~^M in the presence of 4 x 10”^M testosterone* 
showed evidence of epithelial atrophy. Treatment with these 
compounds did not appreciably alter retrogressive changes 
observed in androgen-free control cultures. Furthermore, 
pre-treatment (48 hours) with the estramustine compounds did not 
enhance their ability to inhibit the proliferative response to 
4 x 10~^M testosterone and, their addition 48 hours after that 
of testosterone appeared to reduce the magnitude of the inhibitory 
response. In contrast, treatment with oestradiol-170 at
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concentrations of 4 x 10“9, 4 x 10“? and, in particular,
4 x’10“%M were capable of suppressing proliferative responses 
to both 4 x 10“9 and 4 x 10“?M testosterone. While the 
histological results demonstrated that 4 x 10“%M oestradiol-l79 
exerts a non-specific cytotoxic effect in chemically-defined 
organ cultures of rat ventral prostate, indicating that the 
inhibitory effect oh the proliferative response is not directly 
attributable to specific antiandrogenic properties of the 
oestrogen, the present results have further shown that treatment 
with lower concentrations of oestradiol-17p (4 x 10“9 and 
4 x 10“?M) evoke retrogressive changes in cultures treated with 
either 4 x 10“9 or 4 x 10“?M testosterone. Furthermore, these 
changes become more pronounced as the concentration of testosterone 
decreases, thereby suggesting that oestradiol-179 is capable of 
directly antagonizing testosterone action at the target tissue 
level. Similarly, Lasnitzki (1974, 1975) reported that in semi­
defined organ cultures of young adult rat ventral prostate, 
treatment with oestradiol-17/3 (0.5 g ml“9j 1.8 x 10“%M) in a 
ratio of lilO with testosterone (5*0 g ml"1! 1.7 x 10“%M) 
counteracted the androgen effect, resulting in marked epithelial 
atrophy and loss of secretory function. These results are, 
however, in contrast to those of Feyel-Cabanes et al. (1978, 1980),
O •who found that treatment with oestradiol-^p (1 x 10“9 to 1 x 10 M 
had no antagonistic effect on the action of testosterone (1 x 10“9j 
to 4 x 10“%)) in chemically-defined organ cultures of young adult J 
rat ventral prostate.
By comparison with oestradiol-17g , the present results have 5 
also shown that the non-steroidal oestrogen, diethylstilboestrol, 
is cytotoxic at 4 x 10“%M, but at lower concentrations (4 x 10“? 
and 4 x 10“%) it is completely ineffective in reducing the
proliferative response to testosterone (4 x 10“?M). Similarly, 4
£
• /-T
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Feyel-Cabanes et al. (1978, 1980) found that the androgen
effect predominated in chemically-defined organ cultures of 
rat ventral prostate treated with diethylstilboestrol (0.1 x 10~9 
to 1 x 10"6M) in the presence of 4 x 10"^M testosterone. The 
present results, therefore, suggest that diethylstilboestrol, 
unlike oestradiol-l7^3 , is unable to exert a direct antiandrogenic 
effect on the prostate. Oestradiol-17/3 reportedly exhibits high 
binding affinity for androgen receptor proteins in rat ventral 
prostate (Liao et al., 1972. H/isaeter, 197^1 Blondeau et al.,
1975; Baulieu et al., 1975a), whereas diethylstilboestrol shows 
only negligible affinity (Baulieu et al., 1975a), thus suggesting 
that oestradiol-17l may inhibit androgen action in the prostate 
by direct competition at the receptor level. While specific 
oestradiol-17/3 receptor proteins have'also been demonstrated in 
rat ventral prostate (Jungblut et-al., 1971. Baulieu et al., 1975a. 
O'Toole et al., 1975. Karr and Sandberg, 1979. Jung-Testas et al.,
1981), diethylstilboestrol generally exhibits high binding 
affinity for all known oestrogen receptors (Blondeau et al., 1975; 
Baulieu et al., 1975a. Feyel-Cabanes et al., 1980). Therefore 
it seems unlikely that the oestradiol-17/3 effect is mediated via 
the oestrogen receptor. Alternatively, oestradiol-17/3 is known 
to inhibit rat prostatic 5o-reductase activity (Shimazaki et al., 
1972| Lee et al., 1973a, 1973b. Baulieu et al., 1975a. Johansson, 
197*6. Kadohama et al., 1977) and may, therefore, exert its 
antiandrogenic activity by ' limiting the intracellular metabolism 
of testosterone to 5tt-dihydrota8tosterone. Furthermore, in 
comparing the effects of several oestrogens, including oestradiol- - 
17l and diathylstilboastrol, on the Stf-rseuction of testosterone 
in minces of rat prostate in vitro, Lee et al. (1973a, 1973b) 
found that the natural oestrogen, oestradiol-171, was a far more 
potent inhibitor than diethylstilboestrol and suggested that
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inhibition of 5<a-reductase activity in the rat prostate is
dependent upon a complete steroid structure and a free phenolic | 
hydroxyl group at carbon-3. In contrast. Groom et al. (1971) 
and Nozu and Tamaoki (1974b) have reported that both oestradiol- 
17/3 and diethylstilboestrol inhibit rat prostatic 5<o-reductase j
activity equally. However', more recent studies have'shown that 
the inhibitory effect of oestradiol-i7y3 is highly specific in
.3that it only inhibits 5o-r-ductase activity in tissue from the 
dorsolateral lobe of the rat prostate and has little or no 
effect on the rat ventral prostate (Yamanaka et al., 1975i 4-y
Kadohama et al., 1977), Similarly, Belham and Neal (1971)
reported that diethylstilboestrol had little effect on the
metabolism of %H-testosterone by rat ventral prostate. Although 
these results tend to suggest that the inhibitory effect of 
oestradiol-17p observed in the present study is not related to ,
inhibition of 5a-reductase activity, direct comparisons of i
published data are often not feasible since earlier studies have 
not always specified the lobe of the rat prostatic complex used.
In contrast to oestradiol-^/}, *the he-monercytotoxic agent, 
Estraoyt, and its metabolite, estramustine were found, in the 5
present study, to be much less effective in suppressing
testosterone-induced DNA synthesis in cultured rat ventral
prostate. Selective accumulation of ^--sstrsmiustine has been 
demonstrated in rat ventral prostate following treatment with $either %H-eatramiustine phosphate (Plym-Forshell and Nilsson,
1974j Forsberg and H/isaeter, 1975; H/isaeter, 1976a, 1977) or 
o -%H-estramustine (Yamanaka et al., 1981a, 1981bi Symes and Milroy, <
1982) and Yamanaka et al. (1981a, 1981b) have further shown that 
the ratio of radioactivity present in rat ventral prostate 
following the administration of labelled estramustine is C
significantly greater than that observed after treatment with
- 243 -
either oestradio1~17/3 or cyproterone acetate. While H/isaeter 
(1977) reported that after short-term incubation of minced rat
ventral prostate with %H-estramustine, radioactivity was recovered 
in nuclear preparations, more recent studies indicate that 
subcellular localization of the estramustine complex is almost
exclusively in the cytosol fraction (Yamanaka et al, , 198la,
1981b, Symes and Milroy, 1982) and the radioactivity associated 
with %H-estramustine is retained by the cytosol for at least 
24 hours (Yamanaka et ai*, 1981a, 1981b). This suggests that a 
specific mechanism exists in the cytosol of rat ventral prostate 
for the retention of estramustine. Rat ventral prostate is known 
to contain a glycoprotein which constitutes almost 20% of the 
total cytosol protein and exhibits a high binding affinity for 
estramustine (Forsgren et al. , 1979). This estramustine-binding 
protein is distinct from the classic androgen receptor (Yamanaka 
et al., 1981b, H/eiaeter•et al., 1981)•but has several properties 
in common with previously described steroid binding proteins in 
the rat ventral prostate, which have been variously designated as 
"prostatic binding protein" (Heyns and DeMoor, 1977, Heyns et al., 
1978a, 1978b, Heyns , 1980), "prostatein" (Lea et al., 1977) and 
"a-protein" (Liao et al., 1975> 1980). Thus, it appears that the 
presence of such a binding protein in rat ventral prostate may 
play a critical role in the retention of estramustine. A similar 
estramustine-binding protein has also been demonstrated in human 
prostatic tissue, but is present at a much lower concentration 
than in rat ventral prostate (Kirdani et al., 1981). Consequently 
the high concentration of this receptor protein in rat ventral 
prostate may detract from the suitability of this tissue as a 
model for studying the effects of estramustine compounds. 
Furthermore, activation of hormone-cytotoxic compounds is 
dependent upon hydrolysis of the complex into its hormone and
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cytotoxic parts within the target tissue (Mittelman, 1979>
Nilsson and Muntzing, 1980. Pavone-Macaluso, 1982), yet 
Hlisaeter (1975b, 1976a, 1977) was unable to demonstrate any? 
hydrolysis of estramustine by rat ventral prostate in vitro. 
However, after "long-term* (3 days) Estraoyt treatment 1n vivo 
evidence of small amounts of free oestrone were detected in rat 
ventral prostate OiXisaeter, 1976a, 1977). Recently, Symes and 
Milroy (1982) demonstrated that while the cleavage rate of 
estramustine in human prostatic tissue is dose-dependent, and is 
greater at 10~"M than 10M, the rate is nevertheless low. Thus, 
with regard to the present study, these results suggest that the 
inhibitory effect of the estramustine compounds at 4 x 10~"m in 
the presence of 4 x 10""% testosterone may be due to the release 
of some oestradiol-17/3 from the hormone-cytotoxic complex. 
Furthermore, the present results have shown that the degree of 
inhibition in these cultures is comparable to that observed in 
cultures treated with 4 x 10*1M oestradiol-17/3 and 4 x 10"1m 
testosterone.
in contrast to the present study, H/isaeter (1975b) found 
that Estraoyt (4 x 10~-M) had a far more pronounced inhibitory 
effect than an equimolar concentration of oestradiol-17/3 on the 
incorporation of %H-TdR by rat ventral prostate following three 
days of organ culture in semi-defined (51 foetal calf serum) 
medium containing 4 x 10""m testosterone. However, it is of 
importance to note that treatment with 4 x 10“"m testosterone 
alone did not stimulate any increase in %H-TdR uptake, which 
Hlisaeter (1975b) attributed to a masking effect of endogenous 
hormones present in the serum supplement. Therefore, to 
evaluate the possible influence of serum, the present study 
investigated the effects of 4 x 10"1m estramustine phosphate, 
estramustine and oestradiol-17/3 on the proliferative response to
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4 x 10~"m testosterone, both in the presence and absence of 
foetal calf serum. The results of this study have shown that 
in the presence of », 1 0 or 20% foetal calf serum, the 
estramustine compounds and oestradiol-17/3 nere all equally 
inhibitory, nhereas in the serum-free system only oestradiol-l?y5 
suppressed the testosterone-stimulated proliferative response. 
Thus, it appears that the presence of serum potentiates the 
antiandrogenic action of the estramustine compounds, nhile it 
reduces the inhibitory action of oestradiol-l/^#. These results 
nere further substantiated by the marked degenerative changes 
observed in cultures treated nith the estramustine compounds in 
serum-supplemented medium. Honever, cultures treated nith these 
drugs in serum-free medium exhibited good maintenance, similar 
to that observed in the testosterone controls. In contrast, 
treatment nith oestradiol-l^ nas markedly cytotoxic in serum- 
free cultures, but in the presence of serum it produced an 
antiandrogenic effect, characterized by flattened alveolar 
epithelium and loss of secretory activity. The presence of 
steroid hormone binding proteins, such as TEBG, in the serum 
supplement may be involved in the elimination of the cytotoxic 
effect of oestrad io 1-17/3 by reducing the concentration of free 
oestrogen in the medium. Similarly, the presence of steroid 
binding proteins may account for slight reductions observed in 
the stimulatory effect of testosterone on the proliferative 
activity of rat ventral prostate cultured in serum-supplemented 
medium. On the other hand, honever, the results did not 
indicate that increasing the serum concentration from 5 to 11 or 
21% further affected the action of either testosterone or 
oestira^c^ J^o--17#^.
Histologically, the results observed in the present study 
in serum-supplemented medium nere remarkably similar to those of
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H/fisaeter (1975b)» indicating that Estracyt had a more
pronounced deleterious effect than oestradiol-17/3 on cultured 
rat ventral prostate. However * as Estracyt does not cause 
profound morphological changes in rat ventral prostate in vivo 
(H/rfisaeter» 1976bj Yamanaka et al.* 1977) or in serum-free 
organ culture * it appears that interactions between serum and 
Estracyt in vitro are involved in the production of the inhibitory 
response observed in serum-supplemented organ culture. Clearly* 
serum also influences the activity of oestradiol-17/3 in vitro.
The ability of serum to modify the biological activity of hormones 
and chemotherapeutic agents in vitro further emphasises the 
complexity of serum supplements and may well represent a serious 
obstacle in the realization of the full potential of prostate 
organ culture as an experimental model for assessing the direct 
effects of hormones and drugs.
In contrast to organ culture* cell culture methodology 
involves disruption of the histological architecture of the 
tissue* thus identification of individual cell types can no 
longer be based on morphology alone* but requires the use of 
cell specific markers. The intense acid phosphatase activity 
of the human prostate epithelium is most frequently used as a 
histochemical marker for identifying isolated or cultured 
prostatic epithelial cells. Burstone (1958) first demonstrated 
the successful use of the azo-dye coupling technique for the 
histochemical localization of acid phosphatase activity. This 
technique involves incubation of the tissue specimen with a 
napthol AS-phosphate substrate and a diazonium salt. As a 
result of acid phosphatase activity* napthol AS is liberated* 
which immediately couples with the diazonium salt forming an n 
insoluble and visible pigment at sites of acid phosphatase 
activity. More recently* Carson (1973) adapted this method
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for differentiating between prostatic and non-prostatic acid 
phosphatase in cryostat sections of human tissue. This method 
is based on the fact that prostatic acid phosphatase is more ' 
resistant to inhibition by formalin than acid phosphatase from 
other human tissues. Cryostat sections of human prostatic 
tissue incubated in 10% neutral formalin for at least 24 hours 
remain acid phosphatase positive* whereas the enzyme activity 
in human liver and kidney is inactivated after 5 hours of 
formalin treatment (Carson, 1973; Stonington et al.* 1975)*
Results of the present study have also shown that human 
BPH remains acid phosphatase positive following 24 hours of 
formalin fixation, although the intensity of the reaction is 
reduced. In contrast to human prostatic tissue, however* the 
acid phosphatase reaction in young adult rat ventral prostate 
is less Intense and disappears after 5 hours of formalin 
fixation. Similarly* the acid phosphatase activity in rat 
liver and kidney is no longer detectable after 5 hours of 
formalin treatment. Thus* the use of formalin resistance as 
a means of differentiating between prostatic and non-prostatio 
acid phosphatase does not appear to be directly applicable to 
rat tissue.
Differences in the intensity of the acid phosphatase 
reaction and the formalin sensitivity of human and rat prostatic 
tissue may be related to the absolute amount of acid phosphatase 
present in these tissues. Gutman and Gutman (1938a) reported 
that the amount of acid phosphatase in the human prostate is 
1000 times greater than in any other human tissue and more 
recent studies have indicated that the ration of acid phosphatase 
in human* as compared to rat* prostatic tissue is 1200«1 (Coffey 
and Isaacs* 1980). Since human non-prostatic acid phosphatase 
activity disappears after 5 hours of formalin fixation, while
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human prostatic acid phosphatase activity declines only* ■ after 
24 hours of formalin treatment, Carson (1973) suggested that 
inactivation or destruction of the enzyme may be proportional 
to the duration of formalin fixation. Thus, the greater 
concentration of acid phosphatase in the human prostate, as 
compared with other human tissues or rat ventral prostate, may 
enable human prostatic tissue to remain acid phosphatase 
positive for prolonged periods of formalin treatment. Reductions 
observed in the intensity of the acid phosphatase reaction in 
human prostatic tissue following 24 hours of formalin fixation 
tend to support this hypothesis.
Unlike young adult rat ventral prostate, acid phosphatase 
activity in prostatic tissue from aged ( x 12 months old) rats 
was not homogeneously distributed throughout the glandular 
epithelium, but rather it appeared in discrete clumps, which 
persisted after 5 hours of formalin fixation. A similar shift 
in the distribution of acid phosphatase activity in rat ventral 
prostate from both castrated and aged rats has been observed 
(Brandes, 19&3# 1966, 1974b; Paris and Brandes, 1974; Mainwaring 
and Brandes, 1974; Brandes and Kirchheim, 1977) ■ ■ and attributed 
to the concentration of lysosomal enzymes in autophagic vacuoles 
associated with prostatic involution (Paris and Brandes, 1974). 
While the size and number of acid phosphatase positive granules 
appears to increase during androgen-deprivation or aging, 
suggesting increased acid phosphatase activity, it seems unlikely 
that synthesis of new enzymes occurs during regression of the 
tissue (Paris and Brandes, 1974). Alternatively, it has been 
suggested that lysosomal enzymes are degraded slowly, and 
possibly selectively retained by regressing prostatic tissue, 
thereby resulting in an apparent increase in acid phosphatase 
activity in atrophic prostatic epithelial cells (Paris et al,,
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1972; Paris and Brandes, 1974). The increased formalin
resistance of acid phosphatase observed in aged rat ventral 
prostate may, therefore, be related to the slow turnover of 
lysosomal enzymes during age-associated prostatic atrophy.
Although Rubenstein and Anderson (1980) indicated that 
the histochemical demonstration of formalin-insensitive acid 
phosphatase activity had been used to identify epithelial 
cells isolated from young adult rat ventral prostate, the cells 
were incubated in 10% neutral formalin for only one minute. 
However, the present study has shown that acid phosphatase 
activity in cryostat sections of young adult rat ventral 
prostate, liver and kidney fixed for at least fifteen minutes 
in 10% neutral formalin did not differ from that observed in 
replicate sections fixed either in cold acetone (15 minutes) 
or air dried without fixation. Moreover, prostatic epithelial 
cells derived from rat ventral prostate and fixed for one 
minute in formalin were indistinguishable from those which had 
been fixed in acetone (1 minute) or air dried without fixation. 
Hence, these results suggest that short-term incubations in 
formalin are not necessarily indicative of formalin-insensitive 
acid phosphatase activity in rat ventral prostate. However, as 
the acid phosphatase reaction in rat ventral prostate is 
confined to the epithelium, the histochemical demonstration of 
this enzyme still provides a means of distinguishing between 
epithelial and stromal cells derived from rat ventral prostate. 
Thus, in the present study, histochemically demonstrable acid 
phosphatase activity was used to identify epithelial cells 
isolated from mixed cell suspensions of young adult rat ventral 
prostate by isopycnic sedimentation.
Dow and Pretlow (1975) first investigated the use of density 
gradients as a means of separating purified populations of
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epithelial cells from rodent prostate. However, using
gradients ranging from 4,1 to 43% (%/w) Ficoll% (approximately 
1.02 to 1.20g ml"1), cells with positive acid phosphatase 
activity broadly overlapped with other prostatic cells bewteen 
densities of 1.05 to l,12g ml %. On the other hand, both Dow 
and Pretlow (1975) and Rubenstein and Anderson (1980) found 
that purified fractions of viable epithelial cells could be 
successfully isolated from rodent prostate using gradients 
ranging from 2.7 to 5.5# (w/w) Ficoll (approximately 1.01 to 
l.lOg ml"%). However, preparation of the Ficoll gradient 
requires the use of special apparatus as the success of the 
separation is highly dependent upon the linearity and viscosity 
of the gradient, as well as on the speed • and time of 
centrifugation (Pretlow and Boone, 19&9l Pretlow, 1971f Helms 
et al., 1976; • Rubenstein and Anderson, 1980). Alternatively, 
Pertoft et al. (1977) demonstrated the successful use of Percoll 
as a density gradient medium for separating viable cells of 
different types. Also, unlike Ficoll, the preparation of 
Percoll density gradients requires only a simple dilution 
procedure.
The present study, therefore, investigated the use of a 
discontinuous Percoll density gradient ranging from 1.02 to 
l.lOg ml" for the isolation of prostatic epithelial cells from 
young adult rat ventral prostate. Three reproducible cell 
bands were easily identified on the gradient 1 (1) a band containing 
cellular debris, (2) the epithelial cell enriched band and (3) a 
less distinct band containing primarily erythrocytes and some 
nucleated cells. The epithelial cell fraction, as identified by 
both cell morphology and positive acid phosphatase activity, 
sedimented at the 1.04g ml"% interface on the discontinuous 
gradient. In contrast, Clark et al. (1982) reported that
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epithelial cells derived from rat ventral prostate were
recovered in the range of 1,05 to 1.065g ml" using a
continuous Percoll density gradient. However, on the basis
of cell morphology, it appears that the epithelial cell 1
fractions described in bo-tti Btudies are equivalent. Furthermore, 
using a biochemical determination, Clark et al. (1982) demonstrated d 
positive acid phosphatase activity in the epithelial cell fraction,- 
while in the present study this was performed histochemically.
The successful use of the discontinuous Percoll gradient for 
isolating viable prostatic epithelial cells was further 
demonstrated by the exclusion of trypan blue dye and the ability 
of the isolated cells to rapidly establish monolayer cultures 
and incorporate %H-TdR. While the cells were apparently unable 
to proliferate in suspension cultures, as reflected by the j
decline in 12^I-UdR uptake, this is probably due to the lack of 
surface area available for attachment (Riid et al,, 1980; Holley,
1980 > Ham, 1981). As in the present study, however, previous 
investigations have also shown that epithelial cells isolated 
from rat ventral prostate generate monolayer cultures (Pomtlow
et al., 1977> Rubenstein and Anderson, 1980) which exhibit a 'Ihigh rate of %H-TdR incorporation after 72 hours in culture 
(Pretlow et al., 1977). The present procedure is, therefore, 
regarded as a rapid, reproducible and simple method for the 
isolation, characterization and culture of viable prostatic
epithelial cells, which can be routinely performed in a standard
laboratory.
£
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Normal rat ventral prostate remains androgen-dependent
and responsive in organ culture. This provides an in vitro .
system for investigating the direct effects of androgens, as
well as antiandrogenic compounds, on prostatic growth, which 
can be evaluated both quantitatively and qualitatively using 
the 12^I-UdR labelling technique. However, variations in organ 
culture media and methodology can influence the proliferative
activity of rat prostate in vitro and its response to hormone 
and drug treatment, thereby limiting the potential value of this
experimental system.
In particular, the routine use of serum and, less frequently, 
insulin supplements in prostate organ culture can modify the 
proliferative response of the tissue. Serum supplements, which 
vary considerably as to species of origin and final concentration 
in the medium, often introduce unknown types and quantities 
of endogenous hormones. Furthermore, the presence of steroid- 
hormone binding proteins in most sera can alter the response to 
androgens by limiting the amount of free hormone available to 
the tissue. The presence of • such steroid binding proteins can 
also necessitate the use of supraphysiological concentrations 
of testosterone in serum-supplemented organ culture, whereas 
equivalent concentrations in serum-free medium are often cytotoxic. 
Moreover, in chemically-defined organ culture, physiological 
concentrations of testosterone have been shown to effectively 
maintain the structural and functional integrity of rat ventral 
prostate in a state comparable to the intact gland. Similarly, 
serum may influence the effect of oestrogens on the proliferative 
response to testosterone and can also modify the actions of 
chemotherapeutic agents, such as Estracyt. Likewise, insulin 
modifies the proliferative activity by acting synergistically 
with testosterone and, possibly, serum. Although its mechanism
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of action is unknown, insulin also appears to havera direct 
prostatic effect in chemically-defined organ culture. In view 
of the complexity of serum and insulin supplements and the 
fact that neither appear necessary for short-term organ culture 
of rat ventral prostate, their elimination from culture media 
should allow more precise definition of proliferative responses 
to hormone and/or drug treatment.
While the majority of studies employ the same basic organ 
culture technique, there is marked individual variability in 
experimental procedure which is often not adequately documented 
or fully justified. In chemically-defined organ cultures of 
young adult rat ventral prostate, the pattern of the proliferative 
response to stimulation with an optimal concentration of 
testosterone is characterized by a lag phase of approximately 
48 hours, followed by a peak of DNA synthetic activity on day 4 
and a decline thereafter*, despite the continued presence of 
testosterone. However*, variations in organ culture methodology 
and experimental procedure have been shown to modify the pattern 
and magnitude of this response. Moreover, the characteristic 
pattern of the response, itself, clearly demonstrates the 
difficulty in comparing results when different time points have 
been used to evaluate hormone or drug effects. Inherent 
differences in the various lobes of the rat prostatic complex 
may also be responsible for differences in the pattern of 
proliferative activity in'vitro. While the ventral prostate 
is the most frequently studied lobe, widespread variation in 
the age of this tissue must be taken into consideration when 
attempting to compare proliferative responses. Furthermore, 
despite similarities between rat ventral and human prostate 
with regard to the mechanism of action of androgens, this lobe 
of the rat prostate is not necessarily the most representative
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of the human prostate nor the most suitable for studying the 
action of mstramustinm compounds since it contains a high 
concmnaoatifn of msaoahusaine-binding protein. Thus, differences 
between the resentt results and other pubis^^ data may be 
explained, at llast in part, by variations in exmo^hmeatbt 
conditions. In addition, histological criteria, the most 
common method used to assess the effects of hormones and drugs 
on pofsaaalc tissue in vitro, renders comparisons difficult 
because of the inherent subjectivity of this technique. In - 
contrast, quantitative organ culture, using the iiil-UdR 
labelling technique, permits both DNA synthesis and the 
histological response to be evaluated in the same tissue sample. 
This advantage is of particular importance with regard to 
studies of the human prostate, where tissue is available only 
in limited quantities.
The emphasis placed on variations in culture media and 
methodology is not intended to discourage the use of organ 
culture but, rather, to stress the need for caution in the 
interpretation of results, particularly in comparing results 
between different experimental systems, unless the techniques 
are carefully co-ordinated. Clearly, organ culture technology 
has been refined to the point whereby the system can be used 
to obtain valuable insight into parameters governing the 
properties of prostatic tissue. Nevertheless, it is evident 
that further research and standardization is necessary before 
organ culture can be used with maximum efficacy within the 
intrinsic limitations of the system. Yet, despite,a lack of 
uniformity in technique, extensive organ culture studies of 
rat ventral pofsaaam have repeatedly shown that the effects 
of androgens on d^^re^ation and proliferation mimic that of 
the prostate in vivo. Thus, rat ventral prfsaate in
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quantitative organ culture represents a particularly useful 
in vitro model for studying the direct actions of testosterone 
and its metabolites in a controlled and easily reproducible 
environment. This technique also allows investigation of 
interactions between other hormonal and non-hormonal factors 
which may influence the growth and/or function of prostate 
in vivo. Furthermore, the proliferative response of rat ventral 
prostate to testosterone stimulation in organ culture provides 
another approach for investigating the antiproliferative action 
of hormones and chemotherapeutic agents which may be of potential 
value in the treatment of prostatic cancer. In addition, the 
experience obtained from investigations of rat prostate in organ 
culture provides a valuable reference for the interpretation of 
hormonal and drug responses and a foundation for the further 
application of this technique to human prostatic tissue.
In contrast to -the extensive investigations conducted on 
rat ventral prostate in organ culture, to date - comparatively 
little has been achieved in prostate cell culture research, 
as techniques for the isolation of purified populations of 
viable prostatic epithelial cells have only recently become 
available. While the epithelial origin and the ability of these 
cells to proliferate in vitro has been demonstrated, a critical 
characterization of this experimental system must be undertaken 
before it can be used for studies of cell-growth, differentiation 
and carcinogenesis. It is imperative that not only morphological 
characteristics of cells in culture be documented as epithelial 
and similar to their jn vivo counterparts, but that they be 
shown to retain normal hormonal dependency. Nevertheless, in 
vitro model systems of prostatic epithelium will undoubtedly 
augment jn vivo and organ culture studies of hormone responses
of individual cell types. Moreover, this system appears
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promising for studies on epithelial and stromal interactions 
in the prostate as well as for screening chemotherapeutic 
agents and investigating the role of cell aging in prostatic
carcinogenesis* Thus, the use of both cell and organ culture 
models may provide concepts and techniques that will increase 
the understanding of the biology of normal, benign and 
malignant prostate cells.
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